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 Abstract 
 
A disproportionate number of African American women are at increased risk for uterine 
fibroid tumors (UF) compared to their Caucasian, Asian, and Hispanic counterparts. 
Researchers have indicated that women diagnosed with UF can have a poorer health-
related quality of life (HRQOL) when compared to women who do not have a diagnosis 
of UF. The overall aim of this study was to explore the impact of UF symptoms on the 
HRQOL of African American women. A quantitative, cross-sectional design was 
employed utilizing the revised version of Wilson and Cleary’s model of HRQOL. A 
sample was gathered of 80 participants who were African American women between age 
30 and 45 years with a current diagnosis of UF. Linear and multiple hierarchical 
regressions were performed to determine the relationship among UF symptom severity 
and HRQOL based on 6 subscales of HRQOL (as measured by the UFS-QOL). There 
was a statistically significant association between symptom severity, the 6 subscale 
variables of HRQOL, and employment. No significant associations were observed with 
age, family history (hx) of UF diagnosis, body mass index, general health perception, 
overall quality of life, and symptom severity. The social change implication for this study 
is to provide information that can direct health care providers in the development of 
health maintenance programs that are sensitive to the needs of African American women 
diagnosed with UF. In addition it will promote the need for public health professionals 
and medical organizations to increase the availability of information related to UF 
symptoms and the impact of UF symptoms on HRQOL among women.  
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Chapter 1: Introduction 
Introduction 
Uterine leiomyomas or uterine fibroid (UF) tumors are reported to be one of the 
most common forms of tumors for women in the United States (Davis et al., 2009; Flake, 
Andersen, & Dixon, 2003) and identified as the fifth most commonly diagnosed 
gynecological condition for women of reproductive age (Faerstein, Szklo, & Rosenshein, 
2001; Office of Research on Women’s Health [ORWH], 2006). In addition, researchers 
have identified UF as the leading indication for hysterectomies among African American 
and Caucasian women in the United States (Flynn, Jamison, Datta, & Myers, 2006; 
National Institutes of Health [NIH], 2006). Moorehead and Conrad (2001) found that the 
rates of UF diagnoses among African American women were higher when compared with 
women from all other racial backgrounds. As of 2011, African American women were 
diagnosed up to three to nine times more often when compared to Caucasian women 
(NIH, 2011). More specifically, African American women are identified as a “high risk” 
population for developing UFs (Wise, Palmer, Stewart, & Rosenberg, 2005b). Not only 
are African American women more likely to be diagnosed with UF compared to 
Caucasian women, African American women are diagnosed with UF at earlier ages 
(Davis et al., 2009; Wise et al., 2005b), have more tumors, and experience more 
symptomatic tumors at the time of diagnosis (Davis et al., 2009; Hyuck et al., 2008; 
Kjerulff, Lagenberg, & Sieden,1996). Current research findings reflect a disproportionate 
number of African American women are diagnosed with and are treated for UF (Davis et 
al., 2009; NIH, 2011; ORWH, 2006; Wise et al., 2005b). There is a disparity in the 
number of African American women who are diagnosed with UF, the age at which 
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African American women are diagnosed, and the symptoms that are experienced by 
African American women when compared to their racial counterparts. Therefore, there 
was a need for more investigation into how UFs are affecting African American women.  
 It is important to note that not all women diagnosed with UF experience 
symptoms. The NIH (2006) stated many women do not know they have UF, implying the 
prevalence of UF may be more than what has been reported in the past. Mauskopf, Flynn, 
Thieda, Spalding, and Duchane (2005) reported that although a smaller percentage of 
women in the United States are diagnosed with UF when compared to other 
gynecological disorders, 35% to 50% of those women diagnosed seek treatment because 
of the symptoms associated with UF. Women diagnosed with UF who experience 
prominent symptoms often seek treatment because of the difficulty they encounter with 
managing the symptoms effectively and the negative burden UF symptoms can have on 
health-related quality of life (HRQOL).  
HealthRelated Quality of Life 
 HRQOL is a multidimensional, dynamic concept that encompasses the physical, 
social, and psychological aspects associated with a particular disease or treatment 
(Ferrans, Zerwic, Wilbur, & Lawson, 2005; Williams, Jones, Mauskopf, Spalding, & 
Duchane, 2006). The term HRQOL is often used interchangeably with the term quality of 
life within research (Ferrans et al., 2005), suggesting that the two terms are synonymous. 
Although quality of life is generally used to describe an individual’s sense of happiness 
or satisfaction with life (Ferrans & Powers, 1992), HRQOL describes the effects of 
health, illness, and treatment on overall quality of life or simply the impact of disease on 
important areas of an individual’s life (Ferrans et al., 2005; Kimmel, 2000; Phillips, 
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Davies, & White, 2001). In the past, researchers such as Lerner and Levine (1994) 
implied that HRQOL refers to a group of health consequences that interfer with an 
individual’s ability to complete usual daily activities. However, more recently researchers 
have expanded their view of the concept to include the impact of health on the functional 
status, psychological status, overall well-being, and social functioning of an individual 
(Huget, Kaplan, & Feeny, 2008; Jakobsoon & Hallberg, 2006; Kaplan, 2003). For the 
purpose of this study, HRQOL referred to the impact of UF symptoms on important areas 
of an individual’s life, health, functional status, psychological, social functioning, and 
overall well-being. 
The impact of UF symptoms on the HRQOL of women suggests this chronic 
condition can lead to a number of challenging social, physical, and emotional health 
concerns. Compared with women who have similar gynecological disorders (chronic 
pelvic pain, heavy bleeding, and urinary incontinence), women with UF experience a 
poorer HRQOL—socially, physically, and emotionally (Spies et al., 2002; Williams et 
al., 2006). More specifically, studies have indicated that problems related to:  
1) limitations in social life, 
2) anxiety related to inability to predict the onset of menses,  
3) loss of ability to control breakthrough bleeding, leading to embarrassment, 
4) loss of control in planning for future and social activities, 
5) uncertainty about treatments options being able to preserve fertility,  
6) feeling a loss of control in overall health, and  
7) complaints of fatigue and feelings of depression, 
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were identified among women with UF as factors that impact HRQOL (Borah, 
Nicholson, Bradley, & Stewart, 2013; Popovic et al., 2009; Spies et al., 2002; Spies et 
al., 2004). Women diagnosed with a debilitating health condition like UF can have many 
important areas of HRQOL and overall life affected. 
 The progression of UF symptoms is likely to increase throughout a woman’s 
reproductive lifetime (Hartman et al., 2006). Borah et al. (2013) investigated the impact 
of UF on the lives of a racially-mixed group of women age 29 to 59 years in the United 
States. The researchers reported that 51% of the study participants, women who were 
age 40 to 49 years, admitted that their UF “made them feel not in control of life” (p. 
319.e3) as compared to only 11% of those women aged 50 to 59 years. Vines, Ta, and 
Esserman (2010) suggested the presence and progression of symptomatic UF can lead to 
an overall decline in HRQOL and general quality of life in women by “affecting work 
and social activities because of pain and heavy bleeding; and leading to mental distress 
related to the management of the disease symptoms” (p. 5). The symptoms associated 
with UF can negatively influence the HRQOL of women diagnosed—socially, 
physically, and emotionally—when compared to those women who do not have UF 
(Spies et al., 2002; Williams et al., 2006). The overall physical and emotional well-
being, health, social, and functional status of women with UF is impacted negatively. 
Furthermore, it is evident that among African American women, the negative influence 
of UF on their lives and health is increased because they have been shown to have a 
greater risk for diagnosis and experience more problems associated with UF when 
compared to their Caucasian and Asian counterparts. Therefore, exploring the symptoms 
associated with UF and the impact of UF symptoms on HRQOL (functional status, 
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psychosocial well-being, and overall general health) is important to those African 
American women who have been diagnosed with this health issue.  
 Research on risk factors associated with UF and how they influence the health 
and lives of women diagnosed have received more attention within the past 5 to 10 years. 
However, according to Taran, Brown, and Stewart (2010), there has been limited 
reporting of the participants’ race and ethnicity within the studies associated with UF. 
The researchers found among the studies published from 2000 to 2006, approximately 
75% of those studies did not report the participants’ race, and of those remaining studies 
African American women only represented 15% of the sample population. The Black 
Women’s Health Study (BWHS), one of the largest follow- up studies exclusively among 
African American women ages 21 to 69 years conducted in the United States, released 
several UF studies (Wise et al., 2004, 2005a, 2005b; Wise, Radin, Palmer, Kumanyika, & 
Rosenberg, 2010). According to Taran et al. (2010), the BWHS studies were among the 
few that clearly identified the race of their study participants exclusively as African 
American. The studies from the BWHS researchers and Taran et al. (2010) suggests that 
clear reporting of the participants’ race and ethnicity has an important role in UF 
research. More importantly, the need to focus UF studies specifically among women in 
the African American community will help the research community better understand 
why the racial disparity exists among African American women who have been 
diagnosed and treated for UF when compared to their counterparts.  
 This chapter provides an overall review of UF, symptoms associated with a UF 
diagnosis, prevalence of UF among African American women, and the impact UF 
symptoms have on HRQOL among African American women diagnosed with UF. In 
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addition,  the study’s theoretical framework along with a summary of the study’s research 
questions, hypotheses, and overall research approach are included. Last, this chapter 
provides a highlight of the study’s significance and social change implication. 
Background of the Problem 
What Are Fibroids? 
UF tumors are diagnosed in women during routine yearly physical or radiological 
examinations (Evans, 2008; Evans & Brunsell, 2007). The tumors described as lumps or 
growths develop within the wall of the uterus (Evans & Brunsell, 2007). The location of 
the UF tumors can vary within the uterus. Moorehead and Conrad (2001) reported that 
the location of UF tumors occur inside the uterine wall (intramural), in the abdominal 
cavity (subserosal), or in the uterine cavity (sub mucosal). The number of UF tumors 
present in one uterus can range from one single UF tumor up to as many as 20 or more, 
varying in size, with some being so small they are undetectable by means of a physical 
exam (Moorehead & Conrad, 2001; Trivedi & Abreo, 2009).  UF tumors primarily form 
during the reproductive years of women and resolve with the onset of menopause (Evans 
& Brunsell, 2007). Trivedi and Abreo (2009) reported that UF are usually benign and are 
associated with a low mortality rate among women diagnosed in the United States. 
Although researchers are still actively investigating the exact cause(s) for the increased 
prevalence of UF diagnoses, increased symptoms, and growth rates among African 
American women, diet, family history, weight gain, hormonal and estrogen levels are 
some of the preliminary factors that have been associated (Evans & Brunsell, 2007; 
Huyck et al., 2008; Schwartz et al., 2000; Wise et al., 2005a).  
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 Fibroids and Age  
 UFs are reported to be common among women of reproductive age in the United 
States. The findings of several research studies reveal that the UFs and the symptoms 
associated with UF impact more women during their reproductive years (Baird, Dunson, 
Hill, Cousins, & Schectman, 2003; Davis et al., 2009; Wise et al., 2005b). Studies 
performed by both Davis et al. (2009) and Wise et al. (2005) revealed that African 
American women between the ages of 25 and 45 years have a statistically significant (p > 
0.001) greater risk of diagnosis of UF when compared to Caucasian women. More 
specifically, in a study completed by the National Institute of Environmental Health 
Sciences, it was reported that by the age of 50 years, more than 80% of African American 
women and about 70% of Caucasian women in the United States would be affected by 
UF (Baird et al., 2003). Researchers have found that African American women have a 
three-fold increased age-adjusted incidence rate and relative risk of fibroid tumor 
diagnosis when compared to women from Caucasian, Hispanic, and Asian backgrounds 
(Baird et al., 2003; Eltoukhi, Modi, Weston, Armstrong, & Stewart, 2013; Marshall et al., 
1997). The average age of diagnosis among African American women with UFs when 
compared to their Caucasian counterparts was 5.3 years younger; African American 
women usually received a diagnosis on average at 40.8 years of age versus a diagnosis at 
45.1 years of age for Caucasian women (Huyck et al., 2008). Researchers have found that 
African American women are diagnosed and treated for symptoms associated with UF 
more often throughout their reproductive lifetime when compared to their counterparts 
from other racial backgrounds (Hartman et al., 2006; NIH, 2011; Wise et al., 2005a, 
2005b). The increased number of UF diagnoses among African American women of 
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reproductive age compared to the diagnosis of UF among their racial counterparts 
suggests this chronic condition has become a public health concern (Eltoukhi et al., 
2013). 
Prevalence and Uterine Fibroids 
 Prevalence rates of UF vary and are difficult to narrow depending upon the 
population examined (U.S. Department of Health and Human Services [U.S. DHHS], 
2011). Feinberg, Larsen, Catherino, Zhang, and Armstrong (2006) found that UF were 
three times more prevalent among African American women (30.8%) when compared to 
Caucasian women (10.7%) in their study. In the United States, prevalence rates for UF 
are estimated primarily based on the annual rate of hysterectomies and myomectomies 
performed. Researchers Flynn et al. (2006) reported that African American women are 
more likely to require surgical treatment (myomectomy and hysterectomy) for treatment 
of UF when compared to Caucasian women. Mauskopf et al. (2005) reported that, of the 
600,000 hysterectomies performed in the United States on an annual basis, 33% to 40% 
are related to treatment for UF among women diagnosed. In addition, reportedly at least 
34,000 myomectomies are performed annually to remove UF among women diagnosed in 
the United States (U.S. DHHS, 2011).  
 Several studies have listed UF as the principal single indicator for hysterectomies 
among women (Flynn et al., 2006; Hartmann et al., 2006; U.S. DHHS, 2011). Keshavarz, 
Hillis, Kieke, and Marchbanks (2002) investigated the trends of hysterectomies 
performed on women in the United States from 1994 to 1999. Their findings 
demonstrated a 17% increase in the rate of hysterectomies performed related to the 
diagnosis of UF among women. More specifically, Keshavarz et al. (2002) found the rate 
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of hysterectomies for African American women with UF between the ages of 40–44 
years was 16.8 per 1,000 women compared to a rate of 10.8 per 1,000 women for 
Caucasian women in the same age group. According to Myers et al. (2002), the 
cumulative risk of a hysterectomy due to UF for all women between the ages of 25–45 
years is 7%. However, for African American women with UF in that same age category, 
the risk of hysterectomy can be as high as 20% (Myers et al., 2002).  
 The healthcare cost associated with treatment of UF can be substantial for those 
women who are diagnosed with this condition. The Agency for Healthcare Research and 
Quality in their Fibroid Registry report noted that in the year 2000 alone, it was estimated 
that, “253,000 hospital admissions (surgical and nonsurgical) with a principal diagnosis 
of uterine fibroids” (U.S. DHHS, 2011, para. 3) resulted in hospital charges of more than 
$2.6 billion (Flynn et al., 2006). Hartmann et al. (2006) found in their study that direct 
costs (out of pocket expenses associated with in- patient hospitalizations, ER visits, out-
patient procedures, and drug cost) and the indirect cost (work absenteeism and disability 
claims) combined were at least 2.6 times higher for women with UF than for women 
without UF. These researchers suggested that increased medical expenses are likely to be 
incurred by African American women who are apt to experience more severe UF 
symptoms when compared to Caucasian women. UF can have a negative financial impact 
on African American women because of the frequency with which surgical interventions 
are performed due to a UF diagnosis (Mauskopf et al., 2005; U.S. DHHS, 2011) along 
with the increased use of health care resources for treatment of UF (Flynn et al., 2006; 
Hartmann et al., 2006). Although there is a low mortality rate among African American 
women diagnosed with UF (Trivedi & Abreo, 2009), the health distresses and financial 
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and physical burdens of treatment that UF can have on the HRQOL of African American 
women is far more relevant. There is a gap in the literature exploring the severity of UF 
symptoms and the impact of UF symptoms on the HRQOL of African American women 
age 30 to 45 years. 
Theoretical Framework 
A revised version of Wilson and Cleary’s 1995 model of HRQOL (Ferrans, 
Zerwic, Wilbur, & Larson, 2005) guided this study (see Figure 1).  
 
Figure 1. Revised Wilson and Cleary’s model of health-related quality of life. 
From “Conceptual model of health-related quality of life” by C. Ferrans, J. Zerwic, J. 
Wilbur, & J. Larson, 2005, Journal of Nursing Scholarship, 37(4), p,338. Reprinted with 
permission. 
 
 The Wilson and Cleary model was designed in part to help delineate the 
difference between the terms quality of life and HRQOL while drawing the focal point of 
research to address the effects of health, illness, and treatment on the overall individual 
(Ferrans et al., 2005). However, Ferrans et al. (2005) noted that the initial model still had 
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some ambiguity associated with the HRQOL model determinants, and additional 
clarification was needed. They suggested that researchers and practitioners needed a 
causal model that would “clearly indicate the elements of HRQOL and their 
determinants” (Ferrans et al., 2005, p. 336). The researchers revised the initial model to 
add more clarification to the elements of HRQOL and clearly delineate how all of the 
determinants of the model are influenced by characteristics of the individual and the 
environment. The revised Wilson and Cleary model of HRQOL (Ferrans et al., 2005) 
expands the original model to include other domains of life experiences, their influences 
on health, and viewing the individual as a whole including the biological, psychological, 
and social aspects of being. Subsequently, the researchers suggested in the revised model 
that all areas in life affect health, and it is important to recognize how all of these factors 
influence HRQOL (Ferrans et al., 2005).  
 Biological function as the first determinant of the model includes the 
physiological processes that support life (Ferrans et al., 2005). According to Wilson and 
Cleary (1995), biological function is a fundamental determinant of health status and the 
model. The focal point of biological function is to examine the performance of cells and 
organ systems and can often be measured through lab tests, physical assessment, and 
medical diagnosis (Ferrans et al., 2005). The researchers believed that changes in an 
individual’s biological function could influence all the subsequent determinants of the 
model, including symptoms, functional status, general health perceptions, and overall 
quality of life.  
 Symptoms, the next model determinant, is described as “a patient’s perception of 
an abnormal physical, emotional, or cognitive state, which can be categorized as physical, 
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psychological, or psychophysical” (Ferrans et al., 2005, p. 339). According to Ferrans et 
al. (2005), at least three common dimensions of symptoms are generally measured in 
testing instruments: frequency, intensity, and distress. Although these are not the only 
common dimensions that can be used to measure symptoms, it is important that 
instruments used for investigating symptoms allow participants to rate or identify their 
personal experiences with symptoms associated with their disease process. Symptoms are 
an important feature to address when investigating HRQOL as they are unique to the 
individual and may differ in persons who are experiencing the same disease process.  
 The next level of the revised Wilson and Cleary model is functional status, which 
assesses the ability of an individual to perform tasks in several areas: physical, social, and 
psychological (Ferrans et al., 2005; Wilson & Cleary, 1995). The need to measure 
functional status as a separate variable is pertinent because researchers have indicated 
that multiple elements of functionality can be assessed with this component (Ferrans et 
al., 2005; Wilson & Cleary, 1995). Specifically, Ferrans et al. (2005) stated that 
exploration of functional status helps to assess and explore how the capacity to perform 
day-to-day activities, physical activity, and specific tasks has been impacted. More 
importantly, the researchers identified functional status as the focus of how individuals 
maximize the abilities and functions that remain and not necessarily the loss of function. 
 General health perceptions follow functional status as the next level of the model. 
At least two characteristics are important to recognize when reviewing general health 
perceptions: 
1) They synthesize all of the components that come before it in the model. 
2) They are subjective in nature. (Ferrans et al., 2005; Wilson & Cleary, 1995) 
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General health perceptions are a separate component of the model that consists of more 
than just combining the preceding concepts (Ferrans et al., 2005). Ferrans et al. suggested 
this component is highly personal, and additional variables such as physiological 
processes should be included when investigating this concept. According to Ferrans et al., 
people commonly contemplate several aspects of their health, lives, and the relevance of 
each when considering their general health. Although general health perceptions are 
described as being complex and individualized in nature, they are most often simply 
measured on a Likert-type scale from poor to excellent using one single global question 
(Ferrans et al., 2005). 
 All of the previous components of the model ultimately influence overall quality 
of life, the last model component (Ferrans et al., 2005). Overall quality of life is 
individualized and subjective, based on how happy or satisfied individuals may be with 
their life in total (Ferrans et al., 2005; Wilson & Cleary, 1995). Overall quality of life is 
based on the individuals’ perception of their own life satisfaction. This component can be 
complex and multidimensional. According to Ferrans et al. (2005), overall quality of life 
or life satisfaction may be dependent upon several factors including perception of 
personal attributes (e.g., personal characteristics, demographic characteristics, optimism, 
or pessimism) and their internal standards (e.g., personal values, expectation levels, and 
personal needs). It is important to note that overall quality of life can be measured using 
one single global question asking individuals to indicate how satisfied they are with life 
in general measured on a Likert-type scale from poorly satisfied to highly satisfied or 
with several questions that investigate satisfaction level in multiple aspects of a person’s 
life (Ferrans et al., 2005) 
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  According to Ferrans et al. (2012), characteristics of the individual and 
characteristics of the environment were included in Wilson and Cleary’s original model 
but required more delineation and clarity. As a result, characteristics of the individual and 
environment were clearly defined and conceptualized to help provide more clarity as to 
how they influence the five components of the model (Bakas et al., 2012). Characteristics 
of the individual in the revised model are described as those biological, demographic, 
developmental, and psychological factors that influence health outcomes (Ferrans et al., 
2005). Biological factors are those characteristics (e.g., skin color, family history of 
genetically linked disease, and body mass index) that may increase or decrease an 
individual’s potential for developing a health condition or medical problem (Ferrans et 
al., 2005). Demographic characteristics of the individual include gender, age, and 
ethnicity and are generally nonmodifiable. Developmental characteristics of the 
individual take into account the level at which a person is able to comprehend, institute, 
change, or modify a behavior (Ferrans et al., 2005). The researchers indicated that 
although this variable is not static, it also “cannot be changed or altered by interventions” 
(Ferrans et al., 2005, p. 337). However, it is important to consider developmental 
characteristics when deciding which types of health interventions will be successful with 
certain populations of individuals (e.g., children versus adults; Ferrans et al., 2005). 
Psychological factors, according to Ferrans et al. (2005), are dynamic, responsive to 
intervention, modifiable, and include cognitive processes that change individual 
perceptions, such as motivation and beliefs.  
 Characteristics of the environment are either physical or social factors that 
influence health outcomes (Ferrans et al., 2005). Ferrans et al. described physical 
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characteristics of the environment as the unique aspects of various communal settings 
that may influence health outcomes, such as an individual’s home, neighborhood, and 
workplace. Social characteristics of the environment are defined as the influence of 
significant others, such as marriage partners, friends, and cultural heritage on health 
behavior and health practices (Ferrans et al., 2005).  
  The revised Wilson and Cleary model has been used to explore HRQOL among 
an array of racial and ethnic populations with varied health conditions, such as heart 
failure, HIV, and breast cancer (Henderson, Martino, Kitamura, Kim, & Erlen, 2012; 
Heo, Moser, Riegel, Hall, & Christman, 2005; Sammarco & Konecny, 2010). For the 
purposes of this study, the revised Wilson and Cleary model of HRQOL (Ferrans et al., 
2005) was used as a guide to obtain empirical evidence from an existing population of 
African American women ages 30–45 years diagnosed with UF. The following 
determinants of the revised Wilson and Cleary model of HRQOL were the focus of this 
research: characteristics of the individual and environment, biological function, 
symptoms, functional status, general health perception, and overall quality of life (see 
Table 1; more details provided in Chapter 2). More specifically, I used the revised model 
to focus the investigation on the following variables: age, family history of UF diagnosis, 
employment, body mass index (BMI), symptom severity, concern, activities, 
energy/mood, control, self-consciousness, sexual function, health perception, life 
satisfaction (see Table 1), and HRQOL. These variables were examined among African 
American women age 30 to 45 years with a diagnosis of UF.  
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Table 1 
Model Components and Related Study Variables 
Model Components Related Study Variables 
Characteristics of the 
Individual 
Self -reported age in years 
Characteristics of the 
Environment 
Family history of UF diagnosis 
Employment 
Biological Function Body Mass Index 
Symptoms Symptom Severity 
Functional Status 
Concern, Activities, Energy/Mood, Control, 
Self- Consciousness, and Sexual function.  
General Health 
Perception 
How would you rate your current health on a 
scale of 1 to 10 (with 1= poor and 10 = 
excellent)?  
Overall Quality of Life 
 How satisfied are you with your overall life 
in general on a scale of 1 to 10 (with 1 = 
poorly satisfied and 10 = very satisfied) 
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 Although African American women aged 30 to 45 years diagnosed with UF may 
be aware of some of the health, social, and physical barriers that occur with symptomatic 
UF, they may have had limited opportunity to identify and articulate how UF symptoms 
are affecting their HRQOL. I utilized participants’ demographic information along with 
the Uterine Fibroid Symptom and Health Related Quality of Life (UFS-QOL) instrument 
to explore UF symptom severity and the impact of UF symptoms on HRQOL among 
African American women age 30 to 45 years who were diagnosed with UF.  
Problem Statement 
The negative impact UF symptoms can have on HRQOL, along with the 
increased propensity for UF development among African American women, and the 
burden of increased usage on healthcare systems for treatment of UF make this chronic 
and progressive health condition a growing public health concern (NIH, 2011; ORWH, 
2006). Data on HRQOL associated with UF show that women with UF have significantly 
lower HRQOL scores when compared to those women without this condition (Pron et al., 
2003; Spies et al., 2002). Researchers have indicated that women diagnosed with UF are 
not only impacted by their experience with the physical symptoms associated with UF, 
but they also expressed feelings of hopelessness, emotional distress, concerns related to 
body image, problems with sexual function, and relationships (Borah et al., 2013). The 
progressive and chronic impact UF can have on HRQOL has lead several researchers to 
suggest that further research in this area is needed (Cambridge & Sealy, 2012; Harding, 
Coyne, Thompson, & Spies, 2008; Hartman et al., 2008; Lerner et al., 2008). Harding et 
al. (2008) implied that more research that focuses on patient-reported outcomes about the 
problems and issues associated with UF symptoms is important for the development of 
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patient-centered care options and to potentially improve patient outcomes. Williams et al. 
(2006) also suggested that continued research that offers details and descriptions of the 
specific areas in health and daily lives of women that are most affected by UF is 
necessary. Exploring the impact of UF symptom severity on the HRQOL of African 
American women provided a unique opportunity to gain a better understanding of the 
personal impact of UF symptoms on overall health and HRQOL and support informed 
decision making among African American women whose lives may be impacted 
adversely by symptomatic UF.  
  African American women have a higher number of UF diagnoses that result in 
increased need for surgical treatments (i.e., hysterectomy and myomectomy) because of 
the symptoms associated with UF compared to Caucasian women (Davis et al., 2009; 
NIH, 2011). More importantly, researchers have also suggested that the presence of 
symptomatic UF can lead to an overall decline in job performance and impact African 
American women negatively both socially and emotionally (Lerner et al., 2008; Vines, 
Ta, & Esserman, 2010). Researchers associated with the BWHS have published studies 
that have addressed risk factors associated with UF diagnosis (Wise et al., 2004, 2005a) 
and environmental factors that may impact UF among African American women (Wise et 
al., 2005b, 2010). Other researchers have investigated and compared risk factors, 
environmental factors, or social factors associated with UF among African American 
women and Caucasian women (Davis et al., 2009; Hartman et al., 2006; Lerner et al., 
2008; Mauskopf et al., 2005; Smith, Upton, Shuster, Klein, & Schwartz, 2004; Vines, Ta, 
& Esserman, 2010). Borah et al. (2013) have investigated the impact of UF on the quality 
of life among a racially diverse group of women age 29 to 59 years. Spies et al. (2002) 
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and Spies et al. (2004) have investigated UF symptoms and factors that affect HRQOL 
among white and black women in their studies. However, none have explored UF 
symptom severity and the impact of UF symptoms on HRQOL among African American 
women age 30 to 45 years. There is a gap in the literature regarding symptom severity 
associated with UF and the impact of UF symptoms on HRQOL among African 
American women aged 30 to 45 years.  
Purpose of the Study 
 The purpose of this study was to explore the severity of symptoms associated with 
UF and the impact of UF symptoms on HRQOL of African American women ages 30 to 
45 diagnosed with UF. The study was designed to aid in determining the relationship of 
specific factors that influence HRQOL among women who have been diagnosed with 
UF. It was also designed to offer these women’s personalized perspective on how their 
lives are being impacted by UF symptoms in order to assist investigators in their 
continued efforts to monitor HRQOL and the impact of issues that influence HRQOL.  
 In this study, the revised Wilson and Cleary model of HRQOL was utilized as the 
foundation to investigate the following factors: BMI, symptoms, functional status, overall 
quality of life, general health perception, characteristics of the individual, and 
characteristics of the environment among African American women age 30 to 45 years 
with a diagnosis of UF. The revised Wilson and Cleary model of HRQOL was used in 
this study to explore HRQOL among African American women who are diagnosed with 
UF. More specifically the determinants of the revised Wilson and Cleary model, was 
utilized to investigate seven distinct UF condition categories: symptom severity, concern, 
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activities, energy/mood, control, self-conscious, and sexual function, based on the UFS-
QOL instrument.    
Research Questions and Hypotheses 
 The following research questions and hypotheses were developed and were used 
in order to explore the severity of UF symptoms and the impact of UF symptoms on 
HRQOL.  
The specific goal of the first six research questions was to examine the association 
between symptom severity and the six HRQOL subscale variables (concern, activities, 
energy/mood, control, self- consciousness, sexual function), as measured by the UFS-
QOL.  
Research Question 1: What is the association between symptom severity, as 
measured by the UFS-QOL instrument, and concern (a dimension of HRQOL) among 
African American women ages 30 to 45 years diagnosed with UF? 
H01: There will not be an association between symptom severity, as measured by 
the UFS-QOL instrument, and concern (a dimension of HRQOL) among African 
American women ages 30 to 45 years diagnosed with UF.  
HA1: There will be an association between symptom severity, as measured by the 
UFS- QOL instrument, and concern (a dimension of HRQOL) among African American 
women age 30 to 45 years diagnosed with UF. 
Data analysis: Linear regression analysis will be used to determine if there is a 
relationship between symptom severity and concern. 
  Dependent variable: Concern (summed score of questions 9, 15, 22, 28, 32 
on the survey). 
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 Independent variable: Symptom Severity (summed score of questions 1-8 on the 
survey) 
 Research Question 2: What is the association between symptom severity, as 
measured by the UFS-QOL instrument, and activities (a dimension of HRQOL) among 
African American women ages 30 to 45 years diagnosed with UF? 
H02: There will not be an association between symptom severity, as measured by 
the UFS-QOL instrument, and activities (a dimension of HRQOL) among African 
American women ages 30 to 45 years diagnosed with UF.  
HA2: There will be an association between symptom severity, as measured by the 
UFS- QOL instrument, and activities (a dimension of HRQOL) among African American 
women age 30 to 45 years diagnosed with UF  
Data analysis: Linear regression analysis will be used to determine if there is a 
relationship between symptom severity and activities. 
Dependent variable: Activities (summed score of questions 10, 11, 13, 19, 20, 27, 
29 on the survey). 
Independent variable: Symptom Severity (summed score of questions 1-8 on the 
survey). 
Research Question 3: What is the association between symptom severity, as 
measured by the UFS-QOL instrument, and energy/mood (a dimension of HRQOL) 
among African American women age 30 to 45 years diagnosed with UF? 
H03: There will not be an association between symptom severity, as measured by 
the UFS-QOL instrument, and energy/mood (a dimension of HRQOL) among African 
American women age 30 to 45 years diagnosed with UF.  
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HA3: There will be an association between symptom severity, as measured by the 
UFS- QOL instrument, and activities (a dimension of HRQOL) among African American 
women age 30 to 45 years diagnosed with UF  
Data analysis: Linear regression analysis will be used to determine if there is a 
relationship between symptom severity and energy/mood. 
Dependent variable: Energy/mood (summed score of questions 12, 17, 23, 24, 25, 
31, 35 on the survey). 
Independent variable: Symptom Severity (summed score of questions 1-8 on the 
survey). 
Research Question 4: What is the association between symptom severity, as 
measured by the UFS-QOL instrument, and control (a dimension of HRQOL) among 
African American women age 30 to 45 years diagnosed with UF? 
H04: There will not be an association between symptom severity, as measured by 
the UFS-QOL instrument, and control (a dimension of HRQOL) among African 
American women age 30 to 45 years diagnosed with UF.  
HA4: There will be an association between symptom severity, as measured by the 
UFS- QOL instrument, and control (a dimension of HRQOL) among African American 
women age 30 to 45 years diagnosed with UF  
Data analysis: Linear regression analysis will be used to determine if there is a 
relationship between symptom severity and control. 
Dependent variable: Control (summed score of questions 14, 16, 26, 30, 34 on the 
survey). 
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Independent variable: Symptom Severity (summed score of questions 1-8 on the 
survey) 
Research Question 5: What is the association between symptom severity, as 
measured by the UFS-QOL instrument, and self-consciousness (a dimension of HRQOL) 
among African American women age 30 to 45 years diagnosed with UF? 
H05: There will not be an association between symptom severity, as measured by 
the UFS-QOL instrument, and self-consciousness (a dimension of HRQOL) among 
African American women age 30 to 45 years diagnosed with UF.  
HA5: There will be an association between symptom severity, as measured by the 
UFS- QOL instrument, and self-consciousness (a dimension of HRQOL) among African 
American women age 30 to 45 years diagnosed with UF  
Data analysis: Linear regression analysis will be used to determine if there is a 
relationship between symptom severity and self-consciousness. 
Dependent variable: Self- Consciousness (summed score of questions 18, 21, 33 
on the survey). 
Independent variable: Symptom Severity (summed score of questions 1-8 on the 
survey). 
Research Question 6: What is the association between symptom severity, as 
measured by the UFS-QOL instrument, and sexual function (a dimension of HRQOL) 
among African American women age 30 to 45 years diagnosed with UF? 
H06: There will not be an association between symptom severity, as measured by 
the UFS-QOL instrument, and sexual function (a dimension of HRQOL) among African 
American women age 30 to 45 years diagnosed with UF.  
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HA6: There will be an association between symptom severity, as measured by the 
UFS- QOL instrument, and sexual function (a dimension of HRQOL) among African 
American women age 30 to 45 years diagnosed with UF  
Data analysis: Linear regression analysis will be used to determine if there is a 
relationship between symptom severity and sexual function. 
Dependent variable: Sexual Function (summed score of questions 36 and 37 on 
the survey). 
Independent variable: Symptom Severity (summed score of questions 1-8 on the 
survey). 
A. The specific goal of Research Question 7 was to examine the associations 
between symptom severity, body mass index (BMI), and overall HRQOL. The specific 
goals of Research Questions 8 and 9 were to examine the associations between symptom 
severity, body mass index (BMI), and overall HRQOL, controlling for three covariables 
(age, family hx of UF, and employment). 
Research Question 7: What is the association between symptom severity as 
measured by the UFS-QOL instrument, BMI, and HRQOL total score as measured by the 
UFS-QOL instrument among African American women ages 30 to 45 years diagnosed 
with UF? 
H07: There will not be an association between symptom severity as measured by 
the UFS-QOL instrument, BMI, and HRQOL total score as measured by the UFS-QOL 
instrument among African American women age 30 to 45 years diagnosed with UF. 
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HA7: There will be an association between symptom severity as measured by the 
UFS-QOL instrument, BMI, and HRQOL total score as measured by the UFS-QOL 
instrument among African American women age 30 to 45 years diagnosed with UF. 
Dependent variable: HRQOL score (sum of 6 subscale scores range 29 to 145)  
Independent variable: Symptom Severity (summed score of questions 1-8 on the 
survey) and BMI =Overall calculated value based on participants height and weight 
(participant’s response to two questions on the DI form: question #2- What is your 
height? and question #3-What is your weight?)  
Research Question 8: When controlling for characteristics of the individual (age) 
what is the association between symptom severity as measured by the UFS-QOL 
instrument, BMI, and HRQOL total score as measured by the UFS-QOL instrument 
among African American women age 30 to 45 years diagnosed with UF? 
 H08: When controlling for characteristics of the individual (age) there will not be 
an association between symptom severity as measured by the UFS-QOL instrument, 
BMI, and HRQOL total score as measured by the UFS-QOL instrument among African 
American women age 30 to 45 years diagnosed with UF. 
 HA8: When controlling for characteristics of the individual(age) there will be an 
association between symptom severity as measured by the UFS-QOL instrument, BMI, 
and HRQOL total score as measured by the UFS-QOL instrument among African 
American women age 30 to 45 years diagnosed with UF.  
Dependent variable: HRQOL score (sum of 6 subscale scores range 29 to 145)  
Independent variable: Symptom Severity (summed score of questions 1-8 on the 
survey) and BMI =Overall calculated value based on participants height and weight 
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(participant’s response to two questions on the DI form: question #2- What is your 
height? and question #3-What is your weight?)  
Covariant Characteristics of the Individual: Age (participant’s response to one 
question about age #1 on the DI form). 
Research Question 9: When controlling for characteristics of the environment 
(family hx of UF diagnosis and employment) what is the association between symptom 
severity as measured by the UFS- QOL instrument, BMI, and HRQOL total score as 
measured by the UFS-QOL instrument among African American women age 30 to 45 
years diagnosed with UF? 
 H09: When controlling for characteristics of the environment (family hx of UF 
diagnosis and employment) there will not be an association between symptom severity as 
measured by the UFS-QOL instrument, BMI and HRQOL total score as measured by the 
UFS-QOL instrument among African American women age 30 to 45 years diagnosed 
with UF. 
 HA9: When controlling for characteristics of the environment (family hx of UF 
diagnosis and employment) there will be an association between symptom severity as 
measured by the UFS-QOL instrument, BMI, and HRQOL total score as measured by the 
UFS-QOL instrument among African American women age 30 to 45 years diagnosed 
with UF. 
Dependent variable: HRQOL score (sum of 6 subscale scores range 29 to 145)  
Independent variable: Symptom Severity (summed score of questions 1-8 on the 
survey) and BMI =Overall calculated value based on participants height and weight 
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(participant’s response to two questions on the DI form: question #2- What is your 
height? and question #3-What is your weight?)  
Covariants Characteristics of the Environment: 
 Family History of UF diagnosis (participant’s response to one family history of 
UF diagnosis question #5 on the DI form) 
 Employment (participant’s response to question # 4 on the DI form: Yes, No, I do 
not know). 
Data analysis (Research Questions 7, 8, 9): Hierarchical multiple regression 
analysis will be used determine if there is a relationship between symptom severity, BMI, 
and HRQOL, when controlling for three co- variables (age, family hx of UF, and 
employment). The variables will be added to the model in three steps. In step one, the 
control variables characteristics of the individual (age), and characteristics of the 
environment (family history of UF diagnosis, and employment) and the dependent 
variable HRQOL score will be added to the model. In step two, the variable symptom 
severity and the dependent variable HRQOL score will be added to the model. In step 
three, the variable BMI will be added to the model, and the dependent variable HRQOL 
score. 
B. The specific goal of Research Question 10, was to examine the association 
between symptoms severity, HRQOL total score, and general health perception. The 
specific goals for Research Questions 11 and 12 was to examine the association between 
symptom severity, HRQOL total score, and general health perception, controlling for 
three co- variables (age, family history of uterine fibroids and employment history). 
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Research Question 10: What is the association between symptom severity as 
measured by the UFS-QOL instrument, HRQOL total score as measured by the UFS-
QOL instrument and general health perception among African American women age 30 
to 45 years diagnosed with UF? 
 H010: There will not be an association between symptom severity as measured by 
the UFS-QOL instrument, HRQOL total score as measured by the UFS-QOL instrument 
and general health perception among African American women age 30 to 45 years 
diagnosed with UF. 
HA10: There will be an association between symptom severity as measured by the 
UFS-QOL instrument, HRQOL total score as measured by the UFS-QOL instrument and 
general health perception among African American women age 30 to 45 years diagnosed 
with UF.  
Dependent variable: General health perception (participants response to one 
global question #7 on the DI form- “How would you rate your current health on a scale 
from 1 to 10 (with 1= poor and 10 = excellent)?”). 
Independent variable: HRQOL score (sum of 6 subscale scores range 29 to 145) 
and Symptom Severity (summed score of questions 1-8 on the survey). 
Research Question 11: When controlling for characteristics of the individual (age) 
does symptom severity as measured by the UFS-QOL instrument, and HRQOL total 
score as measured by the UFS-QOL instrument have an association with general health 
perception among African American women age 30 to 45 years diagnosed with UF? 
H011: When controlling for characteristics of the individual (age), symptom 
severity as measured by the UFS-QOL instrument, and HRQOL total score as measured 
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by the UFS-QOL instrument will not have an association with general health perception 
among African American women age 30 to 45 years diagnosed with UF. 
HA11: When controlling for characteristics of the individual (age), symptom 
severity as measured by the UFS-QOL instrument, and HRQOL total score as measured 
by the UFS-QOL instrument will have an association with general health perception 
among African American women age 30 to 45 years diagnosed with UF. 
Dependent variable: General health perception (participants response to one 
global question #7 on the DI form- “How would you rate your current health on a scale 
from 1 to 10 (with 1= poor and 10 = excellent)?”). 
Independent variable: HRQOL score (sum of 6 subscale scores range 29 to 145) 
and Symptom Severity (summed score of questions 1-8 on the survey). 
Covariant Characteristics of the Individual: Age (participant’s response to one 
question about age #1 on the DI form) 
Research Question 12: When controlling for characteristics of the environment 
(family hx of UF diagnosis and employment) does symptom severity as measured by the 
UFS-QOL instrument, and HRQOL total score as measured by the UFS-QOL instrument 
have an association with general health perception among African American women age 
30 to 45 years diagnosed with UF? 
H012: When controlling for characteristics of the environment (family hx of UF 
diagnosis and employment), symptom severity as measured by the UFS-QOL instrument, 
and HRQOL total score as measured by the UFS-QOL instrument will not have an 
association with general health perception among African American women age 30 to 45 
years diagnosed with UF. 
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Sub HA12: When controlling for characteristics of the environment (family hx of 
UF diagnosis and employment), symptom severity as measured by the UFS-QOL 
instrument, and HRQOL total score as measured by the UFS-QOL instrument will have 
an association with general health perception among African American women age 30 to 
45 years diagnosed with UF. 
Dependent variable: General health perception (participants response to one 
global question #7 on the DI form- “How would you rate your current health on a scale 
from 1 to 10 (with 1= poor and 10 = excellent)?”). 
Independent variable: HRQOL score (sum of 6 subscale scores range 29 to 145) 
and Symptom Severity (summed score of questions 1-8 on the survey). 
Covariants Characteristics of the Environment: 
 Family History of UF diagnosis (participant’s response to one family history of 
UF diagnosis question #5 on the DI form) 
 Employment (participant’s response to question # 4 on the DI form: Yes, No, I do 
not know) 
Data analysis (Research Questions 10, 11, 12): Hierarchical multiple regression 
analysis will be used to determine if there is a relationship between symptom severity, 
HRQOL and general health perception controlling for three co variables (age, family hx 
of UF, and employment). The variables will be added to the model in three steps. In step 
one, the control variables characteristics of the individual (age), and characteristics of the 
environment (family history of UF diagnosis, and employment) and the dependent 
variable general health perception will be added to the model. In step two, the variable 
symptom severity and the dependent variable general health perception will be added to 
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the model. In step three, the variable HRQOL will be added to the model, and the 
dependent variable general health perception. 
 The specific goal of Research Question 13 was to examine the association 
between symptom severity and overall quality of life. 
Research Question 13: What is the association between symptom severity as 
measured by the UFS-QOL instrument and overall quality of life among African 
American women age 30 to 45 years diagnosed with UF? 
H013: There will not be an association between symptom severity as measured by 
the UFS-QOL instrument and overall quality of life among African American women age 
30 to 45 years diagnosed with UF. 
HA13: There will be an association between symptom severity as measured by the 
UFS-QOL instrument and perception of overall quality of life among African American 
women age 30 to 45 years diagnosed with UF. 
Data analysis: Linear regression analysis will be used to determine if there is a 
relationship between symptoms severity and overall quality of life among African 
American women age 30 to 45 years diagnosed with UF. 
Dependent variable: Overall quality of life (response to one global question #8 on 
the DI form- ‘How satisfied are you with your overall life in general on a scale from 1 to 
10 (with 1 = poorly satisfied and 10 = very satisfied)?”) 
Independent variable: Symptom Severity (summed score of questions 1-8 on the 
survey). 
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Nature of the Study 
 In this study, the severity and impact of UF symptoms on HRQOL of African 
American women age 30 and 45 years diagnosed with UF was explored. The exploratory, 
nonexperimental, quantitative research method was chosen for this study. This method 
was suitable for this study because none of the independent variables (symptom severity, 
BMI, HRQOL, age, and family history of UF diagnosis) were able to be ethically 
manipulated.  
 The aim of the study was to investigate the perspective of African American 
women’s experiences with UF symptoms and their impact on HRQOL utilizing the 
Wilson and Cleary revised model of HRQOL. I investigated seven UF condition- specific 
categories: symptom severity, concern, activities, energy/mood, control, self- 
consciousness, and sexual function, based on the UFS-QOL survey. A more detailed 
presentation of the methodological process for this study is presented in Chapter 3. 
 The sampling frame for this study included African American women who are 
affiliated with two graduate chapters of Delta Sigma Theta Sorority, Inc.—Marietta-
Roswell Alumnae (MRACDST) located in Cobb County and Stone Mountain Lithonia 
Alumnae (SMLACDST) located in DeKalb County. Additionally, women who are 
affiliated with Run Girl Run (RGR), a running group for African American women in 
Atlanta, received an invitation to participate in the study. The combined membership of 
SMLACDST, MRACDST, and RGR totals approximately 1,600 women. Based on a 
G*Power analysis of Faul, Erdfelder, Buchner, and Lang (2009), an anticipated sample 
size of 92 study participants was required. The invitation for participation was sent to the 
organizations’ leadership teams via e-mail to distribute to the members and affiliates of 
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their organizations. African American women who have a current diagnosis of UF, are 
between the ages of 30 and 45 years, have never received treatment in the form of a 
myomectomy, hysterectomy ,or uterine artery embolization, and are members or affiliates 
of the identified organizations were asked to participate in the study.  
Operational Definitions of Terms 
 The following terms are defined as they are used in this study. 
 African American women: Any women of African heritage (African American, 
descendants of Africans); throughout this research the terms African American and 
Blacks are interchangeable and mutually inclusive. 
 Hysterectomy: Invasive surgical procedure that removes the uterus leaving 
women with the inability to get pregnant/conceive (Evans & Brunsell, 2007). 
 Myomectomy: Invasive surgical procedure to remove/excise uterine fibroids 
tumors from the uterus that leaves the uterus intact for conception (Evans & Brunsell, 
2007).  
 Uterine artery embolization: Procedure designed to cut the blood supply to UF 
tumors, causing them to shrink (Wolanske & Gordon, 2004). 
Assumptions, Limitations, and Delimitations 
 Two assumptions provided the basis for this research. In this study, it was 
assumed that HRQOL exists as a multidimensional construct, and that abstract and 
unobservable constructs, such as symptom severity and health perception among African 
American women age 30 to 45 years with a diagnosis of UF, can be quantified and tested 
by the UFS-QOL survey instrument. In this study, it was also assumed that African 
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American women age 30 to 45 years with a diagnosis of UF will accurately and honestly 
answer questions that measure the concepts of interest in this study.  
The inclusion of only African American women between the ages of 30 and 45 
years limits the findings from being generalized to the entire African American female 
population, or to other racial or ethnic groups. Another limitation of the study is that 
biological function as a study construct was self-reported by study participants as I had 
no access to participants’ personal medical healthcare records. The revised theoretical 
model characteristics of the individual are comprised of four focus areas: psychological, 
development, biological, and demographic. Biological characteristics of the individual 
such as diet (D’Aloisio, Baird, DeRoo, & Sandler, 2010; Radan, Palmer, Rosenberg, 
Kumanyika, & Wise, 2010; Villarosa, 2003), obesity (Flake, Anderson, & Dixon, 2006; 
Parazzi et al., 2004; Trivedi & Abreo, 2009), and estrogen level (Dixon et al., 2006; 
Flake et al., 2006) are reported to have an association with UF. However, access to 
participants’ medical records was unavailable to me as the researcher and was required in 
order to ascertain information related to a diagnosis associated with these biological 
characteristics of the individual. In addition, inquiries into the participants’ dietary habits 
were outside of the focus area of the study and the study survey instrument. 
Developmental characteristics of the individual focus on the individuals’ intellectual 
capacity to change or modify behavior, while psychological characteristics of the 
individual center on the different types of motivation for starting and maintaining certain 
behaviors (Ferrans et al., 2005). To date, no developmental studies investigating an 
individual’s intellectual capacity for behavior change related to UF have been published, 
and psychological factors associated with the need for and ability to sustain behavior 
35 
 
change related to UF was outside the scope of this research. Therefore, as a study 
delimitation, characteristics of the invidual only included the following biological and 
demographic factors: family history of UF, sex, age, and race. Also the developmental 
factors of the characteritics of the indvidual (participants intellectual capacity to 
participate in the study) was delimited to and addressed as a part of the eligibility criteria 
for participation in this study (see Chapter 3).  
An additional limitation of the study was that questionnaires that are self-
reporting present difficulties in accuracy of response and recall. Participants may also 
experience some level of discomfort with providing information about medical history in 
the questionnaires. The last limitation of this study was that the researcher used a 
convenience sample in which participants were recruited because they were accessible to 
the researcher based on their affiliation with RGR, MRACDST, and SMLACDST.  
UFs affect many women, but there is a higher prevalence among African 
American women of child- bearing age compared with women of other races (Davis et 
al., 2009; Wise et al., 2005b). A delimitation of this study was that the participants were 
only African American women who had a current diagnosis of UF, and age 30 to 45 
years. Another delimitation of this study was to focus on women who had not received 
medical treatment in the form of a hysterectomy, myomectomy, or UFE for the 
alleviation of UF tumors or the symptoms associated with UF. The aforementioned study 
delimitation was important to note because the questions on the UFS-QOL instrument are 
UF-condition specific and based upon participants having the presence of UFs at the time 
of completion of the survey (Coyne et al., 2012). 
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Significance of Study 
 The symptoms associated with UF can be debilitating for women. Women who 
have been diagnosed with UF face a myriad of issues related to how to effectively 
address the UF symptoms, minimize financial burden, and limit interruption in their 
lifestyle. According to Davis et al. (2009), African American women diagnosed with UF 
typically have more than one UF tumor, a variety of symptoms, and more prominent 
health problems related to the diagnosis. As the role of African American women 
continues to evolve in the work force, community, and in the home, the troubles of 
lengthy recovery times and extended leaves from work associated with the symptoms or 
medical treatment of UF no longer appear to be a functionally or financially conducive 
option. The ability of African American women to continue leading active and 
meaningful lives while addressing the problems associated with UF and UF symptoms 
depends on the impact of this chronic condition to their HRQOL. In this study, data 
obtained from participants’ demographic history along with the UFS-QOL instrument 
were used to explore UF symptom severity and the impact of UF symptoms on HRQOL 
among African American women age 30 to 45 years who are diagnosed with UF. The 
following variables based on the revised Wilson and Cleary model of HRQOL were used 
to guide this research: age, family history of UF diagnosis, employment, BMI, symptom 
severity, concern, control, activities, self-consciousness, sexual function, energy/mood, 
general health perception, and overall quality of life, with more details provided in 
Chapter 3. 
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Social Change 
 Research suggests problematic UF has had a negative impact on various areas of 
HRQOL and lead to increased distress on health and life of African American women 
who are diagnosed with this condition (Cabness, 2010; Cambridge & Sealy, 2012; Lerner 
et al., 2008; Popovic et al., 2009; Spies et al., 2002). Specifically, researchers have found 
a number of UF symptoms have been associated with poorer job performance, high levels 
of stress, increased need for surgical intervention, and limited social interaction among 
African American women diagnosed with UF (Lerner et al., 2008; Mauskopf et al., 2005; 
Smith et al., 2004; Spies et al., 2002, 2004; Vines, Ta, & Esserman, 2010). The social 
change implication of exploring personal health factors associated with UF and their 
specific impact on HRQOL is key in supporting health care providers in the development 
of health maintenance programs that can aid African American women with 
implementing improved symptom management and potentially enhancing HRQOL. The 
availability of information related to UF symptoms and impact of UF symptoms on 
HRQOL may help decrease adverse outcomes associated with UF and positively support 
the continued well-being of African American women diagnosed.  
Summary 
UFs are a medical condition with widespread symptoms that occur among women 
of all races. The Office of Research on Women’s Health (2006) indicated that 20–25% of 
all women in the United States of reproductive age have symptomatic UF. However, 
African American women are likely to be diagnosed up to three times more when 
compared to their Euro American, Asian, and Hispanic counterparts (Moorehead & 
Conrad, 2001; NIH, 2011). Researchers have identified that UF symptoms and the 
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problems associated with UF symptoms can affect the HRQOL among women 
diagnosed. The impact of UF symptoms on the HRQOL of African American women 
ages 30 to 45 years diagnosed with UF requires further attention. This study investigated 
the experiences among African American women diagnosed with UF ages 30 to 45 years 
regarding symptom severity associated with UF and impact of UF symptoms on HRQOL. 
This study explored these variables using the revised Wilson and Cleary model of 
HRQOL as a theoretical guide.  
Chapter 1 offered an overview of UF and its impact on the HRQOL of women. 
Chapter 1 also provided the basis for the importance of the research with an overview of 
current research. Literature relevant to the purpose of the research is presented in Chapter 
2. In Chapter 3, I discuss the selected methodology in this study, including sampling 
procedures, research procedures, and sample characteristics. Details on the reliability and 
validity of the instruments used in the study are also discussed in Chapter 3. In Chapter 4, 
the results of the research study and the analysis used in this study are outlined. In 
Chapter 5, I will communicate the summary, possible implications, conclusion and 
recommendation(s) for further research. 
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Chapter 2: Review of Literature 
Introduction 
 This chapter includes a review and analysis of relevant literature that pertain to 
African American women and UF. The methodologies implemented in previous research 
studies and those utilized in this dissertation are also reviewed. The review begins with 
correlates that have been associated with UF risk factors and HRQOL, UF treatment, and 
financial implications, then moves to the revised Wilson and Cleary model of HRQOL 
that guided the study, and narrows with measures that have been used to investigate 
HRQOL among women with UF. The social change construct and its relevance to the 
impact of UF on HRQOL among African American women are also reviewed. Because 
the prevalence of UF is high among African American women and their HRQOL is being 
impacted, further investigation into the burden and impact of UF symptoms is warranted. 
The following literature review will support these variables as well as summarize 
previous and current research findings. This chapter will also identify topic areas that 
require further investigation and review in future research. 
 I identified information for use in this literature review by searching for peer-
reviewed journal articles, scholarly books, electronic dissertations, and published 
manuscripts dated from 1988–2015. I sought to identify only relevant studies and sources 
for this research project, regardless of date. The seminal literature sources utilized for this 
research project relate to information specific to the participating sorority-community 
service organization (Giddings, 1988), the theoretical framework (Ferrans & Powers, 
1992; Leidy, 1994; Lerner & Levine, 1994; Wilson & Cleary, 1995), and UF (Kjerulff, 
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Lagenberg, & Sieden, 1996; Marshall et al., 1997), as these factors are central variables 
in this research project. The primary search engines utilized were EBSCO databases of 
Academic Search Premier, CINAHL PLUS, MEDLINE, SociIndex, PsychINFO, and 
PsycArticles. An array of key search terms (African American, Black, women, uterine 
fibroids, uterine leiomyomata, health related quality of life, quality of life, symptoms, 
hysterectomy, myomectomy, hospital, treatment, risk factors, impact of uterine fibroids) 
were used to narrow and focus the search for relevant research literature.  
Women, Uterine Fibroid Risk Factors, Symptoms,  
and Health-Related Quality of Life 
The etiological factors associated with a diagnosis of UF continue to be 
investigated. It has been difficult for researchers to narrow the cause to any one specific 
factor. Researchers have identified the following as having an increased risk for diagnosis 
of UF: dietary practices (D’ Aloisio, Baird, DeRoo, & Sandler, 2010; Radan, et al., 2010; 
Villarosa, 2003), hormone and estrogen levels (Dixon et al., 2006; Flake, Anderson, & 
Dixon, 2006), and obesity or weight gain (Faerstein, Szklo, & Rosenshein, 2001; Parazzi 
et al., 2004; Trivedi & Abreo, 2009; Wise et al., 2005a). Approximately 60% of African 
Americans reportedly do not engage in the recommended amount of exercise (Centers for 
Disease Control and Prevention [CDC], 2007). Many African Americans report dietary 
practices that are high in fat and lacking in fruit, vegetables, and whole grains (Felton, 
Boyd, Bartoces, & Tavakoli, 2002). It is important to note that obesity, weight gain, and 
dietary practices have consistently been noted as risk factors among African American 
women with a diagnosis of UF. 
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Modifiable Uterine Fibroid Risk Factors   
 Diet. Dietary practices may influence the risks associated with a diagnosis of UF 
(D’ Aloisio et al., 2010; Radin et al., 2010; Trivedo & Abreo, 2009). Radin et al. (2010) 
found that foods that raise an individual’s blood glucose concentration have been 
associated with an overall risk of development of UF among younger women. Trivedi 
and Abreo (2009) also reported that women who had vegetarian or primarily fish-eating 
diets were three times less likely to have UF when measured against women who were 
primarily red-meat eaters. The study findings of D’ Aloisio et al. (2010) suggest that soy 
based food products may increase the risk of fibroid development among women due to 
the high concentrations of estrogenic isoflavones. In a study of dietary practices of Black 
women, Wise et al. (2010) reported that eating foods high in fat content and lower in 
dairy products were inversely associated with UF risk among Black women who were 
symptomatic.  
 Estrogen/hormones. The exact role and influence of hormonal and estrogen 
levels in the development of UF continues to be explored. However, some researchers 
have found that hormonal and estrogen levels in women have an influence on the 
development of UF tumors (Evans, 2008; Radin et al., 2010; Wise et al., 2005a). 
According to Flake et al. (2003), dietary practices can also have an impact on the 
stimulation of estrogen metabolism in premenopausal women. The researchers indicated 
that diets that are high in fiber and low in fat may be a contributing factor in reducing 
serum estrogen. Baird et al. (2006) found that Black women who exercised at least 4 
hours per week had lower circulating sex hormones (estrogen), and insulin levels were 
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found to have a slower onset of UF development. It is important to note that the problems 
associated with UF development tend to decline with the onset of menopause in Black 
and White women suggesting that the growth of UF tumors are sensitive to the sex 
hormones estrogen and progesterone (Stewart, 2001).  
Obesity or weight gain. Not only has obesity been shown to have an association 
with increased risk for diagnosis of UF, but weight gain has also been reported to have an 
association. Flake et al. (2003) reported an association between an elevated BMI or 
obesity and the presence of UF particularly among women in the United States. 
According to Van Voorhis (2009), weight gain among African American women was 
associated with the existence of UF. In a retrospective study conducted by Trivedi and 
Abreo (2009), 2,540 cases of UF diagnosis over a 14-year period among women ages 23–
51 years were reviewed for pre-disposing factors associated with UF occurrence among 
women. The researchers found an 18% increase in the incidence rate of UF occurrence 
for every 10-kg rise in weight among women in their study population. The researchers 
suggest that an association exists between UF diagnosis and higher BMI. According to 
Wise et al. (2005a), weight gain had a positive risk association with UF among parous 
African American women only in the Black Women’s Health Study. The researchers also 
found premenopausal African American women with a BMI between 20.0–22.4 
demonstrated an association with increased risk of UF when compared to those with a 
BMI less than 20.0.  
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Nonmodifiable Uterine Fibroid Risk Factors 
  Age. Studies demonstrate that African American women are more likely to 
develop UF at an earlier age, have more than one UF tumor, have UF tumors that are 
larger, and experience more severe symptoms compared to women of other races (Evans 
& Brunsell, 2007; Flake et al., 2003; Huyck et al., 2008; Kjerulff, Lagenberg, & Sieden, 
1996). Study findings by Peddada et al. (2008) indicated the rate at which UF tumors 
grow are similar for both African American and Caucasian women under the age 35; 
however, as women get older, the growth rate declines for Caucasian women, but 
increases for African American women. Davis et al. (2009) conducted a 4-year study 
between 2001 and 2004 investigating UF growth, symptoms, and clinical outcomes 
among African American and Caucasian women ranging in age from 20 to 54 years. The 
researchers found that African American women in the following age categories had the 
highest percentage of UF diagnosis: 30–34 years, 29%; 35–39 years, 22%; and 40–44 
years, 29%. In addition, they found that 80% of African American women versus 69% of 
Caucasian women in the study population with UF were between the ages of 30 and 44 
years. The Black Women’s Health Study (Wise et al., 2005b) also reported a peak age of 
diagnosis for UF among African American women to be 40 to 45 years.  
 Race. Davis et al. (2009) also found that 90% of the women in their study, both 
African American and Caucasian, reported having more than one UF tumor and 
approximately 33% had more than 10 UF tumors. However, the researchers also found, 
despite the increased number of UF tumors reported by both African American and 
Caucasian women, the African American women in their study population still had a 
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statistically significant (p = 0.004) higher number of diagnoses of UF in comparison to 
the Caucasian women (Davis et al., 2009). Research indicates African American women 
are at greater risk for development of UF when compared to Caucasian and Asian women 
(Davis et al., 2009; Moorehead & Conrad, 2001; ORWH, 2006). Hyuck et al. (2008) 
found that the Black participants in their study population reported increased symptoms 
of menstrual pain and fewer days between menstrual cycles when compared to the White 
participants.  
 Family history. Studies specifically examining the relationship between family 
history of UF and UF development are limited; however, some researchers have found a 
correlation between the two factors. Schwartz et al. (2000) found that participants in their 
study population who had a mother or sister with a diagnosis of UF were 33.2% more 
likely to have UF when compared to the control group who did not have relatives with 
UF. Peddada et al. (2008) reported study findings that women in their study population 
with an identical twin sister were observed to have a risk for earlier onset of UF 
development when compared to women who did not have an identical twin. Studies 
among African American women with UF have also found that family history of UF has 
some correlation to UF development and symptom severity. Hyuck et al. (2008) reported 
African American women with a family history of UF diagnosis expressed increased 
severity of UF symptoms when compared to Caucasian women.  
Uterine Fibroids Symptoms and Health Related Quality of Life 
 The symptoms associated with UF can lead to negative health consequences for 
diagnosed women. In addition, UF tumors cause an array of burdensome health problems 
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which can negatively impact HRQOL including excessive menstrual bleeding, painful 
cramping, frequent urination, lower back pain, spot bleeding in between periods, and 
painful sexual intercourse (Evans, 2008; Fennessy, Kong, Tampany, & Swan, 2011; 
Villarosa, 2003). Exploration into the views of African American women diagnosed with 
UF on how UF symptoms are impacting their health and HRQOL was conducted by  
Cabness (2010) who found that 60% of the women in her study admitted that symptoms 
associated with UF was a factor involved in their thought process prior to selection of 
medical intervention. The researcher suggested that the perception of symptom severity 
caused by UF among African American women with UF plays a fundamental role in 
determining the type of medical treatment they will select. 
 Some of the more problematic physical symptoms associated with the presence of 
UF have led to miscarriages and even resulted in the loss of the uterus for some women 
(Moorehead & Conrad, 2001; Williams et al., 2006). The aforementioned is of significant 
import because a diagnosis of UF can make the ability to have children difficult if not 
impossible and potentially cause a negative effect on HRQOL for some women in their 
reproductive years. The NIH (2011) indicated that African American women were less 
successful in positive reproductive treatment outcomes and more likely to have UF when 
compared to their Caucasian counterparts among the category of women who were 
pursuing treatment for reproductive health problems. Researchers have demonstrated that 
UF can negatively affect the reproductive health of African American women 
(Moorehead & Conrad, 2001; NIH, 2011; Williams et al., 2006) and that there is a need 
48 
 
 
to further understand the unique experiences that occur among African American women 
diagnosed with UF who are of reproductive age. 
 Symptoms. The symptoms associated with UF can have a direct bearing on the 
functional ability, emotional state, work performance outcomes, and self-perception of 
health in women diagnosed (Cote, Jacobs, & Cumming, 2003; Downes et al., 2010; 
Lerner et al., 2008; Spies et al., 2002). Lerner et al. (2008) found among women with UF, 
reports of more difficulty managing physical and interpersonal job tasks, increased at-
work productivity loss, increased fatigue, and difficulty concentrating were consistently 
higher among African American women compared to Caucasian women in their study 
population. Using data from a multicenter clinical trial in Ontario, researchers Pron et al. 
(2003) found of the 85% of the women with UF who were working in their study 
population, almost half had work absences related to symptoms associated with uterine 
fibroids. Downes et al. (2010) conducted an analysis of 1,756 women in five European 
(France, Germany, Italy, Spain, and United Kingdom) countries diagnosed with or 
experiencing UF related symptoms. Their study findings demonstrated a loss in work 
productivity by 36% and a 37.9% decrease was noted in the general activity level for 
women with UF compared to women without UF in their study population.  
 Problems with bloating, pain, feeling of fullness and heaviness in the abdomen, 
bleeding that may interfere with sexual function and cause uncontrolled soaking of 
clothing, bleeding that inhibits some social and physical activities are common among 
women with UF (Spies et al., 2004). Moreover, researchers have demonstrated that some 
of the aforementioned problems interfere with and limit the important roles women are 
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able to play in their family, community, and workplace (Cambridge & Seally, 2012; 
Lerner et al., 2008; Spies et al., 2004). Researchers indicated UF are the most common 
benign tumors in women of child bearing age, and many women commonly experience 
physical problems with abnormal and excessive bleeding, urinary and bowel problems, 
and severe pelvic pain, along with other impediments such as limited physical and social 
activity, and fatigue (Kjerulff et al., 1996; Walker & Stewart, 2005). Spies et al. (2002) 
also reviewed several reoccurring themes among women related to UF symptoms. The 
authors found that physical symptoms such as pelvic pressure, back and pelvic pain, 
fatigue, and break through bleeding often were identified as problematic issues among 
women with UF. Multiple researchers have found increased fatigue, depressive 
symptoms, difficulty concentrating, and feelings of anxiety are commonly reported 
concerns among African American women with UF (Cabness, 2010; Lerner et al., 2008; 
Popovic et al., 2009). Symptoms such as breakthrough and untimely bleeding, pelvic 
pain, cramping, and frequent urination have been identified as a concern among African 
American women with UF and supported by research as having a negative impact on 
HRQOL.  
 Health related quality of life. When reviewing UF and symptoms associated 
with UF development, the varied ways in which HRQOL is affected is important. Evans 
(2008) found that many women strive to understand “safer and more natural approaches” 
(p. 31) to UF development and symptom prevention, in order to minimize the impact of 
UF on HRQOL. Fennessy et al. (2011) suggested that HRQOL factors such as motivation 
for later childbearing and shorter recovery time may be reasons why women are 
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increasingly seeking “minimally invasive” (p. 786) treatment options for UF. Side effects 
associated with UF (bleeding, pain, and bulkiness) along with women’s desire to avoid 
surgical interventions that may negate their ability to remain childbearing are some of the 
factors identified by Evans (2008). Indeed, concerns related to invasive treatment options, 
reproductive health outcomes, and symptom management, among others, can shape 
perceptions of how HRQOL is being affected by UF and support reasons why African 
American women desire to become more knowledgeable about UF influencing factors. 
Vines, Ta, and Esserman (2010) reported that African American women with 
elevated levels of stress had a modest association with the presence of UF when 
compared with Caucasian women in their study population. Feelings of increased anxiety 
related to insecurity and shame of breakthrough bleeding prevented African American 
women with UF from attending social events were reported in one study (Cabness, 2010). 
More specifically, Lerner et al. (2008) found feelings of depression (fatigue and difficulty 
concentrating) were consistently higher among African American women with UF 
compared to African American women without UF among their study population. The 
emotional burden of high stress levels and increased anxiety found to be associated with 
the presence of symptomatic UF among African American women can potentially have a 
negative influence their HRQOL. 
      Zimmerman et al. (2012) found among women with UF in their study population, that 
work performance, sexual function, family, and relationships, were some of the important 
life dynamics that were negatively impacted by problems associated with UF. Spies et al. 
(2002) found other life dynamics such as concern over inability to control bleeding, 
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concern or fear of soiling clothes, and decreased level of energy to participate in activities 
were frequently identified as quality of life issues among women. The researchers also 
found that of the six HRQOL variables (concern, activities, energy/mood, control, self- 
conscious, sexual function) associated with UF, Black and White women identified, 
concern (soiling cloth, soiling bed linens, inability to predict onset of periods), and 
control (ability to participate in social activities, productivity, overall health) as two of 
the highest problem areas.  
      Aiding African American women’s understanding of the problems associated with 
UF symptoms can influence decisions related to health treatment options and symptom 
management. Ankem (2007) investigated the information seeking behavior among 28 
women aged 20 to 58 years diagnosed with symptomatic UF. The demographic 
breakdown of the study population was 81.6 % African American, 12.3% Caucasian, and 
the remaining 6.1% were of other ethnicity or racial backgrounds. The researcher noted 
among the women in his study population, “almost all expressed a great need for 
information on diagnosis, treatment and self-care” (Ankem, 2007, p. 167) related to UF. 
Their research findings demonstrate that African American women are seeking to gain 
more insight into options for care and treatment of symptomatic UF.  
 African American women with UF are interested in preserving their ability to 
remain child bearing. Research suggests that African American women with UF are 
actively seeking out information related to UF symptoms and ways they can minimize 
those symptoms from impacting their lives (Ankem, 2007). Therefore, more investigation 
that focuses specifically on patient-reported problems and issues associated with UF 
52 
 
 
symptoms may support health professionals and African American women alike in 
gaining more insight into some of the problems faced by women diagnosed with this 
condition. Studies conducted that have investigated the impact of UF on HRQOL of 
women with UF (Davis et al., 2009; Lerner et al., 2008; Popovic et al., 2009; Spies et al., 
2004) have compared pre and post UF treatment symptom severity and manifestation of 
UF symptoms only as the measure of HRQOL. To date none has explored the impact of 
UF symptoms on the HRQOL of African American women aged 30 to 45 years.  
Uterine Fibroid Treatment and Financial Implications 
      The increased number of UF diagnoses and expanded utilization of health care 
resources for treatment of UF suggests this chronic condition is becoming an increased 
health concern. Problematic UF symptoms often lead African American women to seek 
the advice of health care practitioners and potentially pursue medical intervention. The 
myomectomy, Uterine artery embolization (UAE) or hysterectomy, are the most common 
medical procedures used to treat UF. Evans and Brunsell (2007) reported findings 
indicating 30% of the hysterectomies performed are associated with the “presence of 
uterine fibroid tumors” (p. 1506). Myers et al. (2002) found the cumulative risk of a 
hysterectomy due to uterine fibroids for all women between the ages of 25-45 years is 
7%. However, for African American women in that same age group with UF the risk 
goes up to as high as 20%.  
Uterine Fibroid Treatments 
      Hysterectomy is a treatment method used to impede women from having a 
reoccurrence of UF growth by removing the uterus. However, because the uterus is 
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removed during this procedure women are then prevented from being able to conceive 
children. Increased health concerns related to the symptoms (bleeding, reproductive 
difficulties, pain) associated with UF and the increased number of UF tumors cause 
African American women to be more likely to receive hysterectomies compared to 
Caucasian women (Faerstein et al., 2001; Viswanathan et al., 2007). Myers et al. (2002) 
reported the rate at which hysterectomies are required due to health problems associated 
with UF is up to 20% among African American women compared to 7% among 
Caucasian women. The Agency for Healthcare Research and Quality sponsored a study 
conducted by Viswanathan et al. (2007) which found that 50% of African American 
women, compared with 30% of Caucasian women were likely to require hysterectomies 
because of complications related to UF. Researchers have found the number and size of 
UF tumors are increased among African American women who receive hysterectomies 
compared to Caucasian women (Kjerulff, Lagenberg, & Sieden, 1996; Moorman, 
Leppert, Myers, & Wang, 2013). Subsequently, it is likely that African American women 
who are treated surgically for UF are at increased risk for post-surgical complications 
such as infections and bleeding (Eltoukhi et al., 2013). It is important to note that in spite 
of some of the potential complications associated with the hysterectomy procedure, there 
are additional surgical procedures available to women who want to treat UF that can 
preserve their ability to conceive. 
      The myomectomy procedure is just as surgically invasive as the hysterectomy. 
The most significant difference between the hysterectomy and myomectomy procedures 
is that the latter removes the UF tumors and leaves the uterus intact for women who may 
54 
 
 
want the option of getting pregnant (Evans & Brunsell, 2007; Van Voorhis, 2009). 
Although the UF tumors are surgically removed with the myomectomy procedure, there 
is a strong possibility that the UF tumors can return (Van Voorhis, 2009). While the 
myomectomy supports the ability of women to conceive children, the surgical procedure 
is associated with increased medical cost and greater risk of morbidity (U.S. DHSS, 
2011). Myers et al. (2002) reported that approximately 37,000 myomectomies are 
performed on an annual basis in the United States. This number remains comparable to 
more recent statistics, which indicate that as of 2011 at least 34,000 are performed 
annually in the United States. (U.S. DHSS, 2011). Reducing the burden of treatment and 
providing women with UF the options that support improved health is imperative towards 
positively impacting HRQOL.  
In recent years, research has focused on alternative treatments for UF that are not 
as costly as the hysterectomy or myomectomy procedure. The procedure known as the 
UAE reportedly offers similar relief in symptoms and supports improved HRQOL. UAE 
is the latest method of treatment used to address UF and the symptoms that are associated 
with diagnosis. It was not until the late 1980s that UAE demonstrated a positive response 
in causing UF to shrink and in its effectiveness for controlling the symptoms associated 
with the presence of UF in women (Wolanske & Gordon, 2004). The UAE procedure is 
different from the hysterectomy and the myomectomy in that it does not require being 
operated on under general anesthesia. In this procedure, the blood supply to UF is cut off, 
which causes them to shrink (Beard, 2006; Miller, 2005). Although UAE has been 
demonstrated to be an effective option for UF treatment that allows women to keep their 
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uterus intact and offer shorter recovery times, it is unclear if women will be able to 
successfully conceive and carry a fetus to term after having the procedure (Van Voorhis, 
2009).  
 The emotional and physical burden experienced by women diagnosed with UF 
who have to seek out medical interventions, further suggest that the presence and 
treatment of UF can cause disruption in health and quality of life. According to Dixon et 
al. (2006), more research in the area that focuses on improved symptom management and 
enhanced quality of life is necessary in order to help support continued efforts in the 
development of less invasive treatment strategies and to decrease the negative effect of 
UF on African American women’s reproductive health. Subsequently, in order to assist 
African American women in better understanding how to best approach UF treatment, 
prevention, and improve HRQOL, it is important that the public health community 
continue to review and research the impact of UF on HRQOL for African American 
women with this condition.   
Financial Implications 
      The myomectomy, UAE, and hysterectomy, are the most common medical 
procedures used to treat UF and the symptoms associated with UF (Kershavarz et al., 
2002; NIH, 2011; Pron et al., 2003; U.S. DHHS, 2011). The high number of surgical 
interventions performed due to symptoms associated with UF along with the use of health 
care resources for treatment of UF suggests that UF have a clear financial impact on 
those women diagnosed. The out of pocket care expenditures associated with UF 
treatment are estimated to be approximately $4,624 annually for each woman (Hartmann 
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et al., 2006); this suggests that an economic burden exists for women with UF in the 
United States. The expenses related to drugs used to treat UF, managing the symptoms 
associated with UF (bleeding and pelvic pain), and work loss due to UF symptoms 
present an undue financial burden for these women (Cote, Jacobs, & Cumming, 2002; 
Mauskopf et al., 2005). According to the ORWH (2006), the medical costs associated 
with treatment and management of symptoms of UF are unduly borne by African 
American women due to their increased likelihood to be diagnosed with UF. 
Theoretical Model 
  There are a number of HRQOL models that have been used to investigate the 
interrelationship of concepts related to illness, health, communities, and individuals. 
However, over the past 10 years, three have emerged as the most commonly used models 
of HRQOL that offer a clear, more concise, and less ambiguous framework to guide 
research specific to HRQOL (Bakas et al., 2012).  The three HRQOL models identified 
by researchers Bakas et al. (2012) are the Wilson and Cleary model of HRQOL, the 
World Health Organization International Classification of Functioning Disability and 
Health (WHO ICF), and the Revised Wilson and Cleary model of HRQOL. All three 
models were found to be useful in exploring the causal and reciprocal relationship 
between multiple variables to allow researchers and practitioners to “make sense of real 
world application” (Bakas et al., 2012, p. 4), and brought structure to HRQOL research. 
However, researchers noted that there are some limitations to the WHO-ICF model. The 
WHO-ICF model is restricted in its ability to discriminate between conditions that are 
non-health related, is more applicable for classification and mapping of disease 
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processes, and is not unique to HRQOL research (Bakas et al., 2012; World Health 
Organization [WHO], 2007). The symptoms associated with UF have the potential to 
affect the physical health, functional ability, and emotional health of the women 
diagnosed. Therefore, it is important to have a model that will encompass and explain 
multiple aspects of how UF symptoms can impact HRQOL.  
Original Wilson and Cleary Model of HRQOL 
       The original model developed by Wilson and Cleary is rooted in a disease-based 
framework or model of health-related quality of life (Wilson & Cleary, 1995) to allow 
researchers and healthcare providers the ability to focus on the social, psychological, and 
physical impact of disease on the total being. By integrating two different views of 
health, the biomedical and the social science, Wilson and Cleary (1995) were able to 
focus on understanding relationships between fundamental components of life and health, 
exploring the overall well-being, and functioning of individuals. As a result, the authors 
proposed that the model would focus on five main determinants: biological function, 
symptoms, functional status, general health perceptions and overall quality of life 
(Wilson & Cleary, 1995).  
  In this model, connecting associations between five patient outcome 
measurements (biological function, symptoms, functional status, general health 
perceptions and quality of life) were identified. It is important to note that three of the 
limitations of the original model were that it lacked clarity in identifying causal 
relationships between the model determinants, it was ambiguous in defining the critical 
elements of HRQOL and it contained numerous arrows that were marked with examples 
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(Ferrans et al., 2005). Researchers indicated it was difficult to manage and clearly 
identify relationships between the components of the model because of the examples 
indicated on the arrows (Ferrans et al., 2005).  
The Revised Wilson and Cleary Model of HRQOL 
 The revised Wilson and Cleary model of HRQOL takes into consideration not 
only the original five patient dimensions (biological function, symptoms, functional 
status, general health perceptions, and overall quality of life), but also the impact of 
characteristics of the individual and environment on these dimensions (Ferrans et al., 
2005).  In order to help clarify the impact and streamline the causal relationship between 
all of the model determinants, one of the key changes made in the revised model was to 
address the labels and arrows within the original model. For instance, in the revised 
model, example labels on the arrows were omitted to help streamline causal associations 
between components (Ferrans et. al, 2005). In addition, directional arrows from 
characteristics of the individual and characteristics of the environment were included to 
demonstrate that biological function is influenced by these two elements (Ferrans et al., 
2005). Furthermore, the researchers of the revised model highlighted that the arrows in 
the revised model indicate the “dominant causal associations” (Ferrans et al., 2005, p. 
338) between the model components and the path of the arrows can demonstrate 
reciprocal relationships in the model, but they are not necessarily demonstrated in the 
figure.   
 One of the premises for the revised Wilson and Clearly model of HRQOL is that 
different people with the same condition may experience that condition in different ways 
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based upon their perception of the condition and outside influencing factors. This concept 
is important because an array of health problems and personal concerns have been 
identified among women diagnosed with UF. Some of these issues include increased 
healthcare costs (Cote, Jacobs, & Cummings, 2003; Hartman et al., 2006), functional 
limitations and decreased work performance (Downes et al., 2010; Lerner et al., 2008), 
and constant feelings of fatigue, depression and anxiety (Brolmann & Hurine, 2008; 
Popovic et al., 2009; Spies et al., 2002). Subsequently, in order to gain greater clarity and 
understanding of some of the factors that influence the HRQOL of women who have 
been diagnosed with UF, it is important to further investigate this condition utilizing the 
revised Wilson and Cleary model of HRQOL. The constructs of the revised Wilson and 
Cleary model of HRQOL will be useful in this study because their use will provide a 
broader approach to explore HRQOL among African American women who are 
diagnosed with UF. More specifically, the revised model will be used as the foundation to 
investigate BMI, symptom severity, functional status, quality of life, general health 
perceptions, characteristics of the individual (age), and characteristics of the environment 
(family hx of UF diagnosis and employment) among African American women age 30 to 
45 years with a diagnosis of UF.  
Model Constructs 
 Characteristics of the individual. According to Ferrans et al. (2005), 
characteristics of the individual are identified as factors that influence health outcomes. 
These factors are categorized as demographic, biological, psychological, and 
developmental (Ferrans et al., 2005). While the demographic, biological and 
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developmental characteristics of the individual are usually not modifiable, they do 
provide researchers with relevant information to help determine how and which 
populations should be targeted for health interventions.  
 Demographic factors such as age and race have been linked to increased 
diagnoses of UF among African American women (Davis et al., 2009; NIH, 2011; Wise 
et al., 2005b). In addition, biological factors such as family history of UF does play a role 
in risk for UF diagnosis (Evans & Brunsell, 2007; Schwartz et al., 2000) and increased 
symptomology (Hyuck et al., 2008) among African American women. Therefore, the 
association between age and family history of UF diagnosis will be included as 
characteristics of the individual and will serve as the focus of this research. 
 Developmental characteristics of the individual take into account the level at 
which a person is able to comprehend, institute, change or modify a behavior (Ferrans et 
al., 2005). This variable is not static and is non-modifiable but must be considered when 
considering what population can and should be targeted for interventions designed to 
change or modify behavior (Ferrans et al., 2005). Studies investigating an individual’s 
intellectual capacity for behavior change based on UF symptoms that are unrelated to 
medical treatment have yet to be published. While the focus of this study is not to seek to 
change or modify participants’ behavior, participants’ intellectual capacity and ability to 
articulate how their lives are affected by UF is important. Therefore, developmental 
characteristics of the individual for participants in this study will be addressed utilizing 
the study eligibility criteria by requiring participants to be able to read and understand 
English on at least a 12th grade level. Research specifically related to psychological 
61 
 
 
characteristics of the individual on the ability of individuals to sustain behavior change 
related to UF symptoms is unavailable. It is important to note that the ability to sustain 
behavior change related to UF symptoms and HRQOL is outside the scope of this 
research; therefore, psychological characteristics of the individual will not be included as 
a variable in this study.  
 Characteristics of the environment. Characteristics of the environment are 
either social or physical (Ferrans et al., 2005). According to Ferrans et al. (2005), 
individuals’ cultural heritage plays an important role in how they are affected by their 
social environment. Research suggests that social factors such as a culture of “suffering 
in silence” (Cambridge & Sealy, 2012, p. 21), is widespread among African American 
women diagnosed with UF. Research has identified that “suffering in silence” 
(Cambridge & Sealy, 2012, p. 21) is also common practice among women who 
experience significant problems with UF. Giving voice to women diagnosed with UF is 
important in helping to raise public awareness about some of the health problems 
associated with UF and support the need for further research related to the exact cause of 
this condition among women, particularly African American women. 
 The influence of significant others, such as marriage partners, family, friends and 
other social support systems are also included but not limited to the social characteristics 
of the environment (Ferrans et al., 2005).  Published research relevant to the potential 
relationship or association between social characteristics of the environment such as 
participants’ marital status, family and friend support systems, and other social support 
networks and UF is unavailable and outside the scope of this research. Therefore, the 
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influence of marital status, friends and other social support systems will be excluded as a 
variable in this study.  
 Research indicates that physical factors of the environment such as work and job 
performance can influence HRQOL (Ferrans et al., 2005). Studies have shown that 
decreased work productivity and work loss are pertinent concerns identified by women 
diagnosed with UF and are supported by research as having a negative impact on 
HRQOL (Downes et al., 2010; Lerner et al., 2008; Pron et al., 2003). Cote, Jacobs, and 
Cummings (2002) estimated that costs associated with work loss from symptoms 
associated with UF are around $1,692 annually per woman. Identifying some of the 
unique experiences that occur among women diagnosed with UF particularly African 
American women will help focus attention on the specific concerns of African American 
women who are challenged physically, socially, and emotionally by this chronic 
condition. Therefore, the impact of UF on employment or the need to take time off work 
will be included as the characteristic of the environment variable in this study. 
 Biological function. Biological function is one of the determinants of health 
status and includes the physiological processes that support life (Ferrans et al., 2005; 
Wilson & Cleary, 1995). Biological functions focus on the performance of cells, organ 
systems, and are often measured utilizing lab tests, physical assessments, and medical 
diagnoses (Ferrans et al., 2005; Wilson & Cleary, 1995). Furthermore, alterations in 
biological function can affect all other factors of quality of life such as symptoms, 
functional status and general health perceptions (Ferrans et al., 2005; Wilson & Cleary, 
1995). For example, researchers have found that, among African American women, 
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estrogen level and elevated BMI may increase their risk for developing UF (Faerstein, 
Szklo, & Rosenshein, 2001; Flake, Andersen, & Dixon, 2003). Feelings of anxiety, 
depression, and problems with fatigue are some common physical factors identified 
among African American women with UF. Multiple researchers have found increased 
fatigue, depressive symptoms, difficulty concentrating, and feelings of anxiety are 
commonly reported concerns among African American women with UF (Cabness, 2010; 
Lerner et al., 2008; Popovic et al., 2009). For the purpose of this study, biological 
function will focus on participants BMI. The BMI will be calculated using the CDC 
Adult BMI Calculator tool (CDC, 2013). The participants will self- report their individual 
height and weight using the demographic survey form. Participants’ self- reported height 
and weight will then be loaded into the Adult BMI Calculator tool (CDC, 2013) and their 
corresponding BMI range (underweight, normal, overweight, and obese) will be obtained. 
Estrogen levels as a biological function will be excluded as I will not have access to 
participant’s medical records in order to ascertain this information. 
 Symptoms. According to Figure 1, biological function moves to symptoms, the 
second major determinant of the revised model. According to Wilson and Cleary (1995), 
a symptom may encompass the individual’s perception of any abnormal physical, 
emotional or psychological conditions. Progressive conditions such as symptomatic UF 
generally result in symptoms such as excessive and unpredictable menstrual bleeding, 
pain, abdominal bloating, and frequent urination, which can be distressful for women 
(Evans, 2008; Fennessy et al., 2011; Villarosa, 2003). Zimmerman, Bernuit, Gerlinger, 
Schaefers, and Geppert (2012) reported complaints of pain symptoms, heavy bleeding, 
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sexual-dysfunction, negative impact on relationships, and work performance were 
common among the women with UF who participated in their international study. UF 
symptoms are often individualized and can manifest differently in each individual. 
According to Ferrans et al. (2005), it is important to understand the relationship between 
the physical and emotional symptoms an individual may experience in order to recognize 
how they affect health related quality of life. UF symptom severity will be investigated as 
the symptom component of the theoretical model for this study. Exploring how African 
American women diagnosed with UF evaluate and interpret the severity of UF symptoms 
and the relationship between those UF symptoms and HRQOL, is essential in gaining a 
better understanding of some of the barriers that impede positive HRQOL. 
 Functional status. The third factor of the revised Wilson and Cleary model is 
functional status in which the ability of an individual to perform certain tasks is assessed 
(Ferrans et al., 2005). This multidimensional concept characterizes an individual’s ability 
to perform activities of daily living, fulfilling usual roles, and maintain health and well-
being (Bennett, Steward, Kayser-Jones, & Glasser, 2002; Leidy, 1994). Four domains of 
functioning that are often measured are physical, social, role, and psychological (Wilson 
& Cleary, 1995). Ferrans et al. (2005) in their revised model focused on the effects of a 
health condition on functional status and its impact on daily life. Some of the functional 
limitations expressed by women with UF include but are not limited to: difficulty 
concentrating, depressive symptoms, decreased work performance, and impaired sexual 
function (Cabness, 2010; Lerner et al., 2008; Popovic et al., 2009; Zimmerman et al., 
2012). Multiple researchers have found several functional areas of daily life that have 
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been impacted among women who are diagnosed with UF. Subsequently, for the purpose 
of this study functional status will be investigated in six areas that are often impacted in 
the lives of women with UF based on the UFS-QOL survey instrument (Spies et al., 
2002): concern, activities, energy/mood, control, self-consciousness, and sexual function. 
 General health perceptions. General health perceptions are described as the 
individuals’ overall evaluation of the various aspects of their health, in addition to others 
that may not be depicted by the model (Wilson & Cleary, 1995), and is the next level of 
the revised Wilson and Cleary model. General health perceptions are subjective in nature 
and allow for the individual to: 
1)  summarize all of the aforementioned concepts 
2) place value on the importance of each variable 
3) generate a summation of individual health. 
Ferrans et al. (2005), suggests that general health perceptions can be measured with one 
global rating of health, indicating an overall health rating on a Likert-type scale of poor to 
excellent. Cambridge and Sealy (2012) stated, “…while UF are not as life threatening as 
HIV and cancer, they do affect one’s well-being…” (p. 28). In this study, I will utilize 
one global question based on Ferrans et al. (2005). This question will ask participants to 
rate their current health on a scale of 1 to 10 to examine general health perceptions. It is 
important to evaluate how African American women diagnosed with UF characterize and 
view their overall health. 
 Overall quality of life. All of the aforementioned components of the revised 
Wilson and Cleary model (Ferrans et al., 2005) have an effect on the last component, 
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overall quality of life as a dimension of the total HRQOL model. According to Ferrans et 
al. (2005), overall quality of life is rooted in a person’s sense of well-being that stems 
from satisfaction or dissatisfaction with the areas of life that are important to him or her. 
Indeed, African American women with symptomatic UF are often challenged with 
constant pain, embarrassment, and in some cases limited support systems (Cambridge & 
Sealy, 2012) which can negatively affect their life and sense of well-being. It is important 
to note that the preceding components of the model allow overall quality of life to be 
subjective for each person and allows for individualized perception of illness impact. 
Various researchers have described how UF symptoms have affected the quality of lives 
for women diagnosed in a number of ways. Popovic et al. (2009) reported issues such as 
limitations in social life, loss of control, fatigue, and depression were identified concerns 
among the women with UF in their study population. In addition, other concerns such as 
increased risk for infertility, fatigue, depression, and decreased urinary function because 
of UF development and the symptoms associated with UF have been reported among 
women diagnosed with UF (Brolmann & Hurine, 2008; Moorehead & Conrad, 2001; 
Parazzini et al., 2004; Popovic et al., 2009). Due to the subjective and individualized 
reports of acuity associated with UF symptoms among women diagnosed it is important 
to understand how their personal views of the impact of UF symptoms is shaped by 
various physical, psychological and social attributes of the disease process as suggested 
by Ferrans et al. (2005). Based on Ferrans et al., (2005), I will include one question 
asking participants to rate how satisfied they are with their overall life to serve as the 
overall quality of life measure for this study. 
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Theoretical Model and Other Research Studies 
 Researchers Heo et al. (2005) used the revised Wilson and Cleary model to 
investigate the impact of heart failure diagnosis on HRQOL among their study 
participants. The purpose of their study was to measure the ability of the revised Wilson 
and Cleary model of HRQOL to identify variables that influence HRQOL among patients 
with a heart failure diagnosis. It is important to note that the specific racial makeup of its 
sample population was not identified, but does specify that the sample population was 
only elderly women. The researchers found the revised Wilson and Cleary model of 
HRQOL was useful in predicting an association with health perception and symptom 
status on HRQOL. However, the model was not able to demonstrate a significant 
association among functional status, biological/physiological and overall quality of life 
among participants in their sample population (Heo et al., 2005). Based on the findings of 
the researchers’ some correlation between general health perception and symptoms was 
noted using the revised Wilson and Cleary model; however, the model was limited in 
being able to adequately delineate all of the HRQOL factors associated with persons who 
have complex heart conditions. 
 The revised Wilson and Cleary model of HRQOL was used by Saban et al. (2007) 
to investigate patients’ perspectives and experiences of factors that impacted HRQOL 
among individuals who were undergoing elective lumbar spinal surgery. Their study 
population was composed of participants between 21 and 84 years with a mean age of 
53.4 years.  Over half of their study population (52.6 %) was female and 89.5% were 
White, 8.9% were Black with the remaining percentage classified as American Indian. 
68 
 
 
The study findings demonstrated that the revised Wilson and Cleary model of HRQOL 
was useful in investigating the specific HRQOL factors associated with persons 
undergoing this surgical procedure. The model identified that fatigue, as a biological 
determinant along with other variables remained an issue for the subjects postoperatively. 
Conversely, symptom status, functional status and overall general mood were reportedly 
improved post operatively among the study participants. According to the researchers, 
two of the major limitations to the study were the small sample size and the lack of a 
control comparison group (Saban et al., 2007). This suggests that the revised Wilson and 
Cleary model of HRQOL may be an appropriate model to capture the individuals’ 
perspectives on how their health and life is affected by a progressive medical condition 
like UF prior to treatment. 
 Research suggests that individuals with a positive HIV diagnosis are living longer 
and are likely to experience more co- morbid complications such as liver disease because 
of the antiretroviral medications taken to treat some of the symptoms associated with the 
HIV infection (Henderson et al., 2012). Utilizing the revised Wilson and Cleary model of 
HRQOL to investigate if persons living with HIV and liver disease had a poorer HRQOL 
compared to persons living with only HIV was the focus of the study by Henderson et al. 
(2012). For the comparison and control groups in the study, men represented 67.5 % and 
72.7% respectively of the study population. In addition, it is important to note that 
anywhere from 45% to a little over 50% of the study populations for both groups were 
classified as non-White. The study findings demonstrated that the revised model of 
HRQOL was able to identify race as a strong predictive co-variate linked to symptom 
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status, functional status, and overall general health perceptions. The model also aided 
researchers in determining if symptom status had a direct and significant impact on the 
functional status and overall perception of quality of life among their study participants. 
This information is vital because the revised model was used successfully in determining 
the impact of symptoms on HRQOL of persons with a progressive and chronic condition 
like HIV. Subsequently, the revised model of HRQOL could possibly be used to help 
explore how UF symptoms are impacting the lives of women who are diagnosed with this 
medical condition. 
Measures Used for Assessing Health Related 
Quality of Life and Uterine Fibroids 
Historically, the availability of tools aimed at investigating women’s perceptions 
of the severity of symptoms associated with UF and evaluating the impact on quality of 
life or HRQOL has been minimal. There have been at least three clinical models in recent 
years designed to assess HRQOL measures in women diagnosed with UF according to 
Williams et al. (2006). The three most prominently used instruments identified by 
Williams et al. (2006) are:  
1) Short Form 36 (SF-36) 
2) EuroQol now referred to as the EQ-5D 
3) The Uterine Fibroid Symptom and Health Related Quality of Life (UFS-
QOL).  
According to Williams et al. (2006), the SF-36 and EQ-5D instruments/questionnaires 
were not developed specifically to address HRQOL perceptions in women with UF, but 
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were found useful in being able to assess disease specific measures. Although the SF-36 
and EQ-5D tools in addition to some others were adequate in reviewing symptomology 
associated with UF, they still lacked the capacity to explore the impact of UF and UF 
symptoms on HRQOL, from the patients’ perspective (Spies et al., 2002).   
Created by Spies et al. (2002), the UFS-QOL was designed to investigate the 
impact of UF on HRQOL. This clinical survey instrument was developed specifically to 
address questions regarding the individuals’ personal experiences and feelings as they 
pertain to the impact of UF on HRQOL (Spies et al., 2002). The UFS-QOL is used to 
obtain information on the severity of UF symptoms and six subscales of HRQOL: 
concern, activities, energy or mood, control, self-consciousness, and sexual function 
(Harding et al., 2008; Spies et al., 2002). The subscales aide researchers by:  
1) Providing greater insight into the specific health distresses related to UF 
identified by women diagnosed with the condition.  
2) Reviewing the impact of identified indicators on HRQOL, and  
3) Narrowing the focus on common health and personal concerns related to UF 
diagnosis.  
The UFS-QOL questionnaire has been used in a number of studies related to UF 
research and HRQOL.  Lerner et al. (2008) utilized the UFS-QOL instrument to evaluate 
women’s perception of the impact of UF on their work performance. Smith, Upton, 
Shuster, Klein, and Schartz (2004) successfully utilized the UFS-QOL to investigate 
patient satisfaction on quality of life and HRQOL among women before and after the 
UAE procedure. Spies et al. (2002) the authors of the instrument as well as, Coyne et al. 
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(2012) have successfully utilized the UFS- QOL among Black and White participants and 
identified it as a reliable and valid instrument to measure symptoms and HRQOL in 
women with UF. The UFS-QOL is condition specific and designed specifically to 
investigate the unique experiences among women who are diagnosed with UF (Spies et 
al., 2002). The UFS-QOL instrument provides opportunities for the individual to 
articulate their feelings and experiences with UF symptoms and identify the ways UF is 
specifically impacting their lives. Therefore, the UFS-QOL is considered the most 
appropriate tool to utilize for this study when attempting to explore the impact of UF 
symptoms and HRQOL factors associated with uterine fibroids among African American 
women.  
Summary 
Uterine fibroid research continues to demonstrate that African American women 
are at a greater risk for diagnosis of UF, when compared to their Caucasian and Asian 
counterparts. Moreover, investigation among African American women with UF and UF 
symptoms impact on HRQOL is imperative. There are varying factors being investigated 
as the primary cause of UF development among African American women; however, 
research in the area of UF development and prevention has focused primarily on medical 
treatment.  A significant portion of the research has centered on identifying the most 
efficacious medical treatment options for removal of UF that would decrease the 
extended time of recovery and still allow women of childbearing age the option to keep 
their uterus intact supporting improved quality of life. However, despite increased rates 
of UF diagnoses among African American women, there is limited research on the impact 
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of UF symptom severity on HRQOL among African American women age 30 to 45 years 
utilizing the revised Wilson and Cleary model of HRQOL. Therefore, exploration into 
UF symptom severity and the impact of UF symptoms on HRQOL among African 
American women age 30 to 45 years diagnosed with UF necessitates further 
investigation. 
In Chapter 3, I describe the methodology used in the study. The study 
methodology was designed to explore the impact of UF symptoms on HRQOL among 
African American women and identify HRQOL indicators associated with UF. The 
research design, sampling of the population, instrumentation, disclaimer about the 
protection of participants’ rights, and data analysis were reviewed. 
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Chapter 3: Methodology 
Introduction 
 
In this chapter, the study design that was used for this study, in addition to 
rationale for why this study design and approach were selected, was addressed. This 
included general information regarding the targeted population of interest; sampling and 
data collection protocols; survey instrument used to retrieve data; validity and reliability. 
This section also included data regarding the eligibility criteria for participating in this 
study. Descriptions of the instrument that was used for data collection, the data collection 
process, and the data analysis are also included. In addition, this chapter is comprised of 
information related to the protection of human subjects and maintaining confidentiality 
within this study. 
Research Design 
 The purpose of this study was to explore UF symptom severity and the impact of 
UF symptom on HRQOL among 30 to 45 years old African American women diagnosed 
with UF. The exploratory non- experimental quantitative research method was chosen 
because it provided an in- depth perspective of African American women’s experiences 
with UF and their impact on HRQOL. The primary objective of the study was to obtain 
evidence from an existing population of African American women ages 30 to 45 
diagnosed with UF regarding the symptoms associated with UF and the impact of UF 
symptoms on their HRQOL. This was an exploratory non- experimental quantitative 
study design utilizing a survey instrument. The type of design was selected specifically 
for this study due to the decreased expense and increased efficiency for expedient data 
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collection. The survey was cross- sectional and data was collected electronically. A 
correlational design was used in this study. According to Polit and Beck (2008), a 
correlational design allows the researcher to examine interrelationships and associations 
among dependent variables and the independent variables that cannot be manipulated. 
This approach was suitable for this study because none of the independent variables 
(symptom severity, personal medical history, HRQOL, BMI, age, employment, and 
family hx of UF diagnosis) were able to be logistically or ethically manipulated. The 
cross- sectional design included a sample of African American women with a current 
diagnosis of UF, between 30 and 45 years old who were able to read and understand 
English. Participants of the study electronically self-administered the UFS-QOL 
developed by Spies et al. (2002). 
Target Population 
  In this study, I specifically focused on 30 to 45 year old African American women 
who were currently diagnosed with UF and affiliated with Run Girl Run (RGR) or with 
the graduate chapter sorority, Delta Sigma Theta Sorority (DST), Inc. (community 
service organization) based in Cobb and DeKalb Counties in Georgia. The DST graduate 
chapters were selected because one of the foci of the national and local organization is on 
the physical and mental health for its members, the communities which they serve, and 
racial makeup of the members is primarily African American (Giddings, 1988). The 
emphasis on physical and mental health is a mandate from the organization on a national 
level and has been in place for well over 60 years (Giddings, 1988).  The members of 
Marietta Roswell Alumnae (MRACDST) and Stone Mountain Alumnae (SMLACDST) 
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chapters are comprised of African American women, who were residents of Cobb, North 
Fulton, South Fulton, and DeKalb Counties in the state of Georgia. The RGR 
organization was selected because one of the foci of the organization is to promote 
improved health and a healthy lifestyle among African American women by 
incorporating physical fitness into their lives (personal communication, Jones, N., July 1, 
2013). 
 There are nine graduate DST chapters located throughout Metro Atlanta and its 
surrounding counties. The membership base of the local DST graduate chapters varies 
ranging from approximately 200 to 900 members. The approximately 530 women of the 
MRACDST (personal communication, Pattman, P., September 8, 2012) and 
approximately 854 women of the SMLACDST chapters (personal communication, 
Johnson, T., April 8, 2013) are African American, are early twenties and older, are a 
mixture of married and single women; are all college educated, and are all primarily 
working professionals. The combined membership of the SMLACDST and MRACDST 
chapters totals approximately 1,384 women, which classify the chapters as two of the 
larger graduate chapters of DST located throughout Metro Atlanta and its surrounding 
counties. Information pertaining to the demographic breakdown of the SMLACDST 
membership base is unavailable. However, communication with the chapter’s past 
president revealed that, of the approximate 854 African American women affiliated with 
their chapter, it is estimated that women between the ages of 30 to 45 years reportedly 
represent approximately 50% of the SMLACDST membership base (personal 
communication, Johnson, T., April 8, 2013). According to MRACDST, 73% of the 
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chapters’ membership are between the ages of 25 and 48 years (Marietta Roswell 
Alumnae Chapter, Delta Sigma Theta Sorority, Inc. [MRACDST], 2011). More 
importantly, 60% of the members who responded to the chapter’s survey conducted in 
2009-2010, noted that they had “issues with uterine fibroids” (MRACDST, 2011, para. 2) 
when asked to identify if they had any health concerns. RGR is an organization of 
approximately 200 women who are primarily of African American and between the age 
of 30 and 50 years (personal communication, Jones, N., July 1, 2013). 
 Approximately 1,600 African American women in total were accessible for this 
research project based on their affiliation with at least one of the three organizations. 
Prevalence rates for UF in the United States are estimated primarily based on the annual 
rate of hysterectomies and myomectomies performed (DHHS, 2011), which make it 
difficult to narrow the exact number of women that are currently diagnosed with UF. The 
ORWH (2006) indicated that 20-25% of all women in the United States of reproductive 
age have UF. However, the NIH (2011) reported that African American women were 
diagnosed with UF between three and nine times more often when compared to 
Caucasian women. Therefore, it was reasonable to estimate that at least 30% to 33% of 
all African American women or at least one in three African American women have a 
current diagnosis of UF. Therefore, it was justifiable to expect that at least 30% or 528 
women of the 1600 women in the target population size will have a current UF diagnosis. 
Representatives for all three participating organizations reported approximately 50% to 
70% of their membership base are between the ages of 30 and 45 years, which is the age 
requirement for this study. I estimated approximately 40% or 212 women of the expected 
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target population size of 528 would be ineligible to participate in the project due to their 
age. Therefore, justification for an estimated target population size of 316 women (who 
met the age criteria of 30 to 45 years and had a current diagnosis of UF) to be eligible to 
participate in the study project was appropriate.  
 Sample Size.  The primary model was examined using linear and hierarchical 
multiple regressions. The appropriate a priori sample size for this study was determined 
using G*Power analysis Faul et al. (2009). A total of 92 subjects has 80% power to detect 
a medium effect size f2 equal to 0.15 with 5 predictor variables at a significance of 0.05. 
The effect size is estimated from the findings of Ward and Heidrich (2009) who indicated 
that a medium effect size was adequate to examine group differences in beliefs, coping, 
and perceived stigma among African American ages 25-85 years, utilizing an 
exploratory, cross-section survey design. The model tested whether the independent 
variables (UF symptom severity, BMI, HRQOL, age, and family hx of UF diagnosis) 
predict the dependent/criterion variables (concern, activities, energy/mood, control, self-
conscious, sexual function, general health perception, and overall quality of life).  
Eligibility Criteria 
      In order to participate in this study, the inclusion criteria were:  
1) African American women aged 30 to 45 years,  
2) current diagnosis of UF, 
3) able to give informed consent, 
4)  the ability to read and understand English at a 12th grade level, 
5) have access to internet and able to answer electronic survey, and 
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6) no surgical interventions for UF.  
The exclusion criteria for this study were those African American women who were: 
 1) Over the age of 45 or younger than 30,  
 2) who have been treated for UF with the following surgical procedures 
 (Hysterectomy, Myomectomy, and UFE), 
 3) who do not have a current diagnosis of UF,  
 4) unable to read and understand English at a 12th grade level,  
5) no access to the internet and unable to answer electronic survey. 
The average age of diagnosis among Black women with UF when compared to their 
White counterparts was 5.3 years younger, 40.8 years of age for Black women versus 
45.1 years of age for White women (Huyck et al., 2008).  More recently, Davis et al. 
(2009) reported that Black women in the following age categories had the highest 
percentage of UF diagnosis: 30-34 years 29%; 35-39 years 22% and 40-44 years 29% 
when compared to white women in their study population. Because UF tumors are 
generally noted to form during the reproductive years of women and resolve with the 
onset of menopause (Evans & Brunsell, 2007), for the purpose of this study, women 
ages 30 to 45 only were included.                                                                   
Instruments 
      The Uterine Fibroid Symptom and Health Related Quality of Life (UFS-QOL) 
designed by Spies et al. (2002) to explore perception of symptom severity and the impact 
of UF symptoms on HRQOL was used for this study. Consent was obtained from 
Carolyn Strain, Director of the Society of Interventional Radiology (SIR) Foundation to 
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utilize the instrument for this study (Appendix F). This clinical survey instrument was 
developed specifically to address questions related to the impact of UF symptoms on 
HRQOL matters among women diagnosed with UF (Spies et al., 2002). The UFS-QOL 
seeks to obtain information related to UF symptom severity and HRQOL along six 
subscales of categories from women who are diagnosed: concern, activities, 
energy/mood, control, self-consciousness, and sexual function (Harding et al., 2008; 
Spies et al., 2002). The 37- item survey instrument was used to assess the severity of 
symptoms among African American women with UF and impact UF symptoms on 
HRQOL. The UFS- QOL survey questionnaire is based on a 5- point Likert scale, in 
order to ensure consistency in the participant responses.  
 The survey is divided into two sections: symptom severity and HRQOL. The first 
eight questions of the survey are the symptom severity section of the survey. These 
questions use a 5- point Likert-type scale ranging from 1 (not at all) to 5 (a very great 
deal) for this project. The data obtained from this scale are at the ordinal level. The 
participants received points based upon their response as indicated: 1 point for not at all, 
2 points for a little bit, 3 points for somewhat, 4 points for a great deal and 5 points for a 
very great deal.  This section has eight questions total; therefore, scores for this section 
ranged from 8 to 40 (with scores closer to 40 reflecting greater perceived symptom 
severity) (Spies et al., 2002). According to Spies et al. (2002) the developers of the UFS-
QOL instrument, section one of the survey was successful in discriminating between 
levels of symptom severity among women diagnosed with UF, supporting its ability and 
usefulness to investigate UF symptom severity from an individual perspective. 
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Researchers Harding et al. (2008) also found the UFS-QOL instrument was useful in 
investigating severity of UF symptoms among women diagnosed with UF.  
 Section 2 of the survey evaluates the impact of factors associated with HRQOL 
and consists of 27 questions. This section is broken down into six subsections: concern 
(Questions 9, 15, 22, 28, 32), activities (Questions 10, 11, 13, 19, 20, 27, 29), 
energy/mood (Questions 12, 17, 23, 24, 25, 31, 35), control (Questions 14, 16, 26, 30, 
34), self-conscious (Questions, 18, 21, 33), and sexual function (Questions 36 and 37). 
The subscales are used to assess feelings and experiences regarding the impact of uterine 
fibroids symptoms on various areas of each participant’s life. These questions use a 5 
point Likert scale ranging from 1 (none of the time) to 5 (all of the time) for this project. 
The data obtained from this scale are at the ordinal level. The participants received points 
based upon their response as indicated: 1 point for none of the time, 2 points for a little 
bit of the time, 3 points for some of the time, 4 points for most of the time and 5 points 
for all of the time.   
 The HRQOL total score is the sum of the item values from each of the six 
subscales. The subscale for concern has a total of 5 questions; therefore scores for this 
section ranged from 5 to 25. The subscale for activities has a total of 7 questions; 
therefore scores for this section ranged from 7 to 35. The subscale for energy/mood has a 
total of 7 questions; therefore scores for this section ranged from 7 to 35. The subscale 
for control has a total of 5 questions; therefore scores for this section ranged from 5 to 25. 
The subscale for self-conscious has a total of 3 questions, therefore scores for this section 
ranged from 3 to 15. The subscale for sexual function has a total of 2 questions; therefore 
81 
 
 
scores for this section ranged from 2 to 10. Therefore, the combined raw scores from 
each subscale represented the total score for HRQOL section and ranged from 29 to 145 
(with scores closer to 145 reflecting greater impact on health related quality of life). The 
UFS-QOL has established reliability and validity with a subscale Cronbach’s alpha range 
from 0.83 to 0.95 with the overall health related quality of life score alpha =0.97 and test-
retest interclass reliabilities correlation coefficients of 0.76 to 0.93 (Spies et al., 2002). 
 The Screening information (SI) form (see appendix B) consisted of questions that 
were used for screening purposes for this project. The SI form had four screening 
questions to ensure that only women who meet the inclusion criteria were allowed to take 
the survey. The Demographic Information (DI) form (see appendix C), had a total of 
eight questions. The first six questions were used to obtain information about each 
participant’s employment or time missed from work, height, weight, family history of 
diagnosis of UF, and age.  The next two questions were designed to measure general 
health perceptions and overall quality of life. The question to measure general health 
perceptions was: “How would you rate your current health on a scale from 1 to 10 with 
1= poor and 10 = excellent?” as suggested by Ferrans et al. (2005). The last question on 
the DI form, measured overall quality of life, was: “How satisfied are you with your 
overall life in general on a scale from 1 to 10 with 1 = poorly satisfied and 10 = very 
satisfied?” as indicated by Ferrans et al. (2005).  
Protection of Human Subjects 
      In this study, I worked diligently to keep information confidential by adhering to the 
Health Insurance Portability and Accountability Act (HIPAA) guidelines and maintaining 
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participants’ anonymity with description and survey data.  Institutional review board 
(IRB) approval from Walden University was obtained prior to conducting research in 
order to ensure that participants’ rights and safety are met and maintained in accordance 
with the University’s identified standards. Participants in this study were assured of the 
confidentiality involved in this research process. Demographic information collected was 
not to be divulged in relation to participation in this study. There were no personal 
identifiers listed on the survey tool. The survey databases were secured in a locked file 
cabinet area in the researcher’s home for complete confidentiality. This research study 
was voluntary and all participants had the right to refuse to participate in the study at any 
time. Participants were asked to review a consent form prior to beginning the study. Upon 
review of the consent form participants were made aware that by accessing the survey 
link they would be providing their consent to participate in the study project. 
Subsequently, I did not collect paper consent forms from the study participants. However, 
participants were able to print and save a personal copy of the consent form for future 
reference, if so desired.  
Data Collection Procedures 
      A convenience sampling method was utilized from the women who volunteered to be 
a part of the study because subjects were accessible through the identified organizations. 
The processes involved in the research study was as follows: following IRB approval to 
conduct research, the leadership teams of RGR, MRACDST, and SMLACDST were 
contacted via email to request dissemination of the survey link to their members and 
affiliates.  
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  Participants were recruited from members of MRACDST, SMLACDST and 
women affiliated with RGR. A contact person from each of the leadership teams of 
MRACDST, SMLACDST, and RGR was identified. The identified contact person(s) for 
each organization placed an informational announcement in the organizations’ weekly 
announcement bulletins to explain the study and seek participants. The announcement 
introduced me to the members of both DST chapters and women of RGR. The 
announcement also highlighted information about the study and the criteria for 
participation, which required participants to be African American women, aged 30 to 45, 
with a current diagnosis of UF, able to give informed consent, able to read and 
understand English, no history of surgical treatment for UF, have access to the internet, 
and able to answer an electronic survey. Potential participants were asked to go online by 
accessing the identified web link to an established web based system (Survey Monkey) to 
review the consent form, SI form, DI form, and the survey. An electronic version of the 
Walden University consent (see Appendix A) form was used in the database for 
participants to review and with a detailed statement that the participant have informally 
consented to be in the study by completing the SI form and all subsequent survey forms 
thereafter. Study participants were prompted to review the consent form prior to 
participation in the study in order to ensure that all participants understood that 
participation in the study was voluntary. More importantly, it also indicated that they are 
not required to participate in the study because of their membership or affiliation with the 
participating organizations. Participants were made aware that they had the right to 
discontinue the study at any time. No identification markers were used. Contact 
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information for the researcher was made available electronically to the participants upon 
entry into the web based survey to provide an opportunity for participants to address any 
questions related to the survey content.  
Upon entry to the web based survey link, participants were prompted to review a 
set of instructions outlining procedures for completing the SI Form, DI form, and UFS-
QOL survey electronically in order to maintain a standardized method of survey 
completion. The set of instructions made participants aware that all information obtained 
in the SI form, DI form, and UFS-QOL survey was confidential and those forms 
instructed them not to include self-identifying information. Because the topic of this 
study required some information of a private nature, it was extremely important to 
maintain participant comfort and confidentiality while minimizing the potential for 
participant embarrassment and reluctance to participate. Participants were prompted 
initially to complete the SI form in order to ensure they meet all of the inclusion criteria 
for participation in the study. Those study participants who did not meet the inclusion 
criteria after completion of the SI form were instructed to stop and were not allowed to 
proceed with completion of the DI form or UFS-QOL survey instrument.  
 After completion of the SI form, those participants who did meet the study 
inclusion criteria were prompted to move forward with completion of the DI form and the 
UFS-QOL 37- item survey instrument as best they can. All study participants were 
instructed to answer questions based upon their current level of understanding and 
familiarity of the subject content. Once participants complete the DI form and UFS-QOL 
survey they were prompted to submit the completed form and survey electronically.  
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Participants were provided with the number and name of a local mental health resource to 
follow up should they become distressed after completion of the survey and desire to seek 
professional assistance; however, this was not an expected reaction.  
I selected an established web based system (Survey Monkey) to aide in 
transferring the testing instruments, screening information and demographic form on line. 
Emails were sent to MRACDST, SMLACDST, and RGR with a request for them to 
distribute directly to their members and affiliates the survey information. The survey 
information included the identified survey web link which asked individuals to complete 
the survey electronically in order to maximize access to all potential participants. 
Utilizing the electronic data collection method afforded this researcher the opportunity to 
administer the survey to multiple parties, offered the ease of being able to take the survey 
at a time that is convenient for the participants, supported participants’ confidentiality, 
and was cost effective.  I believe that the electronic survey method was the most 
advantageous for this study project. Moreover, because the topic of this study was of a 
private nature, it was extremely important for me to maintain participant comfort and 
confidentiality while minimizing the potential for participant embarrassment and 
reluctance to participate. Therefore, the electronic survey process was selected because of 
the need to limit participant bias, maximize access to the entire participant pool, and 
administration of one survey questionnaire was potentially more effective for the 
participants.  
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Data Analysis 
      Initially, the data were checked and verified with the electronic data files to ensure 
accuracy for data entry. The data were then examined for data inaccuracies such as 
abnormal data entry (e.g. survey response > 5) and missing survey response values. After 
review and verification of the data using an excel spreadsheet, survey entries that were 
noted to contain inadequate and missing data were systematically excluded from the data 
analysis.  
 There were two phases to data analysis, descriptive and inferential. In the first 
phase of the analyses, descriptive statistics were used to determine means and the 
standard deviation to describe the continuous variable (age). Frequency and percent was 
used to describe the responses to the survey items. For the second phase of the analyses, 
regression was used to answer the research questions and determine if there was a 
relationship between the identified variables (BMI, symptoms, functional status, general 
health perception, and HRQOL). Statistics software, SPSS version 20.0 for Windows was 
used for all statistical analysis (IBM SPSS Inc., 2011). A p value less than 0.05 was 
considered significant. 
Assumptions for Linear Regression 
1. The relationship between the dependent variable (DV) and independent variable 
(IV) is linear. This assumption was tested by examining the scatter plot. If the plot 
of the data points falls in a line or at least oval or oblong shape the assumption of 
a linear relationship was supported. 
87 
 
 
2. Homoscedasticity (the errors have the same variance; Leech, Barrett, & Morgan, 
2005). This assumption was tested by examining the plots of the standardized 
residuals against the predicted values. If the plots are approximately rectangle 
around the middle y = 0 line, the assumption of homoscedasticity was supported. 
3. The errors are independent of each other: Durbin-Watson Statistic was used to test 
this assumption.  The value of the Durbin-Watson statistic ranges from 0 to 4 
(Leech, Barrett, & Morgan, 2005). As a general rule of thumb, the residuals are 
not correlated if the Durbin-Watson statistic is approximately 2 (an acceptable 
range is 1.50 - 2.50; Leech, Barrett, & Morgan, 2005). If the Durbin-Watson 
statistic falls in this range, the assumption that the errors are independent was 
supported. 
4. The errors or residual are normally distributed residuals: This assumption was 
tested using the Shapiro-Wilk test of studentized residuals. If the p-value of the 
Shapiro-Wilk statistics was greater than .05 the assumption that the errors are 
normally distributed was supported (Leech, Barrett, & Morgan, 2005).  
Assumptions for Multiple Regressions 
 The assumptions for linear regression also apply to multiple regressions and will 
be tested as indicated above. 
 Of most concern with multiple regressions is multicollinearity. This is not an 
assumption as such, but is of concern when conducting multiple regression analyses. 
High inter-correlation among the IVs can result in multicollinearity. Multicollinearity 
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results in unstable equation coefficients. The following steps were followed to check for 
multicollinearity: 
1. Correlation matrix was calculated and constructed in order to examine the 
correlations of the IVs to the DV and the inter-correlations among the IVs. An 
outcome of high correlations between the DV and each IV and low inter-
correlations among the IVs indicates that multicollinearity does not exist. 
2. Examine the Tolerance: A Tolerance close to 0 indicates multicollinearity. The 
cut-off used was 0. If the Tolerance was more than 0.1, multicollinearity among 
the IVs does not exist. 
 The following research questions and hypotheses were developed and used in 
order to explore the severity of UF symptoms and the impact of UF symptoms on 
HRQOL (see Table 2):  
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Table 2 
Research Questions, Study Variables, and Data Analysis 
RESEARCH 
QUESTIONS 
STUDY VARIABLES DATA ANALYSIS 
 RQ 1: What is the 
association between 
symptom severity, as 
measured by the UFS-
QOL instrument, and 
concern (a dimension of 
HRQOL) among African 
American women ages 
30 to 45 years diagnosed 
with UF? 
Dependent: Concern (summed score 
of questions 9, 15, 22, 28, 32 on the 
survey);  
 
Independent : Symptom Severity 
(summed score of questions 1-8 on 
the survey) 
Linear Regression 
RQ 2: What is the 
association between 
symptom severity, as 
measured by the UFS-
QOL instrument, and 
activities (a dimension of 
HRQOL) among African 
American women ages 
30 to 45 years diagnosed 
with UF? 
 Dependent: Activities (summed 
score of questions 10, 11, 13, 19, 20, 
27, 29 on the survey);  
 
Independent: Symptom Severity 
(summed score of questions 1-8 on 
the survey) 
Linear Regression 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2 Continues 
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RQ 3: What is the 
association between 
symptom severity, as 
measured by the UFS-
QOL instrument, and 
energy/mood (a 
dimension of HRQOL) 
among African American 
women ages 30 to 45 
years diagnosed with 
UF? 
Dependent: Energy/mood (summed 
score of questions 12, 17, 23, 24, 25, 
31, 35 on the survey);    
 
Independent: Symptom Severity 
(summed score of questions 1-8 on 
the survey) 
Linear Regression 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RQ 4: What is the 
association between 
symptom severity, as 
measured by the UFS-
QOL instrument, and 
control (a dimension of 
HRQOL) among African 
American women ages 
30 to 45 years diagnosed 
with UF? 
Dependent: Control (summed scores 
of questions 14, 16, 26, 30, 34 on the 
survey);    
 
Independent: Symptom Severity 
(summed score of questions 1-8 on 
the survey) 
Linear Regression 
RQ 5: What is the 
association between 
symptom severity, as 
measured by the UFS-
QOL instrument, and 
self-consciousness (a 
dimension of HRQOL) 
among African American 
women ages 30 to 45 
years diagnosed with 
UF? 
Dependent: Self-consciousness 
(summed score of 18, 21, 23 on the 
survey); 
 
 Independent: Symptom Severity 
(summed score of questions 1-8 on 
the survey) 
Linear Regression 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2 Continues 
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RQ 6: What is the 
association between 
symptom severity, as 
measured by the UFS-
QOL instrument, and 
sexual function (a 
dimension of HRQOL) 
among African American 
women ages 30 to 45 
years diagnosed with 
UF? 
Dependent: Sexual function 
(summed scores of questions 36 and 
37 on the survey); 
 
 Independent: Symptom Severity 
(summed score of questions 1-8 on 
the survey) 
Linear Regression 
RQ 7: What is the 
association between 
symptom severity as 
measured by the UFS-
QOL instrument, BMI, 
and HRQOL total score 
as measured by the UFS-
QOL instrument among 
African American 
women ages 30 to 45 
years diagnosed with 
UF? 
Dependent Variable: HRQOL score 
(sum score of 6 subscale scores 
range from 29 to 145);  
 
Independent: Symptom Severity 
(summed score of questions 1-8 on 
the survey) and BMI – overall 
calculated value based on 
participants height and weight 
(participants response to two 
questions on DI form: question #2- 
What is your height? and question 
#3- What is your weight?) 
Hierarchical multiple 
Regression 
RQ8: When controlling 
for characteristics of the 
individual (age) what is 
the association between 
symptom severity as 
measured by the UFS-
QOL instrument, BMI, 
and HRQOL total score 
as measured by the UFS-
QOL instrument among 
African American 
women ages 30 to 45 
years diagnosed with 
UF? 
Dependent Variable: HRQOL score 
(sum score of 6 subscale scores 
range from 29 to 145);  
 
Independent: Symptom Severity 
(summed score of questions 1-8 on 
the survey) and  BMI – overall 
calculated value based on 
participants height and weight 
(participants response to two 
questions on DI form: question #2- 
What is your height? and question 
#3- What is your weight?) 
Hierarchical multiple 
Regression 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2 Continues 
 
Co-variant-Characteristics of the 
Individual: 
Age (participant’s response to one 
question about age #1 on the DI 
form) 
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RQ9: When controlling 
for characteristics of the 
environment (family hx 
of UF diagnosis and 
employment) what is the 
association between 
symptom severity as 
measured by the UFS-
QOL instrument, BMI, 
and HRQOL total score 
as measured by the UFS-
QOL instrument among 
African American 
women ages 30 to 45 
years diagnosed with 
UF? 
Dependent Variable: HRQOL score 
(sum score of 6 subscale scores 
range from 29 to 145);  
 
Independent: Symptom Severity 
(summed score of questions 1-8 on 
the survey) and BMI – overall 
calculated value based on 
participants height and weight 
(participants response to two 
questions on DI form: question #2- 
What is your height? and question 
#3- What is your weight?) 
Hierarchical multiple 
Regression 
 Co-variants-Characteristics of the 
Environment: 
 A)    Family History of UF diagnosis 
(participant’s response to one family 
history of UF diagnosis question #5 
on the DI form). 
 B)    Employment (participant’s 
response to question # 4 on the DI 
form: Yes, No, I do not know). 
RQ 10: What is the 
association between 
symptom severity as 
measured by the UFS-
QOL instrument, 
HRQOL total score as 
measured by the UFS-
QOL instrument and 
general health perception 
among African American 
women age 30 to 45 
years diagnosed with 
UF? 
Dependent Variable: General health 
perceptions (participants response to 
one global question #7 on the DI 
form- “How would you rate your 
current health on a scale from 1 to 
10 (with 1 = poor and 10 = 
excellent) 
Hierarchical multiple 
Regression 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2 Continues 
 
Independent: HRQOL score (sum 
score of 6 subscale scores range 
from 29 to 145) and Symptom 
Severity (summed score of questions 
1-8 on the survey). 
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RQ11: When controlling 
for characteristics of the 
individual (age) what is 
the association between 
symptom severity as 
measured by the UFS-
QOL instrument, 
HRQOL total score as 
measured by the UFS-
QOL instrument and 
general health perception 
among African American 
women age 30 to 45 
years diagnosed with 
UF? 
Dependent = General health 
perceptions (participants response to 
one global question #7 on the DI 
form- “How would you rate your 
current health on a scale from 1 to 
10 (with 1= poor and 10 = 
excellent)?”).  
 
Independent = HRQOL score (sum 
of 6 subscale scores range 29 to 145) 
and Symptom Severity (summed 
score of questions 1-8 on the 
survey). 
Hierarchical multiple 
Regression 
Co-variant-Characteristics of the 
Individual: 
Age (participant’s response to one 
question about age #1 on the DI 
form). 
RQ 12: When controlling 
for characteristics of the 
environment (family hx 
of UF diagnosis and 
employment) what is the 
association between 
symptom severity as 
measured by the UFS-
QOL instrument, 
HRQOL total score as 
measured by the UFS-
QOL instrument and 
general health perception 
among African American 
women age 30 to 45 
years diagnosed with 
UF? 
Dependent = General health 
perceptions (participants response to 
one global question #7 on the DI 
form- “How would you rate your 
current health on a scale from 1 to 
10 (with 1= poor and 10 = 
excellent)?”). 
Hierarchical multiple 
Regression 
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Independent = HRQOL score (sum 
of 6 subscale scores range 29 to 145) 
and Symptom Severity (summed 
score of questions 1-8 on the 
survey). 
Co-variants-Characteristics of the 
Environment: 
A)    Family History of UF diagnosis 
(participant’s response to one family 
history of UF diagnosis question #5 
on the DI form). 
B)    Employment (participant’s 
response to question # 4 on the DI 
form: Yes, No, I do not know). 
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RQ 13: What is the 
association between 
symptom severity as 
measured by the UFS-
QOL instrument and 
overall quality of life 
among African American 
women age 30 to 45 
years diagnosed with 
UF? 
Dependent = Overall quality of life 
(response to one global question #8 
on the DI form- ‘How satisfied are 
you with your overall life in general 
on a scale from 1 to 10 (with 1 = 
poorly satisfied and 10 = very 
satisfied)?”) 
Linear Regression 
Independent = Symptom Severity 
(summed score of questions 1-8 on 
the survey). 
 
Summary 
      Throughout this chapter, broad information regarding the design of the study was 
presented. An inclusive description that detailed the target population, protection of 
human subjects and information pertaining to the instrument that was used to analyze 
data is addressed. In addition, the data analysis plan was presented. The data analysis 
plan addressed and examined components of the thirteen hypotheses and explored the 
research questions. Chapter 4 presents the data analysis, interpretation of data and 
provide a summarization of the overall results of the study. Chapter 5 will communicate 
the summary, possible implications, conclusion and recommendation(s) for further 
research. 
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Chapter 4: Results 
Introduction 
 
The purpose of the current chapter is to present the results from the statistical 
analyses performed to address the research questions from this study. A description of the 
final sample size is followed by descriptive statistics for the demographic and 
environmental variables from this study. In addition, the HRQOL variables, methods 
used to examine each of the questions, and the results of the tests derived from the linear 
and multiple regression analyses from this study is described. The chapter ends with a 
summary of the key findings from this study.  
Sample 
All three of the participating organizations (MRAC DST, SMLAC DST, and 
RGR) received a recruitment letter via email. In the email, the organizations were asked 
to send out the survey link in their weekly correspondence to their members and 
affiliates. After four months of data collection a total of 103 survey entries were received. 
The data were initially checked to ensure that the entries met the study inclusion criteria 
based on responses to the screening questions and were checked for accuracy in data 
responses. Four screening questions were used to ensure that only women who met the 
inclusion criteria were allowed to complete the survey. Based on the survey screening 
questions, all 103 participants identified their race as African American. Of those 103 
respondents, 3 indicated they had not been informed they had a diagnosis of uterine 
fibroids by a medical professional and they were excluded from the study. Two 
respondents indicated they were outside of the age requirements for the study, 53 years 
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and 47 years, both were excluded from the study. Sixteen respondents replied ‘yes’ that 
they had received treatment for their uterine fibroids and those 16 were not included in 
the study. A total of 21 survey entries were excluded because they did not meet the study 
inclusion criteria based on their responses to the 4 screening questions. In addition, 2 
survey entries were excluded for incomplete data responses. In total, 23 survey entries 
were excluded from this study, leaving a total of 80 respondents who were included in the 
study.  
Ninety-two participants were estimated to have 80% power to detect a medium 
effect f2 equal to 0.15 with 5 predictor variables at a significance of 0.05. It is important 
to note the estimated sample size of 92 was initially based on the target population size of 
1,600 women (the total number of women available from all three participating 
organizations). In chapter 3 however, it was noted that of those 1,600, only 
approximately 316 women would be eligible to participate in the study project based on 
their age and diagnosis of UF. After the data were collected and reviewed for accuracy it 
was evident that the obtained study sample of n= 80 was less than the estimated sample 
size. Therefore, it was determined that a post hoc power analysis was needed. A post hoc 
power analysis using G*Power (Faul et al., 2009) was used to calculate the post hoc 
power for the hierarchical regression to ensure that the obtained study sample size of 80 
would be able to adequately power the study. Post hoc analysis demonstrated with an n = 
80, medium effect f2 equal to 0.15, and alpha = 0.05, the post hoc power was .87 or 87%. 
Therefore, the obtained sample size (n = 80) was enough to adequately power the study 
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because it reflects the true power for the study based on the sample obtained from the 
actual target population size. 
Descriptive Statistics 
 The data were checked and verified using the electronic data file to ensure 
accuracy for data entry. The data were examined using frequencies for data inaccuracies 
such as abnormal data entry (e.g., survey response >5) and there were none. After review 
and verification of the data using the Excel spreadsheet, 23 survey entries were 
systematically excluded from the data analysis because they failed to meet the study 
inclusion criteria prior to the final sample size being established. 
Descriptive statistics for the demographic physical characteristics of the 
participants are shown in Table 3. The participants had a mean age of 39.2 years with a 
mean height of 64.1 inches (5 feet 4 inches). The Body Mass Index (BMI) mean for the 
participants of this study was 30.8. Of the total number of participants in the study 20% 
reported a weight class which placed them in the category of being overweight with a 
calculated BMI range of 25 to 29.9. Another 46.25% of the participants fell into the obese 
category with a calculated BMI range of 30.0 or higher. It is important to note that 
according to the CDC (2013), a normal BMI range is 18.5 to 24.9. 
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Table 3 
Physical Characteristics of the Participants 
 
 N Minimum Maximum Mean Std. Dev. 
Age 80 30 45 39.2 3.8 
Height (in) 80 52 73 64.1 2.8 
Weight (lbs) 80 107 298 180.1 40.0 
BMI 80 19 51 30.8 7.0 
 
Descriptive statistics for the demographic environmental characteristics of the 
participants are shown in Table 4. Participants were asked if they had missed work as a 
direct result of symptoms associated with uterine fibroids. Over one third of the 
participants indicated they had missed work due to uterine fibroid symptoms. Only 
participants that indicated they had a diagnosis of UF were asked to identify which family 
member(s) (mother, aunt, sister, grandmother) if any that also had a UF diagnosis. 
Participants were allowed to select multiple relatives or choose the option “I don’t 
know”, if they were unaware if one of the relatives listed had a UF diagnosis (see Table 
4).  
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Table 4 
Environmental Characteristics of the Participants 
 
a. Missed work as direct result of uterine fibroid symptoms 
Missed 
work? 
Frequency Percent 
Yes 29 36.2 
No 45 56.3 
Don't know 4 5.0 
Missing 2 2.5 
Total 80 100.0 
b. Immediate relative was diagnosed with uterine fibroidsa 
Relative Frequency Percent 
Responses for total sample 
Any relative (yes) 55 68.7 
Any relative (no) 14 17.5 
Any relative (missing, DK) 11 13.8 
Total 80 100.0 
 
Responses for 55 women who indicated do they have a relative 
who was diagnosed with uterine fibroidsb 
 
Mother 40 50.0 
Aunt 26 32.5 
Table 4 Continues 
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Grandmother 12 15.0 
Sister 15 18.7 
None 25 31.3 
a. Respondents could have had more than one relative who had fibroids 
b. percent of total sample of 80 respondents 
 
 
Symptom Severity and HRQOL Scale Descriptives 
The purpose of the UFS-QOL is to obtain information related to UF symptom 
severity and HRQOL along six subscales of categories from women who are diagnosed: 
concern, activities, energy/mood, control, self-consciousness, and sexual function 
(Harding et al., 2008; Spies et al., 2002). The 37- item survey instrument was used to 
assess the severity of symptoms among African American women with UF and the 
impact of UF symptoms on HRQOL. The UFS- QOL survey questionnaire is based on a 
5- point Likert-type scale. The survey is divided into two sections: symptom severity and 
HRQOL.  
Symptom severity. The first set of questions of the survey is the symptom 
severity section. The range for the average response was from 8 to 40 with a mean of 
24.4 (SD 7.7, see Table 5). The midpoint total score was 24 for the symptom severity 
scale descriptive. The mean midpoint total score for symptom severity in this study was 
statistically significant and it fell to the right of the midpoint score. A midpoint total score 
of 24. 4 for symptom severity suggested that, on average, the respondents felt somewhat 
distressed by the severity of symptoms associated with their uterine fibroids. 
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Table 5 
Scores and Scale Descriptives for UFS-QOL Questionnaire 
 
Scale N Minimum Maximum Mean Std. Dev 
Symptomsa 
80 8.0 40.0 24.4 7.7 
Concernb 
80 3.0 25.0 14.6 7.1 
Self consciousnessb 
80 3.0 15.0 7.8 3.4 
Energy/moodb 
80 6.0 29.0 17.9 6.9 
Sexual functionb 
80 2.0 10.0 5.1 2.4 
Activitiesb 
80 6.0 34.0 17.4 8.3 
Controlb 
80 4.0 21.0 11.5 4.8 
HRQOL totalb 
80 29.0 129.0 74.2 29.3 
a scale – 1=not at all, 2=a little bit, 3= somewhat, 4=a great deal, 5=a very great deal  
b scale - 1=none of the time, 2=a little of the time, 3=some of the time, 4=most of the 
time, 5=all of the time 
 
HRQOL. Section 2 of the survey evaluated the impact of factors associated with 
HRQOL and consisted of 27 questions. This section included questions that were 
categorized into one of six subsections: concern, activities, energy/mood, control, self-
conscious, and sexual function. The combined raw scores from each subscale represented 
the total score for HRQOL section and ranged from 29 to 145 (with scores closer to 145 
reflecting greater negative impact on health related quality of life, see Table 5). The six 
HRQOL scales have a different number of items and thus different possible scores. The 
response for each subscale variable are highlighted in Table 5. 
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Concern. There were 5 questions related to concern on the UFS-QOL survey 
instrument. Topics addressed under this variable consisted of problems related to soiling 
clothing and undergarments, soiling bed linens, unpredictability of onset of menses, and 
the inconvenience of having to carry additional feminine hygiene products (Spies et al., 
2002). The calculated midpoint total score for the subscale variable concern was 15. In 
this study the participants mean midpoint total score for concern was 14.6 (SD 7.1, see 
Table 5).  The total score for concern was statistically significant in this study based on 
linear regression analysis; however, it did fall slightly to the left of the midpoint score. 
Nevertheless, the summed score for concern in this study implied that, the respondents on 
average did have concern some of the time regarding the severity of UF symptoms they 
experienced.  
Self-consciousness. There were 3 questions related to self-consciousness on the 
UFS-QOL survey instrument. Topics addressed under this variable consisted of problems 
related to weight gain, physical appearance, and clothing size (Spies et al., 2002). The 
calculated midpoint total score for the subscale variable self-consciousness was 9. In this 
study the participants mean midpoint total score for concern was 7.8(SD 3.4, see Table 
5). Even though the total score for self-consciousness fell to the left of the midpoint score 
it was statistically significant in this study based on linear regression analysis. These 
study findings indicate that between a little to some of the time on average the 
respondents felt self-conscious regarding the severity of UF symptoms they experienced. 
Energy/mood. There were 7 questions related to energy/mood on the UFS-QOL 
survey instrument. Matters addressed under this variable consisted of problems related to 
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feelings of being tired, drowsy, sleepy, sad, hopeless or discouraged, irritable, and feeling 
weak (drained, Spies et al., 2002). The calculated midpoint total score for the subscale 
variable energy/mood was 21. In this study the participants mean midpoint total score for 
energy/mood was 17.9 (SD 6.9, see Table 5). Even though the total score for 
energy/mood fell to the left of the midpoint score, based on linear regression analysis it 
was found to be statistically significant in this study. These study findings suggest 
between a little to some of the time on average the respondents felt their energy/mood 
was adversely impacted by the severity of UF symptoms they experienced. 
Sexual function. The average response ranged from one to five with a mean 
response of 2.5. There were 2 questions related to sexual function on the UFS-QOL 
survey instrument. Topics addressed under this variable were avoidance of sexual activity 
and diminished sexual desire (Spies et al., 2002). The calculated midpoint total score for 
the subscale variable sexual function was 6. In this study the participants’ mean midpoint 
total score for sexual function was 5.1 (SD 2.4, see Table 5). Even though the total score 
for sexual function fell to the left of the midpoint score it was statistically significant in 
this study based on linear regression analysis. These study findings indicate between a 
little to some of the time the respondents on average felt their sexual function was 
diminished and avoided sexual relations as a result of the severity of UF symptoms they 
experienced. 
Activities. There were7 questions related to activities on the UFS-QOL survey 
instrument. Questions under this variable addressed a number of activities that related to 
traveling, exercise, social activities, usual daily activities and the planning of those 
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activities (Spies et al., 2002).  The calculated midpoint total score for the subscale 
variable activities was 21. In this study the participants mean midpoint total score for 
energy/mood was 17.4 (SD 8.3, see Table 5). The subscale variable activities was found 
to be statistically significant using linear regression analysis, even though it fell to the left 
of the midpoint total score. In this study, the findings indicated that, between a little to 
some of the time the respondents on average felt their ability to carry out activities such 
as those listed previously was limited by the severity of UF symptoms they experienced. 
Control. There were 5 questions related to control on the UFS-QOL survey 
instrument.  This variable addressed feelings related to the lack of control a person may 
feel over their personal health, life, and how untimely symptoms could alter plans for 
social engagements, travel or physical activity (Spies et al., 2002).  The calculated 
midpoint total score for the subscale variable control was 15. In this study the participants 
mean midpoint total score for energy/mood was 11.5 (SD 4.8, see Table 5). Using linear 
regression analysis Control was found to be statistically significant in this study with a 
midpoint total score of 11.5. In this study, the findings indicated that, between a little to 
some of the time the respondents on average felt their control to plan and predict their 
activities and life events was limited by the severity of UF symptoms they experienced. 
Total HRQOL. There were no questions related directly to the total HRQOL of 
the participants on the UFS-QOL survey instrument. The total HRQOL score is a sum of 
the 6 subscale scores. The calculated midpoint total HRQOL score was 87. In this study 
the participants mean midpoint total HRQOL score was 74.2 (SD 29.3, see Table 5) and 
it fell to the left of the midpoint score. The mean midpoint total HRQOL score of 74.2, 
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though less than the calculated midpoint score was statistically significant in this study. 
The total HRQOL summed scored in this study indicates that between a little to some of 
the time the respondents felt their total HRQOL was adversely impacted by the severity 
of UF symptoms they experienced. 
Test of Statistical Assumptions  
Prior to conducting regression analyses to address the research questions and test 
the hypotheses, the assumptions for all of the research questions in this study were tested. 
The assumptions of linear regression were tested to assess the relationship between the 
dependent variables (DV) and the independent variable (IV) in research questions 1-6 and 
13. The assumptions of hierarchical multiple regressions were tested to assess the 
relationship between the DV and IVs in research questions 7-12. The four assumptions 
for the regression analyses that were addressed were linearity, homoscedasticity, 
independence of errors, and normality. 
To test for normality of the scale scores, skewness was examined. According to 
Leech (2005), if the skewness is between -1 and +1, the distribution is approximately 
normal. In this study all the scale score had skewness between -1 and +1, indicating the 
distributions are approximately normal (see Table 6). Therefore, recoding for entry into 
the model was not required for the linear and multiple regressions analyses.  
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Table 6 
Skewness for Scale Scores on Health Related Quality of Life Questionnaire (HRQOL) 
Scale N Skewnessa 
Symptoms 80 -.041 
Concern 80 .054 
Self-consciousness 80 .061 
Energy/mood 80 -.079 
Sexual function 80 .341 
Activities 80 .342 
Control 80 .329 
HRQOL total 80 .010 
a skewness between -1 and +1 indicates distribution is approximately normal. 
Linear Regression Assumptions Research Questions 1-6 and 13 
Linearity. The assumption of linearity was assessed by examining scatter plots. 
The correlations of symptom severity (IV) and the HRQOL subscales (DV) are displayed 
in Table 6.  This method was used to identify if the association between symptoms 
severity (IV) and the 6 HRQOL subscale variables (DVs) were statistically significant. 
Statistical significance were identified when the p- value for the association between 
variables was < 0.05. Bivariate correlations showed a strong positive correlation between 
symptom severity and all 6 of the HRQOL subscale variables (see Table 7). All of the 
correlations of the IV to the DVs are significant indicating that symptom severity has a 
linear relationship with all of the HRQOL sub scale variables. Therefore the question of 
107 
 
 
if there was an association between the IV and DV was supported in research questions 
1-6.  
Table 7 
Correlations of HRQOL Scales with Symptom Severity 
 
Scale Severity 
Concern 
.576** 
 Activities 
.581** 
 Energy mood .614** 
 Control 
.590** 
 Self-conscious .505** 
 Sexual 
.443** 
**p < .01, n =80 
 
For research question 13, the correlation of symptom severity (IV) and the overall 
quality of life (DV) is displayed in Table 8 (r = .627). The correlation of the IV to the DV 
is not significant indicating that the IV (symptom severity) does not have a linear 
relationship or association with the DV (overall quality of life). Therefore the assumption 
of an association between symptom severity and overall quality of life in research 
question 13 was not supported. 
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Table 8 
 
Correlations of Overall Quality of Life with Symptom Severity 
 
 SymptomSeverity 
Overall quality of life 
.627** 
**p < .01, n= 80 
 
Homoscedasticity. The assumption of homoscedasticity (the errors have the same 
variance) was tested by examining the plots of the standardized residuals against the 
predicted values. The plots of the standardized residuals against the predicted values in 
research questions 1- 6 were constructed (see Appendix F, Figures 1 - 6). If the plots are 
approximately rectangle around the middle y = 0 line, the assumption of 
homoscedasticity is supported. The plots in Appendix F, Figures 1-6 were approximately 
rectangular around the middle y = 0. Therefore the assumption of homoscedasticity of 
variance is supported in research questions 1-6. 
Appendix I, Figure 13 displays the plot of the standardized residuals against the 
predicted values for research question 13. If the plots are approximately rectangle around 
the middle y = 0 line, the assumption of homoscedasticity is supported. The plot in 
Appendix 1, Figure 13 was approximately rectangular around the middle y = 0. Therefore 
the assumption of homoscedasticity of variance is supported in research question 13. 
Independence of errors. The assumption of independence of error was assessed 
with Durbin- Watson statistic. The Durban -Watson statistic was used to test for 
independence in research questions 1-6. The acceptable range for the Durban-Watson 
statistic is between 1.50 and 2.50 (Leech, Barrett, & Morgan, 2005). The Durban-Watson 
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statistics for all of the hypotheses tests were within this range. Therefore the assumption 
that the errors are independent was supported in research questions 1-6 (see Table 9). 
Table 9 
 
Summary of Assumptions Support for Research Question 1 - Research Question 6, & 
Research Question 13 
 
RQ Relationa Homoscedasticityb Residuals Independentc Residuals Normald 
1 Yes Yes 2.03 .98 (.201) 
2 Yes Yes 1.83 .98 (.247) 
3 Yes Yes 1.71 .94 (.001) 
4 Yes Yes 1.70 .97 (.031) 
5 Yes Yes 2.00 .99 (.895) 
6 Yes Yes 2.15 .99 (.937) 
13 Yes Yes 1.78 .93(.000) 
arefer to correlation matrix in Table 7 & 8; n= 80 
brefer to the scatterplots in Appendix F & I, Figures 1 – 6, 13 
cDurban-Watson statistic - an acceptable range is 1.50 - 2.50 
dShapiro-Wilk statistic - .ss(.ppp) .ss = Shapiro-Wilk statistic, .ppp = probability, .ppp> 
.05 supports the hypothesis 
 
The Durban -Watson statistic was also used to test for independence in research 
question 13. The acceptable range for the Durban-Watson statistic is between 1.50 and 
2.50 (Leech, Barrett, & Morgan, 2005). The Durban-Watson statistic for RQ13 was 
within this range (Durban-Watson = 1.78). Therefore the assumption that the errors are 
independent was supported in research question 13 (see Table 9). 
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Errors of normality. The assumption of normality was assessed by using the 
Shapiro-Wilk test of studentized residuals for research questions 1-6. The Shapiro-Wilk 
statistic was used to test for normality of the residuals. If the p is greater than .05 the 
assumption that the distribution for the residuals is normal is supported. For four of the 
six hypotheses p > .05 (RQ 1, 2, 5, 6) indicating the residual distributions were normal. 
For these four tests the assumption of normality of the residuals was supported. For RQ 3 
and RQ 4 p <.05 indicating the residual distributions were not normal. For these two tests 
the assumption of normality of the residuals was not supported. When  
… some procedures can provide very reliable results even 
when an assumption is not fully met. In such cases a 
condition may offer a rule of thumb that indicates whether 
or not we can safely override the assumption and apply the 
procedure anyway. (Bock, 2014, Distinguish Between 
Assumptions and Conditions, ¶ 3).  
If the histogram is approximately unimodal and symmetric the condition that the 
distribution is nearly normal is supported (Bock, 2014). As the assumption of normality 
is not supported by Shapiro-Wilk, an examination of the histograms for RQ 3 and RQ 4 
was carried out to see if the histograms were approximately unimodal and symmetric (see 
Figures 2 – 3). Both distributions are unimodal and approximately symmetric. Therefore 
the condition of normality is supported in research questions 3-4.  
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Figure 2. Histogram of RQ3 standardized residuals. 
 
 
 
 
Figure 3. Histogram of RQ4 standardized residuals. 
 
The Shapiro-Wilk statistic was also used to test for normality of the residuals in 
research question 13. If the p is greater than .05 the assumption that the distribution for 
the residuals is normal is supported. For RQ13 p < .05 indicating the residual 
distributions was not supported. As the assumption of normality was not supported by 
Shapiro-Wilk, an examination of the histogram for RQ 13 was carried out to see if the 
histogram was approximately unimodal and symmetric (see Figure 4). The distributions 
was unimodal and approximately symmetric. Therefore the condition of normality is 
supported in research question 13. 
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Figure 4. Histogram of RQ13 standardized residuals. 
 
Multiple Regression Assumptions Research Questions 7-9 
The assumptions for linear regression also apply to multiple regressions and were 
tested as indicated previously. The assumptions of multiple regressions were tested to 
assess the ability of the model to see if there was a relationship between symptom 
severity, BMI, and HRQOL, along with three covariates (age, family history of uterine 
fibroids, and employment) in research questions 7-9. The four assumptions of multiple 
regressions that were addressed were linearity, homoscedasticity, independence of errors, 
and normality.  
Linearity. The assumption of linearity was assessed by examining scatter plots. The 
relationship between the DV and IV is linear. The correlations of the HRQOL total score 
(DV) with the IV (symptom severity, BMI) and covariates (age, relative, missed work) 
are displayed in Table 10. This approach was also used to identify if the association 
between symptoms severity, BMI, HRQOL total score and the three covariates were 
statistically significant. Statistical significance was identified when the p- value for the 
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association between variables was < 0.05. Bivariate correlations showed a positive 
correlation between symptom severity, BMI, and employment history with the HRQOL 
total score (see Table 10). All the correlations of the IVs to the DV are significant 
indicating that the IVs (symptom severity and BMI) have a linear relationship with the 
DV (HRQOL total score). Therefore, the assumption of an association between the IVs 
and DV was supported. However, for the covariates only employment history had a 
significant correlation with the HRQOL total score. 
Table 10 
 
Correlations of HRQOL Total Score with Symptom Severity, BMI, and Demographics 
Variable HRQOL Total 
aSeverity of Symptoms 
.627** 
aBMI 
.218* 
aAge 
.109 
bEmployment History 
.392** 
bFamily History 
-.056 
* p < .05      **p < .01 
a n = 80, b n = 77 
 
Homoscedasticity. The assumption of homoscedasticity (the errors have the same 
variance) was tested by examining the plots of the standardized residuals against the 
predicted values. The plots of the standardized residuals against the predicted values were 
constructed (see Appendix G, Figures 7 - 9). If the plots are approximately rectangle 
around the middle, y = 0 line, the assumption of homoscedasticity is supported. The plots 
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in Appendix G, Figures 7-9 were approximately rectangular around the middle y = 0. 
Therefore the assumption of homoscedasticity of variance is supported. 
Independence of errors. The assumption of independence of error was assessed 
using the Durbin- Watson statistic. The Durban -Watson statistic was used to test for 
independence. The acceptable range for the Durban-Watson statistic is between 1.50 and 
2.50 (Leech, Barrett, & Morgan, 2005). The Durban-Watson statistics for all of the 
hypotheses tests were within this range. Therefore the assumption that the errors are 
independent was supported (see Table 11). 
Table 11 
 
Summary of Assumptions Support for Research Question 7 - Research Question 9 
RQ Relationa Homoscedasticityb Residuals Independentc Residuals Normald 
7e yes Yes 1.76 .936 (.001) 
8e Yes Yes 1.76 .934 (.000) 
9f Yes Yes 1.81 .942 (002) 
arefer to correlations in Table 12,  
brefer to the scatterplots in Appendix G, Figures 7 - 9 
cDurban-Watson statistic - an acceptable range is 1.50 - 2.50 
dShapiro-Wilk statistic - .sss(.ppp) .sss = Shapiro-Wilk statistic, .ppp = probability or p-
value,  a p-value > .05 indicates the residuals are distributed normally 
e RQ 7-8 n = 80 
f RQ 9 n = 77 
   
Errors of Normality. The assumption of normality was assessed by using the 
Shapiro-Wilk test of studentized residuals. The Shapiro-Wilk statistic was used to test for 
normality of the residuals. If the p is greater than .05 the assumption that the distribution 
for the residuals is normal is supported. For all three hypotheses p < .05 indicating the 
115 
 
 
residual distributions were not normal. For these tests the assumption of normality of the 
residuals was not supported. If the histogram is approximately unimodal and symmetric 
the condition that the distribution is nearly normal is supported (Bock, 2014). As the 
assumption of normality was not supported by Shapiro-Wilk, an examination of the 
histograms for the residuals was carried out to see if the histograms were approximately 
unimodal and symmetric (see Figures 5 – 7). All three of the distributions are unimodal 
and approximately symmetric. Therefore the condition of normality is supported in 
research questions 7-9.  
 
Figure 5. Histogram of RQ7 standardized residuals. 
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Figure 6. Histogram of RQ8 standardized residuals. 
 
 
Figure 7. Histogram of RQ9 standardized residuals. 
 
Of most concern with multiple regressions is multicollinearity. This is not an 
assumption as such, but is of concern when conducting multiple regression analyses. 
High inter-correlation among the IVs can result in multicollinearity. Multicollinearity 
results in unstable equation coefficients. Therefore, correlation matrix and tolerance were 
used to examine for multicollinearity. 
Correlation Matrix. The correlation matrix was constructed in order to examine 
the correlations of the IVs to the DV and the inter-correlations among the IVs (see Table 
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12). An outcome of high correlations between the DV and each IV and low inter-
correlations among the IVs indicates that multicollinearity does not exist. The correlation 
of the DV (total HRQOL score) and the IVs (symptom severity and BMI) were 
significant. The correlation between the IVs (symptom severity and BMI) was not 
significant. The inter-correlations among the IVs and the covariates were all insignificant 
except between severity of symptoms and employment history, and between age and 
family history. The correlations were small; therefore, the tolerance results were 
examined as a test for multicollinearity. 
Table 12 
 
Intercorrelations of HRQOL Total Score and the IVs  
Variable 1 2 3 4 5 6 
1. HRQOL Totala  
.627** .218* .109 .392** -.056 
2. Severity Symptomsa  
 .144 .019 .283* -.039 
3. BMIa  
  -.028 .128 .016 
4. Agea  
   .061 -.251* 
5. Employment Historyb  
    -.171 
6. Family Historyb  
     
* p < .05      **p < .01  
a n =80   
b n = 77 
 
Tolerance. In Table 13, the calculations for the Tolerance are listed. A Tolerance 
close to 0 indicates multicollinearity. The cut-off used was 0. If the Tolerance is more 
than 0.1, multicollinearity among the IVs does not exist. For all three Regressions, the 
tolerances for the IVs and the covariates were all greater than 0.8 indicating that 
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multicollinearity does not exist among the IVs and the covariates. Because the tolerance 
results were so high they were used as the test for the existence of multicollinearity. 
Table 13 
 
Tolerance to Test for Multicollinearity of the IVs for Research Questions 7 - 9 
RQ Severitya BMIa Ageb Familyb Workb 
7c .979 .979    
8c .979 .987 .999   
9d .903 .969  .968 .879 
Note. A Tolerance greater than 0.1 indicates multicollinearity does not exist 
aIndependent variable 
bCovariate 
c n= 80 
d n= 77 
 
Multiple Regressions Assumptions Continued Research Questions 10-12 
 
The assumptions for linear regression also apply to multiple regressions and were 
tested as indicated previously. The assumptions of multiple regressions were tested to 
assess the ability of the model to see if there is a relationship of symptom severity and 
HRQOL total score with general health perception in research question 10. The 
assumptions of multiple regressions were tested to assess the ability of the model to see if 
there is a relationship of symptom severity and HRQOL total score with general health 
perception, along with three covariates (age, family history of uterine fibroids, and 
employment history of missed work due to uterine fibroids) in research questions 11-12. 
The four assumptions of multiple regressions that were addressed were linearity, 
homoscedasticity, independence of errors, and normality.  
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Linearity. The assumption of linearity was assessed by examining scatter plots. The 
correlations of the perception of general health (DV) with the IV (symptom severity, 
HRQOL total score) and covariates (age, family history, & employment history) are 
displayed in Table 14. This method was also used to identify if the association between 
general health perception, symptoms severity, HRQOL total score and the three 
covariates were statistically significant. Statistical significance were identified when the 
p- value for the association between variables was < 0.05. Bivariate correlations showed 
only the IV HRQOL total score was significantly correlated with the DV (perception of 
general health) indicating HRQOL has a linear relationship with the DV (r = -.254, p = 
.023). The negative correlation indicates that as the HRQOL score (higher score indicates 
higher impact of uterine fibroids with the respondent’s health related quality of life) 
increased, the rating for general health (higher rating indicates higher perception of 
general health) decreased. Severity of symptoms was not significantly correlated with the 
DV (perception of general health) indicating that the IV (symptom severity) does not 
have a linear relationship with the DV (r = -.191, p = .090). Therefore the assumption of 
an association between the IVs and DV was supported for HRQOL total score, but not for 
symptom severity. None of the covariates had a significant correlation with the DV 
(perception of general health).  
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Table 14 
 
Correlations of Perception of General Health with Symptom Severity,  
HRQOL Total Score, and Demographics (n=80) 
 
Variable General Health 
Severity Symptoms 
-.191 
HRQOL Total 
-.254* 
Age 
.015 
Employment History 
-.090 
Family History 
-.061 
* p < .05       
 
Homoscedasticity. The assumption of homoscedasticity (the errors have the same 
variance) was tested by examining the plots of the standardized residuals against the 
predicted values. The plots of the standardized residuals against the predicted values were 
constructed (see Appendix H, Figures 10 - 12). If the plots are approximately rectangle 
around the middle y = 0 line, the assumption of homoscedasticity is supported. The plots 
in Appendix H, Figures 10-12 were approximately rectangular around the middle y = 0. 
Therefore the assumption of homoscedasticity of variance is supported. 
Independence of errors. The assumption of independence of error was assessed 
with Durbin- Watson statistic. The Durban -Watson statistic was used to test for 
independence. The acceptable range for the Durban-Watson statistic is between 1.50 and 
2.50 (Leech, Barrett, & Morgan, 2005). The Durban-Watson statistics for all of the 
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hypotheses tests were within this range. Therefore the assumption that the errors are 
independent was supported (see Table 15). 
Table 15 
 
Summary of Assumptions Support for Research Question 10 - Research Question 12 
RQ Relationa Homoscedasticityb Residuals Independentc Residuals Normald 
10 Mixed Yes 1.85 .942 (.001) 
11 Mixed Yes 1.83 .944 (.002) 
12 Mixed Yes 1.88 .942 (002) 
arefer to correlations in Table 14 
brefer to the scatterplots in Appendix H, Figures 10 - 12 
cDurban-Watson statistic - an acceptable range is 1.50 - 2.50 
dShapiro-Wilk statistic - .sss(.ppp) .sss = Shapiro-Wilk statistic, .ppp = probability or p-
value,  a p-value > .05 indicates the residuals are distributed normally 
 
Errors of Normality. The assumption of normality was assessed by using the 
Shapiro-Wilk test of studentized residuals. The Shapiro-Wilk statistic was used to test for 
normality of the residuals. If the p is greater than .05 the assumption that the distribution 
for the residuals is normal is supported. For all three hypotheses p < .05 indicating the 
residual distributions were not normal (see Table 15). For these tests the assumption of 
normality of the residuals was not supported. If the histogram is approximately unimodal 
and symmetric the condition that the distribution is nearly normal is supported (Bock, 
2014). As the assumption of normality was not supported by Shapiro-Wilk, an 
examination of the histograms for the residuals was carried out to see if the histograms 
were approximately unimodal and symmetric (see Figures 8 – 10). All three of the 
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distributions are unimodal and approximately symmetric. Therefore the condition of 
normality is supported for research questions 10-12.  
 
 
 
Figure 8. Histogram of RQ10 standardized residuals. 
 
 
 
Figure 9. Histogram of RQ11 standardized residuals. 
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Figure 10. Histogram of RQ12 standardized residuals. 
 
Correlation Matrix. The correlation matrix was constructed in order to examine 
the correlations of the IVs to the DV and the inter-correlations among the IVs (see Table 
16). An outcome of high correlations between the DV and each IV and low inter-
correlations among the IVs indicates that multicollinearity does not exist. The correlation 
of the DV (perception of general health) and the IV (total HRQOL) was significant. The 
correlation of the DV (perception of general health) and the IV (symptom severity) was 
not significant. The correlations between the IVs (symptom severity and total HRQOL 
score) were significant. There were significant inter-correlations among the IVs and 
covariates (symptom severity and employment history, total HRQOL and employment 
history, age and family history). The correlations were small; therefore, the tolerance 
results were examined as a test for multicollinearity 
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Table 16 
 
Intercorrelations of Perception of General Health and the IVs 
Variable 1 2 3 4 5 6 
1. Perception of general 
health 
 -.191 -.254* .015 -.090 -.061 
2. Severity Symptoms 
  .627** .019 .283* -.039 
3. Total HRQOL 
   .109 .392** -.056 
4. Age 
    .061 -.251* 
5. Employment History 
     -.171 
6. Family History  
     
* p < .05       
 
Tolerance. In Table 17 the calculations for the Tolerance are listed research 
questions 10-12. A Tolerance close to 0 indicates multicollinearity. The cut-off used was 
0. If the Tolerance is more than 0.1, multicollinearity among the IVs does not exist. For 
all three Regressions, the tolerances for the IVs and the covariates were all greater than 
0.55 indicating that multicollinearity does not exist among the independent variables and 
the covariates. Because the tolerance results were so high they were used as the test for 
the existence of multicollinearity. 
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Table 17 
 
Tolerance to Test for Multicollinearity of the IVs for Research Questions 10 - 12 
RQ Severitya HRQOL Totala Ageb Familyb Workb 
10c .607 .607    
11c .598 .605 .984   
12d .598 .553  .970 .819 
Note. A Tolerance greater than 0.1 indicates multicollinearity does not exist 
aIndependent variable 
bCovariate 
c n = 80 
d n = 77 
 
Test of Hypotheses and Results of Data Analyses 
Linear Regression Analyses Research Questions 1-6 
To test the first six hypotheses, linear regression analysis was used. In the linear 
regression analysis symptom severity was used as IV and the six HRQOL subscale 
variables (concern, activities, energy/mood, control, self- consciousness, sexual function), 
as measured by the UFS-QOL were used as the DV (See Table 18). The objective of the 
first six research questions was to examine the association between symptom severity and 
the six HRQOL subscale variables (concern, activities, energy/mood, control, self- 
consciousness, sexual function), as measured by the UFS-QOL. 
Variables 
The independent variable for all six regressions used in questions 1 – 6 was 
symptom severity. The symptom severity score was obtained based on the total sum 
response of questions 1-8 as measured by the UFS-QOL instrument. The dependent 
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variables for questions 1- 6 were the individual summed scores for each of the 6 subscale 
variables. Concern was the DV in question 1, control was the DV in question 2, activities 
was the DV for question 3, energy/mood was the DV for question 4, sexual function was 
the DV for question 5, and self-consciousness was the DV for question 6. The 6 subscale 
variables were measured by the UFS-QOL instrument.  
Table 18 
Simple Linear Regression Results for HRQOL Scales Regressed on Symptom Severity 
Scale B SE B β F p Adj aR2 
Concern .849 .137 .576 38.72 .000 .323 
Activities .721 .114 .581 39.78 .000 .329 
Energy/mood .645 .094 .614 47.19 .000 .369 
Control .596 .092 .590 41.71 .000 .340 
Self-consciousness .610 .118 .505 26.71 .000 .246 
Sexual function .563 .129 .443 19.03 .000 .186 
a Same size for all regressions n=80 
 
Test of Hypotheses Research Questions 1-6 
The specific goal of the first six research questions was to examine the association 
between symptom severity and the six HRQOL subscale variables (concern, activities, 
energy/mood, control, self- consciousness, sexual function), as measured by the UFS-
QOL.  
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Research Question 1: What is the association between symptom severity, as measured by 
the UFS-QOL instrument, and concern (a dimension of HRQOL) among African 
American women age 30 to 45 years diagnosed with UF? 
Results 
The null hypothesis was not retained, F (1, 78) = 38.72, p < .001. There is a 
significant association between concern and severity of symptoms. The coefficient (B = 
.849) is positive, indicating that as the severity of symptoms increases, concern about the 
adverse impact of their uterine fibroid symptoms on their life also increases. Adj. R2 = 
.323 indicating that severity of symptoms accounts for 32.3% of the variability in concern 
about soiling. 
Research Question 2: What is the association between symptom severity, as measured by 
the UFS-QOL instrument, and activities (a dimension of HRQOL) among African 
American women age 30 to 45 years diagnosed with UF? 
Results 
The null hypothesis was not retained, F (1, 78) = 39.78, p < .001. There is a 
significant association between activities and severity of symptoms. The coefficient (B = 
.721) is positive, indicating that as the severity of symptoms increases, the negative 
impact on their activities due to their uterine fibroid symptoms also increases. Thereby 
suggesting that participants in this study are likely to decrease their activities as their 
severity of symptoms increases. Adj. R2 = .329 indicating that severity of symptoms 
accounts for 32.9% of the variability in the impact on activities. 
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Research Question 3: What is the association between symptom severity, as measured by 
the UFS-QOL instrument, and energy/mood (a dimension of HRQOL) among African 
American women age 30 to 45 years diagnosed with UF? 
Results 
The null hypothesis was not retained, F (1, 78) = 47.19, p < .001. There is a 
significant association between energy/mood and severity of symptoms. The coefficient 
(B = .645) is positive, indicating that as the severity of symptoms increases, the negative 
impact on the respondent’s energy/mood also increases. Adj. R2 = .369 indicating that 
severity of symptoms accounts for 36.9% of the variability in impact on the respondent’s 
energy/mood. 
Research Question 4: What is the association between symptom severity, as measured by 
the UFS-QOL instrument, and control (a dimension of HRQOL) among African 
American women age 30 to 45 years diagnosed with UF? 
Results 
The null hypothesis was not retained, F (1, 78) = 41.71, p < .001. There is a 
significant association between control and severity of symptoms. The coefficient (B = 
.596) is positive, indicating that as the severity of symptoms increases, the negative 
impact on the respondent’s feeling of control of their life also increases. Adj. R2 = .340 
indicating that severity of symptoms accounts for 34.0% of the variability in the impact 
on their control of their life. 
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Research Question 5: What is the association between symptom severity, as measured by 
the UFS-QOL instrument, and self-consciousness (a dimension of HRQOL) among 
African American women age 30 to 45 years diagnosed with UF? 
Results  
The null hypothesis was not retained, F (1, 78) = 26.71, p < .001. There is a 
significant association between self-consciousness and severity of symptoms. The 
coefficient (B = .610) is positive, indicating that as the severity of symptoms increases, 
their negative feelings of self-conscious relating to their uterine fibroid symptoms also 
increases. R2 = .246 indicating that severity of symptoms accounts for 24.6% of the 
variability in their feeling of self-conscious relating to their uterine fibroid symptoms. 
Research Question 6: What is the association between symptom severity, as measured by 
the UFS-QOL instrument, and sexual function (a dimension of HRQOL) among African 
American women age 30 to 45 years diagnosed with UF? 
Results  
The null hypothesis was not retained, F (1, 78) = 19.03, p < .001. There is a 
significant association between sexual function and severity of symptoms. The 
coefficient (B = .563) is positive, indicating that as the severity of symptoms increases, 
the negative impact on their sexual function due to their uterine fibroid symptoms also 
increases. R2 = .186 indicating that severity of symptoms accounts for 18.6% of the 
variability in the impact on their sexual function due to their uterine fibroid symptoms. 
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Hierarchical Multiple Regression Analyses Research Questions 7-9 
The objective of the second set of research questions (7-9) was to examine the 
association between the total HRQOL summed score as measured by the UFS-QOL with 
symptom severity and BMI when controlling for age, employment, and family history. 
Hierarchical multiple regression analysis was used on questions 8 and 9 to determine if 
there is a relationship between symptom severity, BMI, and HRQOL, when controlling 
for three covariates (age, family history of uterine fibroids, and employment) (See Table 
18). The dependent variable was the total HRQOL summed score for all three research 
questions. The independent and control variables were added to the model in steps. In 
order to determine what the control variables, then symptom severity, and lastly BMI 
each contributed to the model, they were added in the following three steps: 
1) In step one, the covariate, characteristics of the individual (RQ 8 - age), and 
characteristics of the environment (RQ9 - family history of UF diagnosis, and 
employment history of missed work due to uterine fibroids) were added to the 
model and the change in R2 was examined.  
2) In step two, the variable symptom severity was added to the model and the change 
in R2 was examined to determine whether or not symptom severity significantly 
increased R2. 
3) In step three, the variable BMI was added to the model and the change in R2 was 
examined to determine whether or not BMI significantly increased R2. 
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Variables  
Dependent = Total HRQOL summed score as measured by the UFS- QOL instrument. 
Independent (all three hierarchical regressions) = Symptom Severity and BMI  
The three covariates were: 
1) Age (characteristics of the individual). This co variant was used in RQ8. 
2) Family History of uterine fibroid diagnosis (this co variant was used in RQ9). For 
regression analysis, family history was coded as 1 = yes and 0 = no, missing or 
don’t know. 
3) Employment (this co variant was used in RQ9). For regression analysis, 
employment history was coded as 1 = yes and 0 = no, did not miss work. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
132 
 
 
Table 19 
Hierarchical Regression Results for HRQOL Scales Regressed on Demographics, 
Symptom Severity, and BMI 
Scale B SE B β F  R2 ΔR2 
a. Research Question #7 (n=80) 
Step 1 Symptom 
Severity 
.664** .093 .627 50.47** .393  
Step 2 Symptom 
Severity 
.644** .094 .608 26.71** .410 .017 
   BMI .019 .013 .131    
b. Research Question #8 (n=80) 
Step 1 – Age .029 .030 .109 .93 .012  
Step 2 – Age .026 .023 .097 25.91** .402 .390*
* 
   Symptom Severity .662** .092 .625    
Step 3 - Age  .027 .023 .101 18.33** .420 .018 
   Symptom Severity .642** .094 .606    
   BMI .019 .013 .134    
c. Research Question #9 (n=77) 
Step 1 – Employ. 
history 
.835** .229 .396 6.76** .154  
   Family history .045 .239 .020    
Step 2 – Employ. 
history 
.483** .195 .229 19.68** .447 .293*
* 
   Family history .031 .195 .014    
   Symptom Severity .599** .096 .566    
Table 19 Continues 
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Step 3 – Employ. 
history 
.460* .195 .218 15.15*** .457 .010 
   Family history .020 .195 .009    
   Symptom Severity .587** .097 .557    
   BMI .015 .013 .101    
* p < .05 ** p < .01 
 
Test of Hypotheses Research Questions 7-9 
The specific goal of question 7 was to examine the associations between symptom 
severity, body mass index (BMI), and overall HRQOL.  The specific goals of research 
questions 8 and 9 were to examine the associations between symptom severity, body 
mass index (BMI), and overall HRQOL, controlling for the three co-variables (age, 
family hx of UF, and employment). 
Research Question 7: What is the association between symptom severity as measured by 
the UFS-QOL instrument, BMI, and HRQOL total score as measured by the UFS-QOL 
instrument among African American women ages 30 to 45 years diagnosed with UF? 
Variables 
Dependent = total summed HRQOL score  
Independent = Symptom Severity and BMI  
Results  
 In step 1 with the IV symptom severity being added, the model was significant, F 
(1, 78) = 50.47, p < .001. R2 = .393. Specifically, symptom severity does contribute to the 
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prediction of total HRQOL summed score. In step 2 with the addition of BMI the model 
remained significant F (2, 77) = 26.71, p < .001. R2 = .410 with the change in R2 =.017 (p 
= .144) which was not significant. The non-significant change in R2 indicates that the 
addition of BMI does not increase explanation of the variability in total HRQOL. BMI 
does not contribute to the prediction of total HRQOL. The coefficient for symptom 
severity (B = .644) was significant and positive, indicating that as the severity of 
symptoms increases, the negative impact on total HRQOL also increases.  
Research Question 8: When controlling for characteristics of the individual (age) what is 
the association between symptom severity as measured by the UFS-QOL instrument, 
BMI, and HRQOL total score as measured by the UFS-QOL instrument among African 
American women age 30 to 45 years diagnosed with UF? 
Variables 
Dependent = Total HRQOL summed score  
Independent = Symptom Severity and BMI  
Co-variable 
Characteristics of the Individual or age (the only co variable in this category). 
Results  
In step 1 with the addition of age, the model was not significant, F (1, 78) = .93, p 
= .337. Age does not contribute to the prediction of total HRQOL summed score. In step 
2 with addition of symptom severity, the model was significant, F (2, 77) = 25.91, p < 
.001. R2 = .402 with the change in R2 = .390, p < .001. The significant change in R2 
indicates that the addition of symptom severity significantly increases the explanation of 
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the amount of variability in total HRQOL. In step 3 with the addition for BMI, the model 
was still significant F (3, 76) = 18.33, p < .001. R2 = .420 with the change in R2 =.018 (p 
= .134) which was not significant. The non-significant change in R2 indicates that the 
addition of BMI does not increase explanation of the variability in total HRQOL. Neither 
age nor BMI were found to have a significant association with total HRQOL summed 
score. Only symptom severity significantly added to the model. The coefficient for 
symptom severity (B = .642) was significant. It is positive, indicating that as the severity 
of symptoms increases, the negative impact on total HRQOL increases (indicated by 
higher total HRQOL summed score).  
Research Question 9: When controlling for characteristics of the environment (family 
history of UF diagnosis and employment history of missed work due to uterine fibroids) 
what is the association between symptom severity as measured by the UFS- QOL 
instrument, BMI, and HRQOL total score as measured by the UFS-QOL instrument 
among African American women age 30 to 45 years diagnosed with UF? 
  Variables 
Dependent = Total HRQOL summed score.  
Independent = Symptom Severity and BMI  
Co- variables 
Characteristics of the Environment 
Family history of UF diagnosis. For regression analysis, family history was coded 
as 1 = yes and 0 = no, missing or don’t know. Two of the participants did not respond to 
this question.  
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Employment history of missed work due to uterine fibroids. For regression 
analysis, employment history was coded as 1 = yes and 0 = no, did not miss work. One of 
the participants did not respond. Because a total of 3 participants did not respond to these 
questions, the sample size for this regression was n=77 instead of n=80. 
Results 
In step 1 with the addition of employment and family history, the model was 
significant, F (2, 74) = 6.76, p = .002. It is important to note that while the overall model 
was significant when the control variables were added, the coefficient for family history 
(B = .045, p = .852) was not significant. Family history did not contribute to the 
prediction of total HRQOL score. However, the coefficient for employment (B = .835, p 
< .001) was significant indicating that employment history was related to total HRQOL 
summed score. Employment history was coded 1 = yes – missed work, and 0 = no – did 
not miss work. For employment “yes” indicates the participant has missed work because 
of uterine fibroid symptoms. The positive coefficient indicates that as employment 
history or days missed from work increases (moves from 0 to 1) the total HRQOL 
summed score also increases. The positive relationship between the total HRQOL 
summed score and employment indicates that the participants who missed work due to 
uterine fibroid symptoms experienced an increased negative impact on their total 
HRQOL (indicated by a higher total HRQOL summed scores). In step 2 with the addition 
of symptom severity the model was significant, F (3, 73) = 19.68, p < .001. R2 = .447 
with the change in R2 = .293, p < .001. The significant change in R2 indicates that the 
addition of symptom severity significantly increases the explanation amount of variability 
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in total HRQOL. In step 3 with addition for BMI, the model was still significant F (4, 72) 
= 15.15, p < .001. R2 = .457 with the change in R2 =.010 (p = .254) which was not 
significant. The non-significant change in R2 indicates that the addition of BMI does not 
increase explanation of the variability in total HRQOL summed score. Only employment 
history and symptom severity significantly contributed to total HRQOL. The coefficient 
for symptom severity (B = .587) was significant. The association is positive, indicating 
that as the severity of symptoms increases, the negative impact on total HRQOL also 
increases (indicated by a higher total HRQOL summed score).  
Hierarchical Regression Analyses continued: Research questions 10-12 
The objective of the third set of research questions (10-12) was to examine the 
association between general health perception with symptom severity and total HRQOL 
score as measured by the UFQOL when controlling for demographics (age, family 
history, employment history) (see Table 20).  Hierarchical multiple regression analysis 
was also used in research questions 11-12, to determine if there was a relationship of 
symptom severity and HRQOL total score with general health perception, controlling for 
three covariates (age, family history of uterine fibroids, and employment history of 
missed work due to uterine fibroids). The dependent variable was general health 
perception for all three research questions. In order to determine what the control 
variables, then symptom severity, and lastly total HRQOL contributed to the model, the 
variables were added to the model in the following three steps:  
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1) In step one, for RQ11 only the control variable age, and for RQ12 only the 
two control variables family history and employment history were added to 
the model and the change in R2 was examined.  
2)  In step two the variable symptom severity was added to the model and the 
change in R2 was examined to determine whether or not symptom severity 
significantly increased R2.  
3) In step three the variable total HRQOL summed score was added to the model 
and the change in R2 was examined to determine whether or not HRQOL 
significantly increased R2. 
Variables  
Dependent variable = General health perception  
Independent variables (all three hierarchical regressions) = Symptom severity and Total 
HRQOL summed score. 
The three covariates were: 
1) Age (this co variant was used in RQ11). 
2) Family History of uterine fibroid diagnosis (co variant was used in RQ12). For 
regression analysis, family history was coded as 1 = yes and 0 = no, missing or don’t 
know. 
3) Employment (this co variant was used in RQ12). For regression analysis, 
employment history was coded as 1 = yes and 0 = no, did not miss work. 
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Table 20 
 
Hierarchical Regression Results for Perception of General Health Regressed on 
Demographics, Symptom Severity, and Total HRQOL Score 
Scale 
B SE B β F 
 R2 ΔR2 
a. Research Question #10 (n=80) 
Step 1 Symptom Severity -.311 .181 -.191 2.94 .036  
Step 2 Symptom Severity -.085 .231 -.052 2.72 .066 .030 
   Total HRQOL Score -.341 .218 -.221    
b. Research Question #11 (n=80) 
Step 1 – Age .006 .046 .015 .018 .000  
Step 2 – Age .008 .045 .019 1.47 .037 .037 
   Symptom Severity -.312 .183 -.191    
Step 3 - Age  .017 .045 .041 1.84 .068 .031 
   Symptom Severity -.079 .232 -.049    
   Total HRQOL Score -.351 .221 -.228    
c. Research Question #12 (n=77) 
Step 1 – Employ. History- -353 .381 -.108 .558 .015  
   Family history -.263 .398 -.077    
Step 2 – Employ. History -.188 .395 -.058 1.06 .042 .027 
   Family history -.256 .396 -.075    
Table 20 Continues 
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   Symptom Severity -.280 .196 -.172    
Step 3 – Employ. History -.015 .408 -.004 1.39 .072 .030 
   Family history -.245 .392 -.072    
   Symptom Severity -.065 .240 -.040    
   Total HRQOL Score -.359 .236 -.233    
 
Test of Hypotheses Research Questions 10-12 
The specific goal of question 10 was to examine the association between 
symptoms severity, HRQOL total score, and general health perception. The specific goals 
for research questions 11 and 12 was to examine the association between symptom 
severity, total HRQOL summed score, and general health perception, controlling for the 
three co variables (age, family history of uterine fibroids, and employment history). 
Research Question 10: What is the association between symptom severity as measured by 
the UFS-QOL instrument, HRQOL total score as measured by the UFS-QOL instrument 
and general health perception among African American women age 30 to 45 years 
diagnosed with UF? 
   Variables 
Dependent = General health perception  
Independent = Symptom severity and Total HRQOL summed score  
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 Results  
In step 1 with the addition of the IV symptom severity, the model was not 
significant, F (1, 78) = 2.94, p = .090. R2 = .036. Specifically symptom severity did not 
contribute to the prediction of general health perception. In step 2 with the addition of 
total HRQOL summed score, the model remained insignificant F (2, 77) = 2.72, p = .072. 
R2 = .066 with the change in R2 =.030 (p = .122) which was not significant. The non-
significant change in R2 indicates that the addition of total HRQOL summed score does 
not increase explanation of the variability in general perception of health.  
 Research Question 11: When controlling for characteristics of the individual (age) does 
symptom severity as measured by the UFS-QOL instrument, and HRQOL total score as 
measured by the UFS-QOL instrument have an association with general health perception 
among African American women age 30 to 45 years diagnosed with UF? 
 Variables 
Dependent = General health perception  
Independent = Symptom severity and Total HRQOL summed score  
Co-variable 
Characteristics of the Individual or age (the only co variable in this category). 
Results  
In step 1 with the addition of age, the model was not significant, F (1, 78) = .02, p 
= .892. The non-significant change indicates that age does not contribute to the prediction 
of general health perception. In step 2 with the addition of symptom severity the model 
was significant, F (2, 77) = 1.47, p = .237. R2 = .037 with the change in R2 = .037, p = 
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.092. The insignificant change in R2 indicates that the addition of symptom severity does 
not significantly increase the explanation of the amount of variability in general health 
perception. In step 3 with the addition of total HRQOL summed score, the model was 
insignificant F (3, 76) = 1.84, p = .147. R2 = .068 with the change in R2 =.031 (p = .116) 
which was not significant. The non-significant change in R2 indicates that the addition of 
total HRQOL summed score does not increase explanation of the variability in general 
health perception.  
Research Question 12: When controlling for characteristics of the environment (family 
history of UF diagnosis and employment history) does symptom severity as measured by 
the UFS-QOL instrument, and HRQOL total score as measured by the UFS-QOL 
instrument have an association with general health perception among African American 
women age 30 to 45 years diagnosed with UF? 
Variables 
Dependent = General health perception  
Independent = Symptom severity and Total HRQOL summed score  
Co-variants-Characteristics of the Environment 
Family history of UF diagnosis. For regression analysis, family history was coded 
as 1 = yes and 0 = no, missing or don’t know. Two of the participants did not respond to 
this question.  
Employment history of missed work due to uterine fibroids. For regression 
analysis, employment history was coded as 1 = yes and 0 = no, did not miss work. One of 
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the participants did not respond. Because a total of 3 participants did not respond to these 
questions, the sample size for this regression was n=77 instead of n=80. 
Results 
In step 1 with the addition of employment and family history, the model was not 
significant, F (2, 74) = .56, p = .575. Specifically employment nor family history were 
found to be a predictor of general health perception. In step 2 with the addition of 
symptom severity, the model was significant, F (3, 73) = 1.06, p = .371. R2 = .042 with 
the change in R2 = .027, p = .156. The insignificant change in R2 indicates that the 
addition of symptom severity does not significantly increase the explanation of the 
variability in general perception of health. In step 3 with addition of total HRQOL, the 
model was remained significant F (4, 72) = 1.39, p = .246. R2 = .072 with the change in 
R2 =.030 (p = .132) which was not significant. The non-significant change in R2 indicates 
that the addition of total HRQOL summed score does not increase explanation of the 
variability in general health perception.  
Linear Regression Analyses Research Question 13 
To test the last hypotheses/research question 13, linear regression analysis was 
used. In the linear regression symptom severity) was used as IV and Overall quality of 
life was the DV (see Table 21).  
Table 21 
 
Linear Regression Results for Overall quality of Life Regressed on Symptom Severity 
Scale B SE B β F p Adj aR2 
Symptom severity -.040 .190 -.024 .05 .833 .012 
a Adjusted for sample size, n = 80 
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Test of Hypotheses Research Question 13 
 
The specific goal of RQ13 was to examine the association between symptom 
severity and overall quality of life. 
Research Question 13: What is the association between symptom severity as measured by 
the UFS-QOL instrument and overall quality of life among African American women age 
30 to 45 years diagnosed with UF?  
 Variables 
Dependent: Symptom severity 
Independent: Overall quality of life 
Results  
The null hypothesis was retained, F (1, 78) = .05, p = .833. There is no significant 
association between overall quality of life and severity of symptoms.  
Summary 
The purpose of this study was to explore the severity of symptoms associated with 
UF and the impact of UF symptoms on HRQOL of African American women ages 30 to 
45 diagnosed with UF. A total of thirteen (13) research questions were developed and 
used in order to explore the severity of UF symptoms and the impact of UF symptoms on 
HRQOL using linear and multiple regression analyses. In this study, the following factors 
were investigated: BMI, symptom severity, functional status (concern, activities, 
energy/mood, control, self- consciousness, sexual function), overall quality of life, 
general health perception, characteristics of the individual (age), and characteristics of the 
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environment (family hx of UF diagnosis and employment) among African American 
women age 30 to 45 years with a diagnosis of UF.  
 The overall goal for research questions 1 – 6 was to determine the association 
between symptom severity and the six HRQOL subscale variables (concern, activities, 
energy/mood, control, self- consciousness, sexual function) as measured by the UFS-
QOL. The linear regressions for all the subscale scores indicated there is a significant 
association with the severity of symptoms and respondent’s health related quality of life 
along the six subscale variables. Bivariate correlations showed a strong positive 
correlation between symptom severity and all 6 of the HRQOL subscale variables (see 
Table 7). All of the correlations of the IV to the DVs are significant indicating that 
symptom severity has a linear relationship with all of the HRQOL sub scale variables. 
Therefore, the null hypotheses related to research questions 1-6 were rejected.  
The overall goal for research question 7 was to examine the association between 
the total HRQOL score as measured by the UFS-QOL with symptom severity and BMI 
using multiple hierarchical regression analysis. The overall goal for research questions 8 
and 9 was to examine the association between the total HRQOL score as measured by the 
UFS-QOL with symptom severity and BMI, when controlling for demographics (age, 
family history, employment history) using multiple hierarchical regressions analyses. The 
three hierarchical regressions indicated there is a significant association with the severity 
of symptoms and employment (missed work due to uterine fibroid symptom).  BMI and 
age did not significantly contribute to the models. R2 for the final three models ranged 
from 41.0% to 45.7%. These relatively high R2 indicate that the severity of symptoms and 
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employment have a strong impact on the respondents’ health related quality of life. 
Therefore, the null hypotheses related to research questions 7-9 were rejected. 
The overall goal for research question 10 was to examine the association between 
the general perception of health score with symptom severity and HRQOL total score 
using multiple hierarchical regression analysis. The overall goal for research questions 11 
and 12 was to examine the association between the general perception of health score 
with symptom severity and HRQOL total score, when controlling for demographics (age, 
family history, employment history) using multiple hierarchical regressions analyses. The 
three hierarchical regressions indicated there was no significant association of general 
health perception with the composite of the variables severity of symptoms, HRQOL 
total score, and employment history (missed work due to uterine fibroid symptom), and 
family history (relative diagnosed as having uterine fibroids. Specifically employment, 
nor family history were found to be a predictor of general health perception in questions 
11 and 12. In questions 11 with the addition of symptom severity, the model was 
significant, F (3, 73) = 1.06, p = .371. R2 = .042 with the change in R2 = .027, p = .156. 
The insignificant change in R2 indicates that the addition of symptom severity does not 
significantly increase the explanation of the variability in general perception of health. In 
question 12 with the addition of total HRQOL, the model was remained significant F (4, 
72) = 1.39, p = .246. R2 = .072 with the change in R2 =.030 (p = .132) which was not 
significant. There was, however, a significant correlation between general perception of 
health and total HRQOL summed score. The correlation was negative, indicating the 
respondents felt a greater negative impact on their health related quality of life, as the 
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rating of their general health perception decreased. Therefore, the null hypotheses related 
to research questions 10-12 were accepted. 
The overall goal for research question 13 was to examine the association between 
symptom severity and overall quality of life using linear regression analysis. The linear 
regressions demonstrated there was not a significant association between the severity of 
symptoms and overall quality of life (F (1, 78) = .05, p = .833). Therefore, the null 
hypothesis related to research question 13 could not be rejected. In Chapter 5, 
interpretation of the findings in the context of the current literature and the overall 
summary are provided. 
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Chapter 5: Discussion, Conclusion, and Recommendations 
This study of health related quality of life (HRQOL) was designed to explore the 
relationship between UF symptom severity and the impact of UF symptoms on HRQOL 
among 30 to 45 years old African American women diagnosed with UF. This chapter 
details the results of the data collected and the interpretations. A description of the 
implications of the study results with regard to social change and future research 
concludes the chapter.  
Overview 
The impact of UF symptoms on the HRQOL of women suggests this chronic 
condition can lead to a number of challenging social, physical, and emotional health 
concerns. Research findings corroborate that a disproportionate number of African 
American women are diagnosed with and treated for UF (Davis et al., 2009; ORWH, 
2006; NIH, 2011; Wise et al., 2005b). More importantly, there is a disparity in the age at 
which African American women are diagnosed, and the symptoms that are experienced 
by African American women when compared to their counterparts from other racial 
backgrounds (Hartman et al., 2006; NIH, 2011; Wise et al., 2005a; 2005b).  There are a 
lack of empirical studies exploring the severity of UF symptoms and the impact of UF 
symptoms on the HRQOL of African American women age 30 to 45 years.  
The purpose of this study was to obtain empirical evidence from an existing 
population of African American women ages 30 to 45 years diagnosed with UF regarding 
the symptoms associated with UF and the impact of UF symptoms on their HRQOL. 
Using an exploratory, non- experimental research design, this study attempted to answer 
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thirteen questions regarding the relationship between UF symptom severity and the 
impact of UF symptoms on HRQOL among African American women ages 30 to 45 
years diagnosed with UF. This approach was suitable for this study because none of the 
independent variables (symptom severity, HRQOL, BMI, age, employment, and family 
history of UF diagnosis) were able to be logistically or ethically manipulated. The revised 
Wilson and Cleary model of HRQOL was used as the foundation for this study to 
investigate the following factors: BMI, symptom severity, functional status, overall 
quality of life, general health perception, characteristics of the individual, and 
characteristics of the environment among African American women age 30 to 45 years 
with a diagnosis of UF. The Uterine Fibroid Symptom and Health Related Quality of Life 
(UFS-QOL) designed by Spies et al. (2002) was used for this study. The survey is 
divided into two sections, with the first eight questions focusing on symptom severity and 
the remaining twenty seven questions evaluating the impact of factors associated with 
HRQOL.  
Linear regression analyses were conducted to test hypotheses 1-6 and 13. 
Hierarchical multiple regressions analyses were conducted to test hypotheses 7-12. 
Assumptions of normality were applied. However, findings could not be generalized due 
to sampling limitations and a smaller than estimated sample size. Given the results of the 
analyses, 9 of the 13 null hypotheses were rejected. Following is an interpretation of 
findings within the context of this study project. 
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Interpretation of Findings 
Uterine fibroid research has demonstrated that African American women are at a 
greater risk for diagnosis of UF when compared to their Caucasian and Asian 
counterparts. UF tumors cause an array of burdensome health problems which can 
negatively impact HRQOL. Multiple researchers have identified a number of symptoms 
and stressors among African American women with UF (Cabness, 2010; Lerner et al., 
2008; Popovic et al., 2009). Some of these symptoms and stressors include but are not 
limited to increased fatigue, depressive symptoms, difficulty concentrating, negative 
impact on sexual life, and decreased performance at work (Cabness, 2010; Lerner et al., 
2008; Popovic et al., 2009; Zimmerman et al., 2012). Researchers have found that more 
women with UF are actively seeking out information related to management of UF 
symptoms, less invasive surgical treatment options, and ways to preserve their fertility 
status in order to minimize the impact of UF on their lives (Khan, Shehmar, & Gupta, 
2014). The physical and emotional burdens found to be associated with the presence of 
symptomatic UF among African American women ages 30 to 45 years can lead to 
undesirable effects on HRQOL. 
Theoretical Framework Variables 
 This study sought to determine if there was a relationship between specific 
factors that influence HRQOL among women who have been diagnosed with UF. It also 
sought to offer a personalized perspective on how the lives of African American women 
ages 30 to 45 years are being impacted by UF symptoms. In the next section, 
interpretations of the study’s findings within the conceptual framework that was used to 
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investigate the following factors: symptoms, functional status, BMI, general health 
perception, characteristics of the individual (age), characteristics of the environment 
(family hx of UF and employment) and overall quality of life among African American 
women age 30 to 45 years with a diagnosis of UF (see Table 1) are addressed. This 
framework was the basis for exploring seven distinct UF condition categories: symptom 
severity, concern, activities, energy/mood, control, self-conscious, and sexual function, 
based on the UFS-QOL instrument (see Table 1).   
Symptoms. The focus of these 8 questions was to determine how distressed the 
respondents were by the physical symptoms (e.g. heavy bleeding, fatigue, passing blood 
clots, frequent urination, changes in duration and length of monthly cycle) associated 
with UF. This measure was then used to help establish a basis for determining if 
symptom severity had an association with the respondents’ functional status as measured 
by the six (6) HRQOL subscale variables in the first six research questions. When 
assessing the association of functional status, total HRQOL and employment history 
(missed time from work), there was a positive association with symptom severity. 
Research has found that symptoms such as pain and multiple bleeding episodes were 
found to have a negative impact on women’s life (Zimmerman et al., 2012). Researchers 
Brito et al. (2014) also found in their study that symptomatic UF or the symptoms 
associated with UF (e.g. bleeding and pelvic pain) had a negative impact on the HRQOL 
for women in their study. The significance of symptom severity and its impact on total 
HRQOL in this study supports current research findings. While the results of these 8 
questions alone was not specifically investigated for this project it was important to 
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measure how the participants rated their personal experience with the symptoms 
associated with UF and if they believed those symptoms to be impactful to their lives. 
Functional Status. Functional status was measured using the six HRQOL 
subscale variables (concern, activities, energy/mood, control, self- consciousness, sexual 
function) as measured by the UFS-QOL. The linear regressions for all the subscale scores 
indicated there is a significant association with the severity of symptoms and 
respondent’s health related quality of life. Functional status was determined based the 
study participants mean score response to questions in each category of the six HRQOL 
subscale variables.   
In each of the six questions the independent variable, symptom severity remained 
the same; however, the dependent variable was different in each question. In Hypothesis 
1, the association between symptom severity and concern was examined. In Hypothesis 
2, the association between symptom severity and activities was examined. In Hypothesis 
3, the association between symptom severity and energy/mood was examined. In 
Hypothesis 4, the association between symptom severity and control was examined. In 
Hypothesis 5, the association between symptom severity and self-consciousness was 
examined. In Hypothesis 6, the association between symptom severity and sexual 
function was examined. The null hypotheses for all six questions in this section were 
rejected.  
These study findings suggest that an association does exist among symptom 
severity and all of the health related quality of life subscale variables. However, the 
subscale variable Concern was identified as having an increased level of association with 
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symptom severity when compared to the other subscale variables in this study. The 
concern subscale variable had a total of five questions. These five questions were 
designed to address the participants’ feelings or level of concern about issues related to 
the symptoms associated with UF. Topics such as anxiety due to unpredictability of onset 
or duration of monthly cycles, concern for soiling clothing and bed linens, and being 
inconvenienced about having to carry extra feminine products to avoid accidents were 
addressed (Spies et al., 2002). Brito et al. (2014) found participants in their study 
expressed feelings of concern more specifically “…huge sensations of fear” (p. 3) related 
to the unpredictability of symptoms associated with UF. Researcher Cabness (2010) also 
found that feelings of increased anxiety related to insecurity and shame of breakthrough 
bleeding prevented African American women with UF from attending social events. This 
study findings suggest that respondents increased level of concern appear to be consistent 
with current research findings related to UF symptom severity.  
The subscale HRQOL variables, Self-conscious and Energy/mood both fell 
slightly left of the midpoint score for their respective categories. The three questions for 
self-conscious were designed to address how participants felt about some of the changes 
in their physical appearance or the impact of bulk symptoms on their HRQOL. Topics 
such as increase in abdominal girth or bloating, weight gain and having to wear larger 
size clothing were the common focus of the questions related to self- conscious (Spies et 
al., 2002). Research indicates that women diagnosed with UF are not only impacted by 
their experience with the physical symptoms associated with UF, but they also expressed 
among other problems, concerns related to body image, problems with sexual function, 
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and relationships (Borah et al., 2013). The seven questions related to energy and mood 
addressed the emotional and physical barriers that women with UF often encounter. For 
example at least two of the three questions related to self- conscious inquired about 
bodily or physical changes that occur (e.g. weight gain, size and appearance of stomach). 
The difference between the two variables in this study though slight may reflect more on 
the participants’ state of mind and the impact of UF symptoms on their outward 
appearance. More importantly it suggests there is a possible dissatisfaction participants 
may feel related to those negative physical changes that occur in their outward 
appearance. 
Spies et al. (2002) found that women with UF who were unhappy about the 
physical appearance were also impacted in their sexual lives. However, researchers 
Ertunc, Uzan, Tok, Doruk, & Dilek (2009) study findings suggest that the pain and 
bleeding symptoms associated with UF may have more of a negative impact on the 
sexual life of women in their study. Participants in this study did indicate they felt an 
impact on their sexual function due to their uterine fibroid symptoms a little of the time to 
some of the time. This study findings appear to correlate with researchers Voogt et al. 
(2009) who found that premenopausal women with symptomatic UF expressed increased 
problems with sexual functioning (i.e. lubrication, orgasm and pain during intercourse) 
prior to having the UAE procedure for treatment of UF. Zimmerman et al. (2012) also 
found that 42.9% of the women in their study with UF expressed problems with sexual 
intercourse and that their sexual life was negatively affected. The researchers concluded 
that UF did have a negative influence on the participants’ sexual life among other areas. 
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The findings of this study show that sexual life is somewhat impacted in a negative way 
by UF symptoms; however, this remains an area that requires further research. 
The two subscale variables activities and control appear to also have a statistically 
significant association with symptom severity. The control subscale variable seeks to 
examine how participants feel about their ability to control their health, life, and future 
(Spies et al., 2002). In particular it addresses how the effects of UF symptoms “…could 
immediately alter all plans for travel, social engagements, or physical activities.” (Spies 
et al., 2002, p 295). The researchers found that control was reported as one of the most 
areas affected the symptoms of UF in the lives of women diagnosed. Zimmerman et al. 
(2012) found that women in their study reported a mild to severe negative impact of UF 
symptoms on ability to perform various activities (e.g. housekeeping, sports, performance 
at work) in their life. In another study Brito et al. (2014) indicated that participants of 
their study had to change or limit their domestic and social activities as a result of the 
symptoms associated with UF. The results of the Brito et al. (2014) and Zimmerman et al. 
(2012) studies demonstrate the lack of ability to control UF symptoms can negatively 
influence the active and social of lives of women impacted by UF. Participants in this 
study indicated they felt the least impact in the subscale variable of control. These 
findings related to the subscale variable control are an interesting discovery given current 
research suggests that control is generally rated higher as an area of interest. However, in 
spite of its ranking the control sub variable is statistically significant in this study and 
indicates this is an area where respondents experience some level of negative impact in 
their HRQOL. This finding remains consistent with current literature. 
156 
 
 
Biological function. Body Mass Index (BMI) was the biological factor selected 
for this study. BMI did not significantly contribute to the regression model; however, it 
did have a significant correlation to total HRQOL (see Table 10). Specifically, the 
findings of the study suggest that even when controlling for the study covariate factors, 
age, family history of UF diagnosis, and employment, BMI continues to not have an 
association to the participant’s HRQOL. The finding that BMI was not a significant 
contributor to the model was an interesting outcome of this study. To date, there are no 
published study findings that have found an association specifically between BMI and 
total HRQOL among women with UF, although researchers Trivedi and Abreo (2009) 
suggest that a relationship exists between UF diagnosis and higher BMI among women. 
Other researchers have also found an elevated BMI along with some other biological 
factors place African American women at an increased risk for developing UF (Faerstein, 
Szklo, & Rosenshein, 2001; Flake, Andersen, & Dixon, 2003; Wise et al., 2005). 
According to the CDC (2013) a normal BMI range is 18.5 to 24.9, 25 to 29.9 being 
classified as overweight and 30 or more being classified as obese. It is important to note 
the range of BMI for participants in this study was 19 to 51, with a mean of 30.8, with 
46.25% of the participants falling into the obese category. Interestingly, the BMI findings 
of this study suggest most of the participants were African American women who meet 
the criteria for being classified as overweight or obese. 
Characteristics of the individual. One characteristic of the individual was 
selected for inclusion in the study, age. The covariate age was not significant in any of 
the regression models. Research by the National Institute of Environmental Health 
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Sciences indicates that by the age of 50 years more than 80% of African American 
women and about 70% of Caucasian women in the United States would be affected by 
UF (Baird et al., 2003). Research findings from Davis et al. (2009) and Wise et al. (2005) 
have revealed that African American women between the ages of 25 to 45 years have a 
statistically significant (p > 0.001) greater risk of diagnosis of UF when compared to 
Caucasian women. Study inclusion criteria required that participants must be between the 
ages 30 to 45 years. The mean age for participants in this study was 39.2 years. Even 
though age did not significantly contribute to the model, it is important to note that this 
study participants mean average age is consistent with the age range (35 to 45 years) for 
African American women with the highest percentage of UF diagnosis (Davis et al., 
2009; Peddada et al., 2008; Wise et al., 2005). 
Characteristics of the environment. There were two characteristics of the 
environment selected for inclusion in the study: (a) family hx of UF diagnosis and (b) 
employment history. At least one characteristic of the environment did significantly 
contribute to the model.  
Family history of UF diagnosis. In this study family history did not contribute to 
any of the regression models, suggesting that family history of UF diagnosis did not 
impact HRQOL among the participants of this study. Over two thirds (67.8%) of the 
respondents in this study stated they had an immediate relative that had been diagnosed 
with uterine fibroids. Fifty percent of the participants identified their mother as the most 
common relative diagnosed with UF. Approximately 18.7% indicated they had a sister 
who had uterine fibroids. However, this percentage should be interpreted with care as all 
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of the respondents did not report whether or not they had a sister. Researchers have found 
women who have a relative with a diagnosis of UF are at increased risk for UF 
development (Hyuck et al., 2008; Peddada et al., 2008; Scwhartz et al., 2000). Family 
history of UF diagnosis did not significantly contribute to any of the regression models. 
Therefore suggesting that family history of UF among African American women age 30 
to 45 years and UF diagnosis in this study may not be related. It is important to note that 
research in this area is very limited and further research is required. 
Employment history. In this study employment history did contribute to the 
regression models. More specifically, there was a significant association with the severity 
of symptoms and employment (missed work due to uterine fibroid symptom) and total 
HRQOL. In this study more than one in three of the respondents indicated they had 
missed work as a direct result of UF symptoms. The significance of employment history 
being impacted by symptoms associated with UF is an important finding. This study 
finding is similar to current research findings which have shown that decreased work 
productivity and work loss are common among women diagnosed with UF when 
compared to women without UF (Downes et al., 2010; Lerner et al., 2008; Pron et al., 
2003). Brito et al. (2014) reported findings that the women in their study felt their 
professional activities were negatively impacted by the symptom associated with UF. 
Zimmerman et al. (2012) reported that performance at work was rated the second highest 
area that was negatively impacted by women with UF in their study. In their study, 
researchers Lerner et al. (2008) found among African American women with UF, reports 
of more difficulty managing physical and interpersonal job tasks, increased at- work 
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productivity loss, increased fatigue, and difficulty concentrating were consistently higher 
when compared to Caucasian women in their study. When trying to evaluate health 
related quality of life among women with UF, results from the current study indicate it 
may be essential to understand the burden of UF on the livelihood and job performance 
of women diagnosed. 
General health perceptions. General health perceptions was measured with one 
single global question which measured perception of health on a scale from 1= poor, to 
10 = excellent. There was no significant association of general health perceptions with 
severity of symptoms, total HRQOL summed score, and employment history (missed 
work due to uterine fibroid symptom), and family history (relative diagnosed as having 
uterine fibroids). General health perceptions are described as the individuals’ overall 
evaluation of the various aspects of their health and are highly personable (Wilson & 
Cleary, 1995). For this reason, general health perceptions were examined with multiple 
variables to determine how it may be impacted by various life factors. The insignificance 
of general health perceptions in this study is a surprising find, given that all six of the 
HRQOL subscale variables were significantly associated with symptom severity.  
Although general health perceptions did not contribute to total HRQOL summed score in 
this study, there was a significant correlation between general health perceptions and total 
HRQOL summed score. The correlation was negative, indicating that as the respondents 
felt a greater impact of uterine fibroids on their health related quality of life, their general 
health perceptions decreased. 
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Overall quality of life. For this study overall quality of life was measured using 
one question, “How satisfied are you with your overall life in general on a scale of 1 to 
10 (with 1 = poorly satisfied and 10 = very satisfied)”. Though similar to general health 
perceptions given that both are individualized and subjective, the two concepts overall 
quality of life and general health perceptions do differ. The major difference is that 
overall quality of life is based on how happy or satisfied individuals may be with their 
life in total (Ferrans et al., 2005; Wilson & Cleary, 1995); whereas general health 
perception, is the individuals’ view on various aspects of their health. The literature 
reviewed suggests that quality of life for women diagnosed with UF can be negatively 
impacted by the symptoms associated (Spies et al., 2002; Williams et al., 2006).  
Cambridge and Sealy, (2012) suggest that African American women with symptomatic 
UF are often challenged with constant pain, embarrassment, and in some cases limited 
support systems which can negatively affect their life and sense of well-being. However, 
in this study the linear regressions indicated there was not a significant association 
between the severity of symptoms and overall quality of life. The findings for this study 
do not support current research findings as it relates to the impact of severity of UF 
symptoms and overall quality of life. Given the significant association between symptom 
severity and the six subscale HRQOL variables in this study, the findings may suggest 
that African American women ages 30 to 45 years with UF may place greater importance 
on how specific areas of their life are being impacted rather than on their overall quality 
of life in general.  
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Health related quality of life. Respondent’s perspective on HRQOL was 
specifically captured in hypotheses 7-12. The findings in this study, suggest that the 
respondents felt a negative impact on their health related quality of life due to their 
uterine fibroid symptoms a little of the time to some of the time. In research questions 7 – 
9 there was a significant association with total HRQOL and symptom severity and 
employment history. The relationship is positive, indicating that as the severity of 
symptoms increases, the negative impact on HRQOL also increases. Therefore, the null 
hypotheses for questions 7-9 were rejected. This study finding supports current research 
which implies the greater the severity of symptoms experienced by women with UF, the 
more their total HRQOL will be negatively impacted (Borah et al., 2013; Spies et al., 
2002; Vines, Ta, & Esserman, 2010). Given the significant association between symptom 
severity and the six subscale variables of HRQOL examined in this study the findings 
that respondents felt their HRQOL was impacted in some way appears to be consistent 
with current research findings. Researchers Brito et al. (2014) and Zimmeran et al. (2012) 
both found that women with UF reported their HRQOL to have been impacted negatively 
in multiple areas. It is important to note that this study findings suggest that African 
American women age 30 to 45 years with UF experience at least some significant 
negative influence on their health related quality of life based on the severity of UF 
symptoms and these findings remain consistent with current research literature. 
The R2 for the three models in research questions 7 – 9 ranged from 41.0% to 
45.7%. The high R2 indicate severity of symptoms and employment have a strong impact 
on the respondents’ health related quality of life. Current research also suggests that days 
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missed at work and decreased work productively is higher among women with UF 
(Zimmerman et al., 2012). Cote, Jacobs, and Cummings (2002) estimated that costs 
associated with work loss from symptoms associated with UF are around $1,692 annually 
per woman. Downes et al. (2010) study findings demonstrated a loss in work productivity 
by 36% and 37.9% noted particularly in the general activity level for women with UF 
compared to women without UF in their study population. The results of this study 
indirectly lends support to the adaptation that non health factors among women with UF 
such as employment and the role it has on HRQOL is related. More importantly, the 
findings in this particular study suggest that more investigation as to the direct and in 
direct impact of work loss on HRQOL among women with UF should be further 
explored.  
BMI and age did not significantly contribute to the models, suggesting that age 
nor BMI have a significant association with total HRQOL. However, this study did find a 
significant correlation of total HRQOL and symptom severity and BMI. The correlations 
of the total HRQOL summed score (DV) with symptom severity (IV), BMI (IV) and the 
covariates (age, relative, missed work) are displayed in Table 10. All the correlations of 
the IVs to the DV are significant indicating that symptom severity and BMI have a linear 
relationship with total HRQOL summed score. The literature reviewed found estrogen 
levels and elevated BMI among African American women, place them at increased risk 
for developing UF (Faerstein, Szklo, & Rosenshein, 2001; Flake, Andersen, & Dixon, 
2003). The correlation of BMI, symptom severity and total HRQOL in this study 
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provides support for the role that BMI may have in the increased development among 
African American women should be further examined.  
For research questions 10 -12, there was no significant association of general 
health perception and HRQOL total score. Therefore, this study failed to reject the null 
hypotheses for questions 10 -12. Given the significant association between symptom 
severity and total HRQOL for this study, the findings general health perceptions and total 
HRQOL are not associated in this study is an interesting find. Since general health 
perceptions largely examines the respondents’ view of their total health and is not 
specific to UF symptoms alone, it may suggest that general health perceptions is not a 
significant predictor for examining HRQOL among African American women with UF. 
While total HRQOL summed score was not significantly associated with general health 
perceptions, the two variables were significantly correlated in this study. General health 
perceptions (r = -.254, p = .023) as the DV and total HRQOL summed score as the IV has 
a linear relationship in this study (see Table 14). The negative correlation indicates higher 
total HRQOL summed score suggest an increased negative impact of uterine fibroids on 
the respondent’s health related quality of life occurs as general health perceptions 
decreases. If a correlation between these two variables exists as suggested by this study 
findings, the connection can be vital for the research community and more investigation 
is warranted. 
The literature reviewed for this study lacked empirical studies that examined all of 
the predictors of HRQOL in the manner that was attempted in this study. This study 
attempted toaddress  that gap in the literature; some reliable measures of HRQOL were 
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obtained in spite of the sampling’s limitations. The findings in the current study 
demonstrate that symptom severity has a significant association with functional status 
and total HRQOL. More specifically, the findings of this study aided in determining how 
various elements in the participants’ life (concern, energy/mood, activities, sexual 
function, self- conscious, concern, and employment history) were significantly associated 
with symptom severity. Conversely, in this study the following variables, symptom 
severity and total HRQOL are not significantly associated with general health perception, 
or overall quality of life even when controlling for covariates such as BMI, family hx of 
UF diagnosis, and age. Therefore, other variables that could be used to explore factors 
associated with HRQOL among African American women age 30 to 45 years with UF 
should be further explored. 
Limitations of the Study 
This was an exploratory non- experimental quantitative study design utilizing a 
survey instrument. The data were collected electronically. The population was identified 
because of their increased risk for UF development. The researcher attempted to broaden 
the sample by using three organizations (RGR, MRACDST, and SMLACDST) with a 
wide-ranging base of African American women. Several limitations were identified that 
could limit the generalizability of the findings. Overall, the limitations involve 
respondents characteristics/demographics, sample size, survey administration, and self-
reporting of information. 
 The first limitation involved use of a convenience sample which included only 
African American women ages 30 to 45 years. The age inclusion for this study was 
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specific to women who were ages 30 to 45 years because research has demonstrated this 
age range among African American women are at an increased risk for UF development. 
The average age was 39.2 years for the respondents of this study. Research has indicated 
that African American women are diagnosed at a higher rate and suffer more from UF 
when compared to women from other racial and ethnic backgrounds (Davis et al., 2009; 
ORWH, 2006; NIH, 2011; Wise et al., 2005b). Therefore, this study only included 
women who self-identified their race as being black or African American. According 
toTaran, Brown, & Stewart (2010) there has been limited reporting of the participants 
race and ethnicity within the studies associated with UF. Racial diversity in the sample 
population was lacking in that this researcher only sought to explore HRQOL factors 
among African American women only between the ages of 30 to 45 years to help fill that 
gap in literature. However, only having African American women between the ages of 30 
to 45 years limited generalizability of this study findings to women from other racial and 
ethnic backgrounds and those outside of the specified age range. 
 The second limitation of the study was the small sample size. A total of 103 
surveys were received. Twenty three were excluded from the study leaving a total of 80 
who were included in the study. While the actual study sample size obtained for the study 
was sufficient enough to be adequately power the study, a larger sample size may have 
produced stronger statistically reliable results. 
 The third limitation of the study was that the survey was based online and only 
administered electronically. While electronic administration of the survey was more 
feasible and allowed participants to support this research anonymously, it also meant that 
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only women who had access to a computer and the internet could respond to the survey. 
Therefore, economically or educationally advantaged African American women are more 
likely to have responded to the survey. Subsequently, the experiences of African 
American women with UF from lower socio-economic communities may be 
underrepresented in the study findings.  
 The fourth limitation was that participants self-reported personal health data such 
as history of UF diagnosis and no history of treatment for UF. In order to increase the 
likelihood of participants having a diagnosis of UF, they were asked if they had been 
informed by a health practitioner that they had a diagnosis of UF. Additionally, 
participants were asked to self-report information such as height, weight, race, and if they 
had received medical treatment for UF. There was lack of access to participants’ medical 
records by the researcher in order to confirm height, weight, race, and treatment history 
of UF by the participants. Therefore, it is likely that some women with UF were excluded 
from the study because they have yet to seek medical attention or receive a preliminary 
diagnosis from a health practitioner which could have potentially increased the number of 
women eligible to participate in the study. In addition, the study findings are limited to 
those women with a first time diagnosis because a sub section of women with a second 
diagnosis of UF were excluded because they may have received treatment in the past but 
their UF have returned.  
Recommendations 
There is limited documentation on symptoms associated with UF and the impact 
of UF symptoms on HRQOL African American women ages 30 to 45 years. The results 
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from this study added important information to the current knowledge base in this area. 
In addition, the results from this study provides valuable information on the symptoms 
and specific functional elements (concern, activities, energy/mood, self- conscious, 
sexual function, and control) that influence HRQOL among African American women 
ages 30 to 45 years that have been diagnosed with UF. More importantly, the findings 
from this study help promote the need for continued research that is patient centered and 
focused on African American women whose lives are more likely to be impacted 
negatively by UF.  
The revised Wilson and Cleary revised model of HRQOL has been reviewed in 
depth in previous sections of this paper. No previous studies were found that used this 
conceptual framework to investigate the impact of symptom severity on HRQOL among 
African American women ages 30 to 45 years with UF. While this model was found to be 
effective in this study in exploring multiple factors that can influence HRQOL among 
women diagnosed with UF, each component of the model needs continued research to 
determine which factors can best influence HRQOL. The present study used the revised 
Wilson and Cleary model of HRQOL as the foundation to investigate the following 
factors: BMI, symptoms, functional status, overall quality of life, general health 
perception, characteristics of the individual, and characteristics of the environment 
among African American women age 30 to 45 years with a diagnosis of UF. Functional 
status, symptoms (severity), and employment history one of the characteristics of the 
environment were important and significant determinants of HRQOL. Because only these 
three model components were significant in the overall model, other variables which 
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might explain HRQOL among women with UF need to be reviewed and examined. 
Subsequently, further studies using this model examining factors associated with UF and 
HRQOL are needed. 
 Employment history, as one of the two variables selected for characteristics of 
the environment in this study was found to have a significant association with HRQOL. 
Based on this finding, the impact UF symptoms has on job performance and potential 
work loss specifically among African American women with UF should continue to be 
examined. Age, as the only characteristics of the individual and BMI one of the two 
characteristics of the environment selected for this study were insignificant. The 
association of age and BMI with HRQOL among African American women with UF 
remains unclear. However, BMI was found to have a significant correlation with total 
HRQOL score. The finding that BMI is significantly correlated to the total HRQOL score 
suggests that additional investigation is warranted to determine a more specific 
correlation between BMI and health related quality of life among women with UF.  
The convenience sample in this study was different from most of the literature in 
that it only included African American women ages 30 to 45 years, thus limiting the 
generalizability. African American women are likely to be diagnosed up to three times 
more when compared to their Euro American, Asian, and Hispanic counterparts 
(Moorehead and Conrad, 2001; NIH, 2011). Therefore, it was important to focus this 
research on the community of women likely to be impacted by UF at an increased rate 
when compared to their racial counterparts. Stakeholders may benefit from this study by 
understanding and identifying the specific areas in health and the daily lives of African 
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American women ages 30 to 45 years that are most affected by UF. More specifically, 
Women’s health care professionals could more routinely incorporate communications 
related to the particular areas of HRQOL that may be impacted and identify some of the 
barriers to care that exist among African American women with UF. Additionally public 
health professionals could help with development of educational materials; thereby, 
playing a vital role towards ensuring current and relevant information is available to 
support delivery of sensitive and thoughtful care related to treatment of UF. 
Implications for Social Change 
Significant association between some of the predictor variables and symptom 
severity and total HRQOL was found in this study. Data on HRQOL associated with UF 
show that women with UF have significantly lower HRQOL scores when compared to 
those women without this condition (Pron et al., 2003; Spies et al., 2002). In order to 
provide sensitive patient centered care women’s health care professionals need to have an 
understanding about the specific distresses that are experienced by women diagnosed 
with and suffering from UF. Researchers Harding et al. (2008) implied that more research 
that focuses on patient-reported outcomes about the problems and issues associated with 
UF symptoms are needed for the development of patient centered care options and to 
potentially improve patient outcomes. The rate at which African American women are 
diagnosed, the negative impact UF symptoms can have on HRQOL, and the burden of 
increased usage on healthcare systems for treatment of UF make this chronic and 
progressive health condition a growing public health concern (ORWH, 2006; NIH, 2011). 
This study’s social change implication involves providing information that can stimulate 
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health care providers in the development of health maintenance programs that are 
sensitive to the needs of African American women diagnosed with UF. Research suggests 
that African American women with UF are actively seeking out information related to UF 
symptoms and ways they can minimize those symptoms from impacting their lives 
(Ankem, 2007). Another social change implication for this study is that public health 
professionals and American medical organizations also can be motivated to increase the 
availability of information related to UF symptoms and the impact of UF symptoms on 
HRQOL. Thereby, supporting increased education and awareness about a chronic health 
condition that is likely to impact at least 1 in 3 African American women in their lifetime. 
These combined efforts can positively support the continued well-being of African 
American women diagnosed with UF and encourage more dialogue to help minimize the 
current culture of suffering in silence (Cambridge & Sealy, 2012) noted among African 
American women diagnosed.     
Summary 
Uterine fibroids are a medical condition with wide spread symptoms that occur 
among women of all races. According to the Office of Research on Women’s Health 
(2006) approximately one quarter of all women in the United States of reproductive age 
have symptomatic UF. African American women however, are diagnosed up to three to 
nine times more often when compared to Caucasian women (NIH, 2011). In addition, 
there is a higher prevalence among African American women of child bearing age 
compared with women of other races (Davis et al., 2009; Wise et al., 2005b). Research 
has identified that UF symptoms and the problems associated with UF symptoms can 
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affect the HRQOL among women diagnosed. Often times women who are diagnosed 
with UF that experience prominent symptoms seek treatment because of the difficulty 
they encounter with managing the symptoms effectively and the negative burden UF 
symptoms can have on HRQOL.  
Currently, much of the research related to UF is centered on identifying the most 
efficacious medical treatment options for removal of UF that would decrease the 
extended time of recovery and still allow women of childbearing age the option to keep 
their uterus intact supporting improved quality of life. This study attempted to obtain 
empirical evidence from an existing population of African American women ages 30 to 
45 diagnosed with UF regarding the symptoms associated with UF and the impact of UF 
symptoms on their HRQOL. Participants reported a significant association with symptom 
severity and total health related quality of life and symptom severity and all of the health 
related quality of life subscale variables or functional status. More specifically 
participants noted at least some to a little distress in the areas of concern, activities, 
energy/mood, self- conscious, sexual function, and control as it’s related to the symptoms 
associated with UF. Participants also reported that symptom severity did negatively 
impact their employment leading to days missed from work. General health perception, 
overall quality of life, BMI, age, nor family hx of UF diagnosis did not show a significant 
relationship with HRQOL.  
Uterine fibroids is a chronic condition, which can be debilitating to the health and 
lives of women who experience severe symptoms. African American women who have 
been diagnosed with UF face a myriad of issues related symptom management, treatment 
172 
 
 
options, increased financial burden, and interruption in their daily lives. Aiding African 
American women and health professionals understanding of the problems associated with 
UF symptoms and how they influence HRQOL can impact decisions related to treatment 
options and how to better manage symptom. For that reason, continued exploration into 
the personal health factors associated with UF and their specific impact on HRQOL is 
warranted to further highlight factors that can influence HRQOL. Therefore, future 
research particularly on the effects of factors that are related to UF symptoms impact on 
HRQOL is recommended to support an enhanced personal sense of well-being for 
African American women diagnosed.  
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Appendix A: Consent Form 
 
You are invited to participate in a research study of health related quality of life in 
African American women. You have been selected as a possible participant because you 
identify yourself as African American, female, current diagnosis of UF and between the 
ages of 30-45 years. Please read this form. This form is part of a process called “informed 
consent” to allow you to understand this study before deciding whether to take part. 
  
This study is being conducted by: Ilisher Ford, doctoral candidate at Walden University. 
 
Background Information: 
The purpose of this study is to explore symptom severity associated with uterine fibroids 
and the impact of UF symptoms on health related quality of life. Participants in this study 
will represent African American women ranging in age from 30-45 with a current 
diagnosis of UF and have not received any surgical treatment for uterine fibroids. The 
participants in this study will be members of a community service organization and a 
running group for women. The findings of this study will assist the Public Health 
community in effectively exploring the factors that are associated with uterine fibroids 
among African American women. 
 
Procedures: 
If you agree to participate in this study, you will be asked to do the following things: 
Review this consent form, complete a 37 item questionnaire, and complete a form with 
background information about you.  
 
Voluntary Nature of the Study: 
PLEASE NOTE:  You have the freedom to decide not to participate in this study. Your 
participation in this study is strictly voluntary. Your decision whether or not to participate 
will not affect your current or future relations with the researcher or your organizational 
affiliation. If you initially decide to participate, you are still free to withdraw at any time 
later, without affecting those relationships.  
 
Risks and Benefits of Participation: 
Being in this type of study involves some risk of the minor discomforts that can be 
encountered in daily life, such as fatigue, stress or becoming upset. Being in this study 
would not pose risk to your safety or wellbeing. 
 
 
PLEASE NOTE: in the event you experience stress or anxiety during your participation 
in the study, you may terminate your participation at any time. You may refuse to answer 
any questions you consider invasive or stressful. You may also seek additional counsel 
with Cobb and Douglas Community Services Boards, call ________ or Dekalb 
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Community Services Board, call __________, should you feel any anxiety or stress as 
a result of your participation in this study. 
Compensation: 
There is no compensation to be gained from participation in this study. 
 
Confidentiality: 
The records of this study will be kept private. In any report of this study that might be 
published, the researcher will not include any information that will make it possible to 
identify you as a participant. Research records will be kept in a locked file; only the 
researcher will have access to the records. 
 
Contacts and Questions: 
The researcher conducting this study is Ilisher Ford. The researcher’s adviser is Dr. 
Precilla L. Belin, PhD, MA, CHES. You may ask any questions you have now. If you 
have questions later, you may contact her at ____________. The Research Participant 
Advocate at Walden University is __________; you may contact her at ___________, if 
you have questions about your participation in this study. Walden University’s approval 
number for this study is ________ and it expires on ___________.  
 
 
 
Thank you for participating! Please print or save this consent form for your records.  
 
Statement of Consent: 
 
I have read the above information and I feel I understand the study well enough to make a 
decision about my involvement. By clicking the identified link, I understand that I am 
agreeing to the terms described above. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
189 
 
 
Appendix B: Screening Information 
 
 
 
Instructions: PLEASE READ CAREFULLY 
This section asks four questions that may or may not describe some general 
characteristics about you. The information obtained from this form will be kept private 
and confidential. PLEASE DO NOT LIST ANY NAMES OR INCLUDE ANY 
PERSONAL IDENTIFYING INFORMATION WHEN COMPLETING THIS FORM. 
 
Direction: Please select the one response that best fits your current status. 
 
1. Do you identify yourself as Black/African American? YES or NO  
 
2. Have you ever been informed by a medical healthcare practitioner (Medical 
Doctor, Nurse Practitioner, Physician Assistant) that you have a diagnosis of 
Uterine Fibroids? YES or NO 
 
3. Are you currently between the age of 30 to 45 years? YES or NO 
 
If you responded NO, to any one of the three questions above, please STOP here and do 
not proceed forth with completion of the survey.  
 
 If you responded YES to all three of the questions above please proceed forth to the next 
question. 
 
4. Have you ever received medical treatment in the form of Uterine Fibroid 
Embolization, Myomectomy, or Hysterectomy for your Uterine Fibroids? YES or 
NO 
 
If you responded YES to the question above, please STOP here and do not proceed forth 
with completion of the survey.  If you responded NO, to the question above, please 
proceed forth to the next section. 
 
Thank you for your time and willingness to support this research project. 
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Appendix C: Demographic Information Form 
 
 
 
Instructions: PLEASE READ CAREFULLY 
This section asks questions that describe some general characteristics about you and your 
family. This information helps us to understand general characteristics of the people who 
have completed this survey. The information obtained from this form will be kept private 
and confidential. PLEASE DO NOT LIST ANY NAMES OR INCLUDE ANY 
PERSONAL IDENTIFYING INFORMATION WHEN COMPLETING THIS FORM. 
 
Direction: Please fill in the blank or select the response that best fits your current status 
 
1) How old are you?  
        Age: __________ in years 
 
2) What is your current height? ________ Feet ______ Inch(es) 
  
3) What is your current weight? ______lbs 
        
 4) Have you ever missed days or time off work as a direct result of the symptoms you 
have experienced from Uterine Fibroids? 
 
Yes _____ 
 No _____ 
I do not know ______ 
  
5) Has anyone in your immediate (e.g. mother, sister, grandmother, aunt) family ever 
been diagnosed with UTERINE FIBROIDS?  
   
Yes _____  
No ______ 
I do not know ______ 
 
 
6) If your response to question five (5) is YES, please select all that apply. 
 
 Mother _____ 
Aunt _______ 
Grandmother ______ 
Sister _______ 
I do not know ______ 
Not Applicable ______ 
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7)  How would you rate your current health on a scale from 1 to 10 (with 1= poor and 10 
= excellent)? ________ 
  
8)  How satisfied are you with your overall life in general on a scale from 1 to 10 (with 1 
= poorly satisfied and 10 = very satisfied)? __________ 
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Appendix D: Survey Instrument 
 
            
 
 
 
 
©Copyright 2015 SIR Foundation. All rights reserved. 1 
f:\institut\cultadap\project\hc1617\question\original\final\ufsoriq.doc-21/12/2001
Please do not include your name or 
any personal identifiers on this form. 
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Appendix E: Research Survey Instrument Permission Document 
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Appendix F: Homogeneity of Variance Assumption Tests, Research Questions 1 Through 
6 
 
Figures used to test the homogeneity of variance assumption. 
Research Question 1 through Research Question 6. 
 
 
  
 
Figure F1. RQ1 - concern                     Figure F2. RQ2 activities 
 
  
 
Figure F3. RQ3 - energy/mood                  Figure F4. RQ4 control 
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Figure F5. RQ5 - self-consciousness           Figure F6. RQ6 sexual function 
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Appendix G: Homogeneity of Variance Assumption Tests, Research Questions 7 
Through 9 
 
Figures used to test the homogeneity of variance assumption. 
Research Question 7 through Research Question 9 
 
 
  
Figure G7. RQ7 - IVs = severity, BMI         Figure G8. RQ8 - IVs = severity, BMI, age 
 
 
  
 
 
Figure G9. RQ9 - IVs = severity, BMI, employment history, family history 
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Appendix H: Homogeneity of Variance Assumption Tests, Research Questions 10 
Through 12 
 
Figures used to test the homogeneity of variance assumption.  
Research Question 10 through Research Question 13. 
 
 
 
  
 
  
Figure H10. RQ11 - IVs = severity, HRQOL      Figure H11. RQ11 - IVs = severity,  
total score                                         HRQOL total score, age 
 
 
  
 
Figure H12. RQ12 - IVs = severity,   Figure I13. Scatterplot to test homogeneity 
HRQOL total score, employment history, of variance for RQ13. 
family history 
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